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Abstract 
Background: Stress during early life such as exposure to prenatal and postnatal 
depression or receiving reduced levels of parental care can produce long-lasting 
behavioural effects. Such long-term disruptions in stress-related behaviours have been 
seen in both human and rodent studies in offspring exposed to a variety early-life 
stressors such as maternal depression. Importantly, offspring exposed to early life stress 
have increased susceptibility to maternal depression themselves suggesting a mechanism 
by which stress could be intergenerationally inherited through maternal stress. 
Aims: The overall aim of this study was to explore the major possible mechanisms 
underlying how maternal stress and reduced care is able to increase the risk of developing 
stress-related behavioral disorders in the offspring. This included: 1) programming 
neuroendocrine and immune changes; 2) epigenetic alterations driving changes in 
regulation of stress-related genes; 3) alterations in endocrine and immune factors in milk. 
Methods: This study investigated a rat model of intergenerational inheritance of maternal 
depressed maternal care stress and two human studies of maternal depression. 
Endocrine and immune factors were measured using ELISA and epigenetic changes in a 
rat model and 2 human cohorts using bisulphite pyrosequecning. RNASeq was used to 
investigate genomewide RNA, transcriptome, changes across generations.  
Results: A literature review found supporting evidence for the hypotheses and revealed 
key targets for endocrine, immune and epigenetic regulation that became a focus of the 
following studies. Analyses in Study 1 showed alterations between the generations in 
endocrine factors important for stress and maternal care with further changes in specific 
immune factors and epigenetic alterations at key genes involved in stress regulation.  
Tanscriptome analyses in Study 2 revealed changes in genes important for calcium binding 
signaling and levels of shared gene expression between generations. Epigenetic 
investigations in Study 3 found associations with maternal depression and stress with at 
at homologous gene regions tested in Study 1 suggesting a level of conservation in 
v 
 
mechanisms important for stress regulation in maternal depression. Within Study 4  milk 
from stressed dams there were reduced levels of endocrine stress factors important in 
regulation of stress and maternal behavior. 
Conclusions: This thesis found important evidence to support the involvement of immune 
and endocrine factors in the transmission of maternal stress together with epigenetic 
changes at key genes and transcriptome alterations. 
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1 Chapter 1: Literature review 
 
1.1 Introduction 
 
Perinatal maternal depression is associated with an increased risk for stress-related 
behavioral and emotional problems in the offspring (Murgatroyd and Spengler, 2011a). 
Prenatal and postnatal stress and maternal depression may impact offspring through 
possibly different pathways. For example, during pregnancy maternal stress may 
influence intrauterine environment and so impact alterations in neurodevelopment of the 
growing foetus. Postnatal maternal depression could influence offspring through 
variations in parental care that could be influenced by stress and in turn may induce 
stress-related behaviours in the offspring. One might therefore consider that prenatal and 
postnatal maternal depressive symptoms might independently influence development of 
stress-regulatory pathways in offspring. A further concept is that offspring exposed to 
perinatal stress and maternal depression have increased risks for developing maternal 
depression themselves. It is therefore possible that such maternal depression could be 
inherited through multiple generations. Such generational inheritance can be referred to 
as intergenerational. It is important to clarify this terminology. In inter/trans-generational 
inheritance it is speculated that an environmental factor induces a epigenetic change: the 
term intergenerational would refer the adult female animal (F0) and the first (F1) and 
second (F2) generation of offspring being effects because the adult, the foetus, and the 
primordial germ cells in the foetus would be directly exposed to that particular 
environmental factors. Transgenerational would refer to subsequent generations (i.e. F3 
and F4 etc.) also being affected in the absence of exposure to the particular 
environmental factor (Skvortsova et al., 2018). Such epigenetic factors could be important 
in driving inheritance of stress-related behaviours across generations, possibly in 
combination with perinatal postnatal behaviour or prenatal uterine environment.  
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Dysregulation of the stress-regulatory Hypothalamic-Pituitary Adrenal (HPA) axis is a 
major component of depression. A possibility is that the dysregulation of this in prenatal 
and postnatal depression could program alterations in the function of the HPA axis in 
offspring. Further possibilities are altered regulation of key hormones important in 
controlling maternal behavior or other neuropeptides important in depression. If these 
might be alternatively regulated in the mother then prenatal effects might be seen 
through the placenta or postnatal changes through inducing depressed maternal care. 
We should also consider the immune system and the role that inflammation plays in 
depression and the stress-response. Immune changes are well described effects of early 
stress (Murgatroyd, 2018) 
The possibility is that there may be large numbers of genes impacted by maternal 
depression and early life stress. For example a recent large genome-wide expression 
study has found that some psychiatric disorders, including depression, share global gene 
expression patterns (Gandal et al., 2018). One question is whether such changes might be 
by the next generation.  
Finally, there is possible role of lactation. If maternal depression might influence factors 
in the milk that might in turn influence stress-related behavior of the offspring. Milk 
contains numerous important endocrine and immune factors that might influence the 
suckling offspring. 
Studying a rodent model of transgenerational stress and maternal depression allows to 
investigate these components and test these hypotheses. It is also important to 
investigate whether such hypotheses might also translate to human studies. 
This review chapter investigates these different hypotheses and collects information form 
relevant studies that will help to inform the subsequent chapters that explore each of 
these possible mechanisms. 
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1.2 Aims  
The aim of this part of this literature review is to collect ideas and mechanisms important 
in the intergenerational inheritance of depression. Studies from a rat model have shown 
that maternal behavior is a key driver of this; however, it is unclear at the molecular level 
as to how this is driven. Using rat studies and human findings, the chapter explores the 
possible role of specific stress, endocrine and immune factors, together with epigenetic 
changes, transcriptome alterations and changes in milk factors. 
As well as exploring any mechanisms, this chapter also looks to identify key factors that 
can be tested in a rat model and the possible translational value to human studies. This 
thesis is novel in that it looks to explore several key hypotheses by which stress may be 
transgenerationally inherited, using both rodent models and human cohorts. 
 
1.3 Objectives  
1. Investigate and identify specific stress-related factors and hormones involved in the 
possible intergenerational transmission of maternal behavior and depression. 
2. Investigate the possible role of immune factors in the intergenerational transmission 
of maternal behavior and depression. 
3. Identify possible epigenetically regulated candidate genes that might be involved in the 
intergenerational transmission of maternal behavior and depression. 
4. Explore the possible role of stress in the regulation of milk factors and identify key 
hormones that might be involved in the intergenerational transmission of maternal 
behavior and depression. 
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1.4 The regulation of stress and depression 
  
1.4.1 Depression  
Depression is a well-defined mental health condition; the Diagnostic and Statistical 
Manual of Mental Disorders—Fourth Edition (DSM-IV) is used in the USA, while the ICD-
10 (International Statistical Classification of Diseases) is used worldwide. DSM-IV defines 
a depressive episode as low mood or anhedonia (loss of interest in previously enjoyable 
activities) for a minimum of two weeks. Major depression disorder has a significant 
impact on society, as it is the most prevalent mental health condition, and is the biggest 
medical burden to middle-aged members of the public. About 80% of patients with a 
depressive episode will have a recurrence at some point in their life. In developed 
countries, it is the largest cause of disability; approximately 1 in 10 people suffer from 
depression each year, and approximately 2 in 10 will develop depression within their 
lifetime (Juruena, 2014). As depression has such a significant impact on public health, 
diagnosis and treatment is effective. Current treatment of depression is not effective, 
with 30-50% of patients not responding to antidepressant therapy (Juruena, 2014). 
It is well known that stressful life events predispose to the development of depression, 
particularly early life stress in the form of childhood adversity is known to significantly 
increase the risk of depression and anxiety in adult life; about 25-33% of children exposed 
to maltreatment develop  major depression in adulthood (Raine, 2002; Heim and Binder, 
2012; Baes et al., 2014; Juruena, 2014). There is a wide range of early-life stressors and 
early traumatic experiences that affect society such as parental loss, childhood illness, 
family violence, and neglect i.e. deprivation of food, clothing, shelter, and love. 
It is thought that genetic differences, gender, personality and family history, combine 
with environmental factors, as early-life stressors, as mechanisms that underlie the risk 
for the development of major depression (Heim and Binder, 2012).  
5 
 
1.4.2 Maternal Depression 
Postnatal depression afflicts from 10% to 20% of mothers following birth. The risk factors 
linked to development of postnatal depression include prior history of depressive 
disorder and/or premenstrual dysphoric disorder, depression during pregnancy, 
inadequate social support, and negative life events. Unlike the more common “baby 
blues,” reported1 to effect more than 50% of new mothers, postnatal depression can 
engender long-term risks to children including cognitive and behavioural problems (Biaggi 
et al., 2016).  
Mood and anxiety disorders in the prenatal and postnatal period affect a large number of 
childbearing women, and carry a significant risk to the well-being of mother and child. A 
review by Choi (Choi and Sikkema, 2016) found evidence to suggest that mood and 
anxiety disorders in the prenatal period, are a significant predictor of negative obstetric 
and infant/child outcomes. Postnatal mood and anxiety disorders were found to disrupt 
mother-child bonding, and cause problems with child growth and long-term development 
(Choi and Sikkema, 2016) 
In the prenatal period, the foetal brain is developing and growing with significant 
plasticity. Hence, having a better understanding of prenatal stress is important in order 
to understand how exposure to stress during this key period affects development of 
mental health in the offspring (Cruceanu et al., 2017). In the postnatal period, mother-
offspring interactions also affect the development of the plastic brain; tactile and 
olfactory stimuli have particularly been implicated as important to the developing brain. 
For instance, preterm human infants demonstrate enhanced growth and 
neurodevelopment when stimulated by touch, and maternal tactile stimulation can 
attenuate infant stress responses. The activation of neural pathways can be stimulated 
by maternal odours the offspring associates with its early rearing environment. This 
response to odours at the neural level is enhanced when combined with tactile 
stimulation in the form of licking (Kingston and Tough, 2014). 
It is important to note that although they are usually studied separately, there is high 
correlation between prenatal and postnatal stress. Therefore, a mother with a history of 
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mental illness or abuse during childhood exposes the foetus to prenatal stress, and is 
more likely to expose the baby to postnatal stress due to increased risk of dysfunctional 
mother-infant bonding, or child abuse etc. As a result, it can be difficult to study prenatal 
and postnatal stress independently, as they go hand in hand (Cruceanu et al., 2017). 
However, it is important to distinguish the effects of prenatal compared with postnatal 
stress on offspring to allow testing the relative effect of maternal mental health compared 
to various postnatal factors, which may help identify which periods and factors have the 
most important effect on child development. It is also important to know which period 
is more crucial i.e. prenatally or postnatally, due to allows for possible treatments 
(Kingston and Tough, 2014). (Brummelte and Galea, 2016) (Figure 1.1) shows a schematic 
of the effect of the prenatal depression and postnatal care on infant development. 
Figure 1.1. Association between prenatal depression, mother-infant interaction and child cognition. Prenatal 
depression, mother-infant interaction could contribute to impaired neurobiological development of child.  
 
1.4.3 The endocrine regulation of stress 
Our neuroendocrine system is key to the regulation of the stress response. A stress 
response is the way in which an organism responds to sudden changes in their 
environment, either physical or emotional that may disrupt their homeostasis (Babenko 
et al., 2015). This response is important to allow the organism to maintain homeostasis 
and to deal with changes in environments whether they be actual, anticipated, or even 
perceived. Stress either perceived through visual, audial, olfactory, and sensory or 
cognitively can activate various parts of the brain that connect to the hypothalamus and 
stimulate the HPA axis by causing the release of corticotrophin-releasing hormone (CRH) 
and arginine vasopressin (AVP) from the paraventricular nucleus (PVN) of the 
hypothalamus. CRH and AVP stimulate the release of adrenocorticotrophic hormone 
7 
 
(ACTH) from the anterior pituitary gland. This in turn stimulates the secretion of 
glucocorticoids which are the main stress steroids, from the adrenal cortex. In humans, 
the major stress glucocorticoid is cortisol, while rodents release a related steroid, 
corticosterone. Negative feedback occurs via cortisol or corticosterone binding to a 
receptor in cell called the glucocorticoid receptor (GR) which is able to bind at GR binding 
sites in genes allowing to regulate these neuropeptides and allow levels to return back to 
baseline once homeostasis is restored (Nephew et al., 2017)  (Figure 1.2).  The HPA axis 
is therefore key to the regulation of the stress response.  
 
Figure 1.2. Schematic of the Hypothalamic Pituitary Axis (HPA). The HPA is activated and releases CRH and AVP from 
the hypothalamus. This induces the release of ACTH from the pituitary that stimulates the release of cortisol from the 
adrenal cortex into the circulation into blood. Cortisol induces many of the responses associated with stress. Cortisol 
also dampens activity of the immune system. Cortisol negatively feedback inhibits HPA axis activity at the pituitary, 
hypothalamus and hippocampus.  
 
A stress response generally promotes survival as it forces an organism to rapidly adapt to 
a sudden change in an environment. Stress may be acute or chronic. Acute stress is 
characterized by a danger that suddenly occurs and may activates what is known as a 
fight-or-flight response. For example, an organism needs to quickly decide to run, fight or 
hide in the presence of a predator. This is usually regulated through adrenaline release 
from the adrenal glands. Chronic stress is characterized by the persistent presence of 
sources of stress that an organism might encounter every day, such as for example the 
constant presence of a nearby predator. This type of stress may involve long-term 
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stimulation of the fight-or-flight response and involves the neuroendocrine pathway 
known as the hypothalamic-pituitary-adrenal (HPA) axis. However, when a stress 
response is too strong or continually activated, or exaggerated in relation to the perceived 
stress, disease or death of an organism may result (Murgatroyd and Spengler, 2011a). 
Humans respond to stress through the same basic endocrine mechanisms described 
above, similar to all other organisms. However, in humans, stress is a very complex 
phenomenon, influenced and resulting from numerous environmental changes that may 
vary in the level of their actual physical or emotional threats.  
 
1.4.4 The role of early-life stress and the HPA axis in depression 
 
Some stressors at specific periods in an organism’s life, especially during early life and 
development can cause long-lasting alterations to the neuroendocrine system. For 
example, early life stressors can cause changes to physiology and behaviour that are long 
lasting together with long-lasting alterations of the HPA axis. Rodent studies in the 
literature, show changes to the HPA axis such as increased glucocorticoid response to 
subsequent stressors, increased plasma levels of ACTH, reduced GR expression in the 
hippocampus, as well as changes in CRH and AVP in the hypothalamus (Murgatroyd and 
Spengler, 2011a).  
There is much evidence reporting that early life stress can induce long-term dysfunction 
of the HPA, which carries on in to adult life. This dysfunction increases susceptibility to 
depression; hyperactivity of the HPA axis in major depression is one of the most well 
defined findings in psychiatry (Juruena, 2014). HPA hyperactivity is characterized by 
chronically increased secretion of CRH, decreased negative feedback, and increased 
circulating ACTH and cortisol. A significant proportion of patients with major depression 
have increased concentrations of cortisol, an inappropriately high cortisol response to 
ACTH, as well as pituitary and adrenal enlargement (Murgatroyd and Spengler, 2011a). 
Although the mechanism underlying the HPA dysfunction is unclear, one proposed 
mechanism is that circulating glucocorticoids lead to an impairment of feedback 
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inhibition. The observed changes to the HPA axis usually improve after the depressive 
episode has resolved (Holsboer, 2000).  
1.4.5 The role of the neuroendocrine system in regulating maternal behaviour and 
alterations following early-life stress 
 
Maternal care involves the consistent and coordinated expression of a variety of 
behaviours over a period of time. Adverse changes in maternal care can have profound 
impacts on neurodevelopment and behaviour of offspring. This complex behavioural 
pattern depends on a number of integrated neuroendocrine mechanisms involving, 
amongst others, the actions of the stress HPA hormones (CRH), (AVP), oxytocin, and 
prolactin (Murgatroyd and Nephew, 2013). Some of these factors important for maternal 
behavior, such as oxytocin and prolactin are also regulated following exposure to a 
stressor, as part of the HPA axis (Slattery and Neumann, 2008).  
 
1.5. Intergenerational inheritance of stress and depression 
 
1.5.1 Impact of maternal depression on stress-related behaviour of offspring 
 
Alterations in social behaviour are well known in offspring (in both human and rodent 
studies) exposed to early life stressors such as reduced maternal care or maternal 
depression (Murgatroyd et al., 2015a). Another aspect is that earlier exposure to early-
life stress can increase the risk for those individuals to develop postnatal depression 
(Heim and Binder, 2012; Heim and Nemeroff, 2001). 
There is much evidence for the observation that exposure to maternal depression can 
predispose to depression in later life. One study found that in those who experienced 
multiple adversities during childhood, the risk of developing depression increased up to 
4-fold (Felitti et al., 1998). In addition results from another study showed a correlation 
between early life stress and the development of mental health conditions in adult life; 
the more severe the childhood adversity, the more likely to develop depression in later 
life (Edwards et al., 2003). Numerous national studies such as the National Comorbidity 
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Survey (Molnar et al., 2001) , the Ontario Health Survey (MacMillan et al., 2001) and a 
New Zealand community survey (Mullen et al., 1996) all reported similar results, where 
early life adversity increases risk of depression. Even twin studies have demonstrated 
concordant findings of early life stress having a role, beyond genetic factors (Kendler et 
al., 2000; Heim and Binder, 2012). 
Studies have shown long lasting effects of early life stress on the brain and its stress 
regulatory HPA system, may lead to the development of a vulnerable phenotype with 
increased sensitivity to stress and risk for a range of behavioural stress related disorders. 
Support for this hypothesis comes from a numerous studies in animal models that provide 
the direct and causal evidence that early adverse experience, such as maternal separation 
or variations in low or high levels of maternal care, lead to changes in HPA regulation a 
connected network of brain regions  (Sanchez et al., 2001; Talge et al., 2007; Lupien et al., 
2009). These effects appear to be present across species and in different models of 
adversity involving, stress in early life. 
A review by Kingston and Tough (Kingston and Tough, 2014) on human studies showed in 
that there was a small to moderate effect of prenatal distress on behaviour, and social 
development in school-age children. In addition, almost 70% of the studies demonstrated 
a significant association with these traits and postnatal depression.  
Research using various animal models and studies in human populations have shown that 
prenatal and postnatal stress can induce a long-lasting effect stress-related behaviour in 
the offspring (Murgatroyd and Spengler, 2011a). 
The early maternal environment of an offspring can have long lasting effects. In rodents, 
the behavior of mother rats (dams) in the early postnatal life can may affect how the 
babies (pups) respond to stress, and subsequently how they mother their own offspring. 
This can relate to circumstantial outcomes as a result of particular actions by the mothers, 
like interaction through touch, for example arch-back nursing, licking and grooming 
(Meaney, 2010). This has been shown, in seminal studies, to induce increased levels of 
Glucocorticoid Recepter (GR) and increased HPA axis feedback (leading to more 
controlled regulation), and lower levels of depression and stress-related behaviors as well 
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as reduced levels of fear. This licking and grooming have been shown to induce epigenetic 
regulation of the GR gene promoter in the hippocampus of the pups (Weaver et al., 2006). 
Further studies have shown that such postnatal behaviours like increased care by 
unstressed mothers can reduce the effects of stress and promote hippocampal 
neurogenesis, as well as influencing and how the offspring themselves behaved as parents 
(Del Cerro et al., 2010). This can be considered adaption, how generations adapt to 
changing environments. 
In 2012 a study on the Wirral Child Health and Development Study (WCHADS), was the 
first to translate the rodent licking and grooming to human investigations. (Sharp et al., 
2012) showed that touch, in the form of stroking by the mother, could reduce the impact 
of prenatal stress. If one considered that stroking could be a human variation of licking 
and grooming in rats and mice then this would support the rodent work in its ability to 
reduce the effects of prenatal stress on depression in the young. 
 
1.5.2 Role of maternal depression in leading to changes in care behavior that in turn 
influence offspring behaviour, i.e. intergenerational inheritance 
 
As discussed, there are numerous studies that show that maternal stress and depression 
can induce an increased risk for the offspring to also developing stress-related disorders 
(Lyons-Ruth et al., 1997; National Research Council, 2009).  
Although the increased risk of major depression in offspring of depressed parents is well 
defined, there is very limited information on the risk to the third generation and to what 
extent this might even extend beyond to further generations. 
 
1.5.3 Role of maternal stress and depression in the regulation of the HPA axis in 
offspring 
Changes to serum cortisol status in patients with maternal depression have been well 
described in the literature; chronic maternal depressive state (greater than one month) 
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tends to cause hypocortisolaemia, while short-term immediate postnatal low mood tends 
to cause hypercortisolaemia. Cortisol status in children has also been reported to change 
with maternal depressive states. On exposure to reduced parental care, nursery-reared 
Rhesus monkeys exhibited lower basal cortisol levels compared to controls raised by their 
mother. In human offspring, exposure to the early life stress of postnatal depression also 
causes low basal cortisol levels, when compared with controls exposed to only moderate 
early life stress (Nephew et al., 2017). 
One probable mechanism is that the as time passes during chronic stress, the stress-
induced hypercortisolaemia observed initially, may transform into hypocortisolaemia as 
a protective development; it is thought that the hypocortisolaemia may develop in order 
to protect the brain and physiological processes from long term exposure to excess serum 
cortisol (Nephew et al., 2017). 
 
1.5.4 Transgenerational inheritance of depression.  
 
1.5.4.1 Rodent studies and the intergenerational CSS maternal depression rat study 
In a CSS rat model F0 mothers were subject to a resident male intruder during lactational 
periods. Maternal care and maternal aggression were the measured in the dams on early 
(day 2), mid (day 9), and late (day 16) stages of lactation to assess the effects of early-life 
CSS at different time points during lactation (Carini and Nephew, 2013; Nephew and 
Murgatroyd, 2013). After a 60-min pup removal, maternal care testing was performed, 
which included reintroduction of all pups into the home cage and video recording of the 
dam for 30 min. Total maternal care included the combined durations of pup grooming 
and nursing. 
This showed that there were significant differences in total maternal care in the F0 
mothers at day 9 only. In the F1 dams there was reduction in only day 2 and in the F2 
dams there were significant reductions in maternal care on all three days of lactation. This 
shows that there is an increased reduction in maternal care across the generations. In 
locomotor activity and allogrooming there were increases from F0 to F2 dams suggesting 
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again increases in depression and anxiety-related behaviours across the generations 
(Figure 1.3). This therefore demonstrates that some aspects of maternal care is 
transgenerationally inherited. However, these behaviours are not as strong as those 
effects seen in the F0 lactating dams (Carini and Nephew, 2013; Nephew and Bridges, 
2011; Murgatroyd et al., 2015b) or the lactating F1 Dam offspring (Carini and Nephew, 
2013; Nephew and Murgatroyd, 2013; Murgatroyd et al., 2015b). 
 
Figure 1.3. Maternal care behavior in F0, F1 and F2 Dams following exposure of the F0 dam to CSS.  Duration of total 
maternal care (pup grooming, nursing, nesting) on days 2, 9, and 16 of lactation during a 30 min maternal care 
observation in control and early life CSS (stress) dams in F0, F1 and F2 dams. *, ** and *** Indicate a significant effect 
of treatment (t-test, p <􏰂 0.05, 0.01 and 0.005 respectively) (Nephew et al. 2018). 
 
This data from the transgenerational CSS study firstly show that the CSS maternal stressor 
causes reductions in maternal care and increases stress behaviour. Secondly, that the 
female offspring of the F0 dams subjected to reduced maternal care, when mothers 
themselves, give lower levels of maternal care and show increased stress. Furthermore, 
their offspring, i.e. grandchildren of the F0 dams also show reduced maternal care. 
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Thirdly, the reductions in maternal care become more exaggerated through the 
generations, i.e. the effect of the stressor actually increases through the generations. 
The mechanisms by which the transgenerational inheritance of CSS has yet to be 
investigated or determined. It is unclear what endocrine and immune markers may be 
regulated through the generations in response to the CSS in the F0 dams and whether the 
decreased maternal behaviour accompanied by changes in plasma corticosterone, 
prolactin, oxytocin, bdnf or immune markers in a transgenerational pattern of 
inheritance. It is also unknown as to whether any epigenetic changes of key genes in the 
brain, such as those involved in HPA regulation, are maintained, i.e. inherited, across the 
3 generations that may underlie alterations in the stress behavior (Table 1.1). 
 
Table 1.1. Inheritance of maternal care behavior resulting from stress in F0 to F1 and F2 
Mechanisms F0 F1 F2 
Maternal care d2- , d9  , d16- D2  , d9-, d12- D2  ,d9  , d16 
Maternal restless d2- , d9   , d16- d2  , d9-,  d12- d2  , d9 , d16  
Milk intake d2 - ,d9  , 
d16 
d2  , d9-, d12- d2- , d9-,  d12- 
HPA regulation, 
corticosterone, 
ACTH 
? ? ? 
Maternal-related 
hormone 
? ? ? 
Growth hormones 
and reproductive 
hormones 
? ? ? 
Immune factors ? ? ? 
Behaviour-related 
neuropeptides 
? ? ? 
Epigenetics 
regulation 
? ? ? 
Endocrine and 
immune factors in 
milk  
? ? ? 
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This mechanism implies that HPA axis function is dependent on the length of exposure to 
stress and the type of stressor. The former in this case refers to acute or chronic stress, 
and the latter refers to depressed maternal care. This is further supported by rodent 
studies demonstrating attenuated corticosterone levels in response to early-life exposure 
to maternal separation (Faure et al., 2006; McEwen et al., 2016). A potentially related 
finding is the lower milk corticosterone levels of F1 CSS dam mothers, i.e. F2 dams 
received lower levels as pups. Interestingly, juvenile offspring of dams given 
corticosterone in the drinking water also display decreased basal corticosterone 
concentrations  (McCormick et al., 2000),  similar to the effect observed in the F2 offspring 
in the present study, where their F1 mothers exhibited elevated levels. Several other 
studies in rodents have shown that ingestion of glucocorticoids via mother's milk has 
beneficial programming effects in offspring that persist into adulthood, including better 
spatial memory (Casolini et al., 1997) and reduced anxiety and altered HPA axis response 
to stress (Catalani et al., 2000). This suggests that the reduced corticosteroid in the F1 CSS 
milk could mediate the depressed maternal care, increased restlessness and 
hypocorticosolemia of the F2 dams. 
Exposure of the foetus to maternal glucocorticoids may be important in foetal 
neurodevelopment  (Cottrell and Seckl, 2009); cortisol is key to normal development of 
the brain, and maternal and infant cortisol levels are well correlated. However, exposure 
to greater amounts of cortisol has long-term effects on neuroendocrine structure, 
function and on behavior. One animal study treated pregnant rats with glucocorticoids 
and found that neurogenesis was significantly inhibited in the subsequent offspring, and 
neuronal structure and synapse formation were altered (Noorlander et al., 2014). A 
human study observed greater amygdala volumes (a brain region known to play a key role 
in the processing of emotions) when maternal cortisol was high in early pregnancy, which 
was associated with increased evidence of affective symptoms in 7-year-old girls 
(Newman et al., 2016).  
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1.5.4.2 Human studies of transgenerational inheritance of depression 
In a study of 800 depressed and never depressed women together with data from their 
children and grandmothers, a positive correlation was found between the mother’s 
depression and the grandmother’s depression, as well as depression in the children (aged 
15) and grandmaternal depression (Hammen et al., 2004). In another study on 251 
women, it was seen found that those individuals with higher risks of major depression 
were the subjects with biological parents and grandparents generations affected by major 
depression. Interestingly, grandparental major depression on its own, did not increase 
the risk in grandchildren and leaving one to conclude that the grandparental depression 
impacts the risk that the parental depression subsequently has on the grandchildren 
(Weissman et al., 2016). (Pettit et al., 2008) also studied three generations to test how 
grandparental and parental major depression could influence grandchild behavior. This 
revealed that parental major depression increased the risk of grandchild 
anxious/depressed scores. However, grandparental major depression did not predict 
higher grandchild anxious/depressed scores although it did interact with parental major 
depression to predict this. Therefore, grandchildren with parents and grandparents 
affected by major depression had the highest risk anxiety/depression score. The results 
of these three studies therefore suggest the presence of the intergenerational 
transmission of depression. 
 
1.5.4.3 Transgenerational epigenetic inheritance 
Transgenerational epigenetic inheritance describes the process by which alterations in 
disease, behaviour or phenotypes are inherited through epigenetic changes that are 
separate from the DNA sequence (Murgatroyd and Spengler, 2011b). For example, 
epigenetic inheritance could allow the inheritance of information through parental-
offspring interactions that could be affected by stress or depression. Such maternal stress 
such a prenatal or postnatal depression is known to be able to induce changes in HPA axis 
regulation in offspring through via transgenerational epigenetic inheritance to one 
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generation (Roth and David Sweatt, 2011). However, research is beginning to show that 
changes to the HPA axis can actually extend to multiple generations (Murgatroyd, 2018). 
Though transgenerational epigenetic inheritance is a well-known subject and well-studied 
in animal models, there is relatively little human research following maternal depression 
through multiple generations with only a few observational studies. Most of the studies 
look at the effect of prenatal stress and depression on the offspring’s HPA activity (Glover 
et al., 2010). Part of the reason that it is hard to research is that there are a number of 
limitations to such studies. Firstly, there is variation between how different mothers 
respond to a variety of stressors and in their levels of perceived stress which tends to 
correlate not so well with HPA activity (Glover et al., 2010). Many studies tend to be 
relatively small with multiple measurements that reduce statistical power. However, 
taken together, maternal prenatal and postnatal stress does tend to correlate with HPA 
activity in offspring, which seem to be inherited by epigenetic mechanisms (Meaney et 
al., 2007; Murgatroyd and Spengler, 2011b; Beijers et al., 2014). However, there is 
relatively little evidence looking at the second generation and beyond. One of the most 
well know cohorts and seminal studies was in pregnant women in the Dutch Winter 
Famine of 1944/1945 who were exposed to extremely low levels of food reaching 500 kcal 
per day. Those in late pregnancy gave birth to babies of reduced birth weight and that 
those female offspring in turn also gave birth to smaller babies (Painter et al., 2008). This 
supports that reduced birth weight from prenatal exposure to famine was inherited, and 
supports the hypothesis of developmental origins of health and disease (DOHaD), that 
exposure to specific environmental influences during development may have significant 
consequences on an individual’s later health. Another study of women who were given 
the synthetic oestrogen diethylstilboestrol, had significantly increased reproductive 
abnormalities and cancers in their children and increased risk of hypospadias in the third 
generation, in boys via the maternal line (Kalfa et al., 2011).  
18 
 
1.5.5 Molecular mechanisms by which the HPA axis can be programmed by early life 
stress 
 
As described above prenatal or postnatal stress or early life stress can lead to changes in 
HPA axis activity in offspring and this can occur through epigenetic changes. The concept 
is that epigenetic changes occurring in stress-related genes important in HPA axis function 
could alter expression of those genes such that different levels of key components of the 
HPA axis are altered (Murgatroyd and Spengler, 2011b). 
 
1.5.5.1 Concept of gene expression 
Gene expression is where information in a gene (i.e. a section of DNA) is converted to a 
functional protein, by first copying the gene into ribonucleic acid (RNA). It can be split into 
two parts-transcription and translation. Transcription is the process where DNA is copied 
into RNA, while translation is the process where RNA is used as a template to create a 
protein.  
The enzyme RNA polymerase is used for transcription, which takes place in the nucleus. 
There are three steps to transcription: initiation, elongation and termination. Initiation 
occurs by the RNA pol molecule binding to the 5’end of the gene at the promoter region, 
with the help of transcription factors that must bind to the promoter before the RNA 
polymerase can bind. RNA polymerase then “reads” the DNA and adds nucleotides to the 
3’ end of the RNA, so that the original DNA strand is copied into an RNA molecule (Figure 
1.4). 
After transcription, the RNA is transported to the cytoplasm from the nucleus were it 
undergoes translation to become its protein equivalent. Here ribosomes essentially 
convert each three-nucleotide sequence of mRNA into its corresponding amino acid, with 
the help of tRNA. The ribosome is also responsible for linking each amino acid by covalent 
bonds to form a polypeptide protein chain.  
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Figure 1.4. Showing concept of gene expression. There are the steps of transcription, while the important molecules 
that facilitate each process are in purple. 
 
1.5.5.2 Epigenetics 
 
The DNA sequence of an organism is identical in all its cells, however epigenetic 
mechanisms can have an effect on which parts of the sequence are expressed by adjusting 
the accessibility of the DNA to the gene transcription machinery. In effect, the genome 
can be thought of as containing two levels of information; the inherited DNA sequence 
from the organisms parents, which is mainly the same in all cells and tissues, as well as 
the varied expression achieved by epigenetic mechanism, which are cell and tissue 
specific  (Murgatroyd and Spengler, 2011b). 
Epigenetics is the way in which environmental factors can alter genetic expression by 
switching genes “on” and “off”, without altering the original DNA sequence (Heim and 
Binder, 2012). For instance, epigenetic changes can influence the activity of neurons in a 
developing brain, which can translate to marked alterations in an organism’s behavior. 
These environmental factors have their influence early in life during development and 
differentiation. Epigenetic mechanisms include chromatin modification, microRNA 
expression and DNA methylation. The latter, DNA methylation, is one of the best-
understood epigenetic mechanisms and it involves adding methyl groups to the DNA 
sequence in this way regulating whether the gene is available for transcription; promoters 
of genes with methyl groups attached are inaccessible to the cell’s transcription 
machinery and are therefore silenced. Hence we can say the gene is “switched off” 
(Alyamani and Murgatroyd, 2018). The process of DNA methylation involves the addition 
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of a methyl group at the cytosine side chain in cytosine-guanine dinucleotides (CpG), by 
the family of enzymes called DNA methyltransferases (Murgatroyd and Spengler, 2011b). 
The insertion of methyl groups changes the appearance and structure of DNA, which may 
either: 1, directly block DNA binding of transcription factors or 2, attract factors that 
preferentially bind to methylated or unmethylated DNA to interfere with transcription 
factor accessibility. Clusters of CpG (called CpG islands) are found throughout the 
genome, however many are found in the 5’ promoter region. Hence, methylation here 
has a significant impact on gene expression, as it blocks the promoter region and inhibits 
expression (Alyamani and Murgatroyd, 2018) (Figure 1.5). 
 
 
Figure 1.5. How DNA methylation can alter gene expression. DNA Methylation can affect gene expression by interfering 
with binding of transcription factors (TF) and RNA polymerase II (Pol II).This schematic shows a gene with an 
unmethylated CpG island, and thus active, promoter region. As the CpG island is not methylated, TFs are able to bind 
and facilitate attachment of (Pol II for transcription. The gene below has been ‘switched off’ where the promoter region 
is methylated, and this represses gene expression as TFs are unable to bind  and  leading to repressed gene expression. 
 
1.8.3 Epigenetic programming by early life stress 
It is hypothesised that maternal stress and the mother’s care determine offspring 
behavioural traits and their stress responses through epigenetic mechanisms 
(Murgatroyd and Spengler, 2011b). For example experiments in rodents show that 
experiences during sensitive periods of development influence DNA methylation patterns 
of several genes and that these patterns represent stable epigenetic modifications that 
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alter gene transcription throughout the lifespan and promote specific behavioural 
outcomes (Murgatroyd et al., 2009). 
Potential associations between epigenetic regulation of HPA axis genes and clinical 
outcomes remain relatively under studied, with DNA methylation of NR3C1 and FKBP5 
being most studied in direct relation to risk for human stress-related disease.  (Tables 
1.2 and 1.3) (Figure 1.6). These genes are particularly important as they are key factors 
in the regulation of the activity of cortisol. 
 
Figure 1.6. Schematic demonstration of the hypothesis of epigenetic regulation by stress-regulatory genes by early 
life stress in rats and humans. Chronic social stress (CSS) on the dam results in altered maternal behaviour which causes 
early life stress (ELS) to the pups. This in turn results in DNA methylation that reduces expression of a candidate gene in 
a rat. Right. Maternal depression in humans causes ELS to the offspring, which results in decreased expression of a gene 
via the same epigenetic mechanism as the rat.  
 
1.5.5.3 Epigenetic regulation of the NR3C1 gene by early-life stress 
The NR3C1 gene codes for the Glucocorticoid receptor (GR). This gene is regulated by a 
very complicated promoter structure with at least eleven untranslated alternative first 
exons regulated by a complex promoter structure with one promoter for each of the 
alternative first exons. It is thought that these alternative first exon transcripts are 
important for the regulation of GR levels in within different cell or tissue or environmental 
conditions by differentially controlling translation efficiency and RNA stability (Bockmühl 
et al., 2015). Although GR is expressed in all cells ubiquitously, its levels are tightly 
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controlled according to tissue, or even cell, type. Therefore, within the brain, levels are 
higher in areas involved in the stress response such as in the hypothalamus and 
hippocampus (Karanth et al., 1997; Uchida et al., 2008; Booij et al., 2013). 
Many studies in rats and mice have investigated the role of early life stress on long-term 
GR regulation. One of the seminal studies from the group of Meaney (as previously 
mentioned) (Meaney, 2010) have shown that rat pups that received higher levels of 
maternal care from mothers, also showed increased levels of GR in the hippocampus. In 
2004 Weaver et al. together with Meaney demonstrated that in rat pups of high maternal 
care mothers Nr3c1 methylation was decreased in hippocampal samples within the GR 
gene’s alternative first exon 1-7 promoter, originally identified as being regulated in the 
hippocampus (Weaver et al. 2004). These differences in methylation rates lasted into the 
offspring’s adulthood. Many further studies have been conducted. (Daniels et al., 2009) 
produced conflicting results, investigating the impact of separating rat pups from their 
mothers between postnatal day 2 and 14 and finding no methylation changes. However, 
numerous other studies have indeed supported Meaney’s findings finding increased 
methylation at Nr3c1 exon 1-7 promoter following various early life stressors, as detailed 
in (Table 1.2). 
 
Table 1.2. Rodent studies investigating the epigenetic regulation of Nr3c1 following Prenatal, postnatal, early-life 
and adult stressors  
Reference Ani
mal  
Form of stress Model Tissues Methylation  
(Weaver et al., 2007) Rat  Increased Early 
maternal care 
High licking and grooming Hipp 1-7  
(Niknazar et al., 2017) Rat  Preconception 
paternal stress 
Males stressed prior to 
mating 
Hipp 1-7  
(Mifsud et al., 2017) Rat Adult acute stress Forced swim test stress Hipp  1-7 
(Brubaker et al., 2015) Mus ELS Maternal separation Hipp 1-7 N/D 
 (Daniels et al., 2009) Rats ELS Maternal separation  Hipp 1-7 N/D 
(Kember et al., 2012) Mus  ELS Maternal separation  Hipp 1-7  
(Henningsen et al., 
2012) 
Rat  Early maternal care High licking and grooming Hipp  1-7 N/D 
(Schuessler et al., 2005) Mus  Early Maternal care High licking and grooming Hipp 1-7  
(Kosten et al., 2014) Rat Early maternal care Reduced care by altering 
litters 
Hipp 1-7  
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(Kundakovic et al., 
2013) 
Mus  Early life stress Maternal separation Hipp 1-7  
(Mueller and Bale, 
2008) 
Mus  prenatal stress Chronic stress to pregnant 
dams 
Brain 1-7 
(Witzmann et al., 2012) Rat  Adult stress Chronic stress Hipp,  
PVN 
1-7  
(Tran et al., 2013) Rat Adult stress Repeated water 
avoidance stress 
Amy 1-7  
Hipp; hippocampus, Mus; mouse, ELS; early life stress, N/D; not different, PVN; paraventricular nucleus, Amy; amygdala. 
 
The results of the above animal studies have led to human studies also investigating 
NR3C1 methylation (Turecki and Meaney, 2016) (Table 1.3). The rat Nr3c1 1-7 promoter, 
is the homologue of exon 1-F in human NR3C1 gene. The first study to look at GR in the 
brain was conducted by (McGowan et al., 2008) looked at two groups of suicide victims-
one with a history of childhood abuse, and another without. In brains from these subjects 
they found increased DNA methylation at the promoter region of the NR3C1 gene 
homologus to the rat studies (Weaver et al. 2004) supporting the animal studies that 
alterations to methylation of the Nr3c1 gene in the hippocampus occur in response to 
early life environment (Figure 1.7). 
 
Table 1.3. Human studies investigating the epigenetic regulation of NR3C1 following, postnatal, early-life and 
adulthood stressors. *studies investigating prenatal stress 
Reference Stress Study, Age collected Tissues Methylation 
(Perroud et al., 2011) Sexual abuse 30-40yrs Blood 1-F 
(Tyrka et al., 2012) Early life trauma 27.3yrs Blood 1-F 
(Schuessler et al., 2005) Childhood abuse and 
bulimia 
25yrs Blood 1-F N/D 
(Yehuda et al., 2013) Early life trauma Pre-treatment, 
post-treatment, 
3 months follow up. 
Blood 1-F     
(Melas et al., 2013) Childhood adversity ( 
depressed) 
55yrs Blood 1-F 
(Perroud et al., 2013) Childhood trauma, 
bipolar 
44.6yrs Blood 1-F 
 Child physical abuse 
 
25yrs 
 
Blood 
 
 
(Van Der Knaap et al., 
2014) 
Early-life trauma 16.3yrs Blood 1-D , 1-F  
(Van Der Knaap et al., 
2014) 
Child abuse and neglect 5-14yrs Saliva 1-F  
(Martín-Blanco et al., 
2014) 
childhood abuse 29.4yrs Blood 1-F  
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(Romens et al., 2015) Child abuse and neglect 12yrs Blood 1-F  
(McGowan et al., 2008) Child abuse, suicide 34yrs Hipp 1-F  
(Labonté et al., 2012) Child abuse, suicide 37yrs Hipp 1-B  , 1-C ,  
1-H    
(Oberlander et al., 2008) Maternal depression At birth Cord blood 1-F  
(Radtke et al., 2011) Maternal stress ( 
violence) 
14.1yrs Blood 1-F * 
(Mulligan et al., 2012) Maternal stress At birth, War stress Cord blood 1-F * 
(Hompes et al., 2013) Maternal anxiety At birth, Cord blood 1-F * 
(Conradt et al., 2013) Maternal depression At birth Placenta 1-F * 
(Essex et al., 2013) Childhood stress 15.1yrs Buccal 1-F  
(Perros et al., 2014) Maternal stress Mother 45yrs,  
children 17yrs,  
exposure to Tutsi 
genocide 
Blood 1-F  
(Yehuda et al., 2013) Preconception stress, 
PTSD 
50yrs Blood 1-F  
(Murgatroyd et al., 
2015a) 
Maternal depression 30yrs Saliva 1-F * 
Hipp; hippocampus, PTSD; Post-traumatic stress disorder. 
 
Oberlander et al. in the first study to explore NR3C1 methylation in blood cells from 
humans in relation to stress, specifically maternal depression, found increased levels of 
DNA methylation in the Exon 1-F promoter in cord blood samples taken from mothers 
who showed increased levels of anxiety and depression during pregnancy at the 2nd and 
3rd trimesters (Oberlander et al., 2008). Perroud and colleagues (Perroud et al., 2011) 
again focusing on exon 1-F they found that in people with MDD those individuals exposed 
to childhood physical abuse and neglect showed significantly increased exon 1F 
methylation compared to those people with MDD but who never exposed to childhood 
abuse. Furthermore, there was a significant and positive dose-response association 
between the number of type of childhood abuse and neglect and methylation. (Conradt 
et al., 2013) reported that newborn offspring exposed to maternal depression in utero 
had increased methylation within exon 1f as well as adverse neurobehavioural outcomes. 
(Radtke et al., 2011) examined DNA methylation using peripheral blood samples taken 
from children (n=24) aged up to 19 years old whose mothers had been exposed to 
violence before, during and after their pregnancy. Increased methylation rates in children 
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were significantly associated with maternal exposure to violence during their pregnancy. 
Methylation was seen in 7 of the 24 children, in 5 of the 10 CpG sites examined and at 
rates of up to 10%. Strikingly, there was no association between child NR3C1 methylation 
and maternal exposure to violence either before or after pregnancy suggesting an 
importance of prenatal stress in inducing these methylation changes. Maternal NR3C1 
methylation was not significantly correlated with methylation levels in their children and 
was unaffected by exposure to violence. This study was the first in humans to show an 
apparently sustained dysregulation of the HPA axis associated with previous early life 
psychological stress.  
In a study using buccal DNA from healthy individuals (n=92) (Edelman et al., 2012) were 
able to show that methylation at a single CpG site within the 1-F promoter correlated with 
cortisol response to stress. In 2010, Alt et al. (Alt et al., 2010) conducted a study exploring 
the possible association between methylation of NR3C1 and depression. The authors 
assessed NR3C1 methylation in post-mortem samples from depressed patients (n=6) in 
multiple limbic brain regions compared to controls (n=6). Hippocampal exon 1f transcripts 
were reduced in depressed patients. However, these data demonstrated very low overall 
levels of methylation in both depressed and control brains, whilst the NR3C1 promoter 
for exon 1f was completely unmethylated in all of the samples taken. Thus, the 
mechanism for this down-regulation in depressed brains appeared to be entirely 
independent of methylation patterns. However, this study included only a very small 
number of samples. More recently Na et al. (Na et al., 2014) compared methylation levels 
of NR3C1’s promoter region in depressed patients (n=45) and controls (n=72). The 
authors found hypomethylation, rather than hypermethylation, at two CpG sites in 
patients. Neither the (Alt et al., 2010) nor the (Na et al., 2014) studies were able to provide 
definitive data regarding HPA axis functioning or childhood trauma. This would appear to 
be crucial, as illustrated by the following studies incorporating early adversity into models 
of depression, HPA axis dysfunction and methylation of NR3C1 at different life stages.  
(Perroud et al., 2011) investigated the correlation of the severity of childhood 
maltreatment with methylation rates in NR3C1 for patients diagnosed with borderline 
26 
 
personality disorder (BPD) (n=101), depression (n=99) or depression with co-morbid post-
traumatic stress disorder (n=15). They were able to show highly significant associations 
between methylation of NR3C1 and the severity and number of sexual abuse episodes. In 
a study by (Melas et al., 2013) salivary DNA from depressed adults (n=92) were compared 
with controls (n=82) increased methylation at NR3C1 significantly associated with early 
parental death.  
Very few studies have identified candidates for human maternal behaviours equivalent 
to rat LG-ABN. However, in rats the effects of licking and grooming have been shown to 
be mimicked by stroking pups with a brush (Mulligan et al., 2012). A study by Sharp et al. 
(2012) (Sharp et al., 2012) demonstrated moderation of the effects of prenatal maternal 
depression upon emotional and physiological outcomes in human infants through 
mothers stroking their babies in their first weeks of life. A very recent follow-up study by 
(Murgatroyd et al., 2015a) has showed reduced NR3C1 methylation associated with 
maternal stroking in these children, suggesting the possible role of epigenetic 
mechanisms in the long-term effects of early life stress and maternal care. Interestingly, 
the same study also found interactive effects between prenatal and postnatal maternal 
depression on methylation of NR3C1’s exon 1f. Infants of mothers with low prenatal 
depression showed increased methylation when exposed to increased postnatal 
depression - consistent with an interplay between prenatal and postnatal environments. 
Finally, it is important to remember that the reason that CpGs in this region of the NR3C1 
gene were investigated in these human studies and found to relate to early-life stress, is 
through the important seminar work of the animal studies. 
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Figure 1.7. Human studies investigating the epigenetic regulation of NR3C1 1.7 promoter following various prenatal, 
postnatal, early-life and adulthood stressors 
 
1.5.5.4 Epigenetic regulation of FKBP5 by early-life stress 
FK506 binding protein 51 is a co-chaperone to GR, which regulates its sensitivity. This is 
encoded for by the FKBP5 gene. (Klengel et al., 2013) demonstrated an increase in DNA 
methylation of this gene in response to childhood trauma. These patients have a greater 
risk of developing adult stress-related psychiatric conditions, and it is thought that the 
demethylation of FKBP5 leads to long-term dysregulation of the HPA axis, 
Numerous studies in rodents, particularly mice, have shown changes in methylation at 
fkbp5 following stress (Table 1.4). For example mice injected with corticosterone for 3 
months showed that decreased DNA methylation at CpGs within the promoter of 
fkbp5 together with enhanced expression of fkbp5 (Lee et al., 2010). Remarkably, DNA 
methylation increased again when the corticosterone injections were stopped after 3 
months (Sabbagh et al., 2014). 
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Table 1.4. Rodent studies investigating the epigenetic regulation of the fkbp5 following various prenatal, postnatal, 
early-life and adulthood stressors  
Reference Animal  Form of stress Model Tissues Methylation  
(Lee et al., 2010) Mus Chronic Pregnant  
stress 
Chronic exposer to CORT 
Via drinking water 
Blood, 
Hipp 
Intron 5  
(Ewald et al., 2014) Mus chronic stress 5 doses of CORT of 
drinking water 
Blood, 
Hipp 
Intron 1  
Intron 5   
(Sabbagh et al., 
2014) 
Mus Depression-like 
behaviours. 
Forced stress and tail 
suspension 
Blood Intron 5   
(Kitraki et al., 2015) Rat Prenatal exposure perinatal BPA exposure Hipp Intron 5  
(Green et al., 2016) Rat Adult rats 
 
Chronic stress exposure Hipp Intron N/D 
(St-Cyr et al., 2017) Rat Adult rats Prenatal stress Amy Intron V  
Mus; mouse, Hipp; hippocampus, N/D; not different, Amy; amygdala. 
 
 
In human studies, increased DNA methylation of the FKBP5 gene has been associated 
with a stress exposure (Table 1.5). Reduced expression of specific transcript variants in 
patients with MDD (Roy et al., 2017) while another study showed DNA methylation 
contributes to the upregulation of FKBP5 transcription with age that effects stress 
resilience (Sabbagh et al., 2014). A study using MRI found a positive association 
with FKBP5 promoter methylation and thickness of the transverse frontopolar gyrus in 
patients with major depression (Han et al., 2017). A landmark study has shown that 
childhood trauma can reduce DNA methylation specifically in the intron 7 of 
the FKBP5 gene in subjects presenting with a specific SNP (Sabbagh et al., 2014), 
suggesting an interaction between genotype, DNA methylation, and the effects of 
environment on the FKBP5 gene transcription. 
Table 1.5. Human studies investigating the epigenetic regulation of the FKBP5 promoter following various prenatal, 
postnatal, early-life and adulthood stressors  
Reference Stress Study, Age collected Tissues Methylation 
(Kang et al., 2013) PSTD N=123, 116 control Blood Intron 7   
(Klengel et al., 2013) PSTD Case-control:in vitro cell 
lone, N=76, 41yrs 
Blood Intron 7  
(Menke et al., 2013) MMD N=68 ,18–65 yrs Blood Intron N/D 
(Yehuda et al., 2013) Early-life trauma Pre-treatment, post-
treatment, 3 months 
follow up.  
Blood Exon 7-8 
 
(Höhne et al., 2014) MMD Case-control; pro-
spective, N=116 
Blood Intron 7  
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(R Fries et al., 2016) MMD Case-control, N=68, 51yrs Blood Intron 7   
                 
(Tyrka et al., 2015) childhood 
maltreatment 
N= 69 preschool, 3-5yrs. 
 
Blood Intron 7    
 
(Kertes et al., 2016) chronic stress, war 
trauma or prenatal 
stress 
24 mother, newborn 
26yrs 
Blood, 
placenta 
Intron 5    
(Yehuda et al., 2016) PSTD N=76, Holocaust survivors  Blood Intron7     
(Han et al., 2017) MMD N= 202, 20-69yrs Blood 
MRI 
Intron 7    
 
(Mulder et al., 2017) maternal stressors 298 14-months-old infants Blood Intron 5   
(Parade et al., 2017) childhood 
maltreatment 
231 preschoolers Saliva Intron 7    
(Roy et al., 2017) MMD N=48,  Blood Intron 2  N/D 
PTSD; Post-traumatic stress disorder, MMD; major depression, N/D; not different. 
 
1.5.5.5 Epigenetic regulation of BDNF following early-life stress 
BDNF is a small dimeric protein that is part of the neurotrophin family of proteins. It is 
particularly expressed in the cerebral cortex and hippocampus, but can be found 
throughout the brain. The main function of BDNF is to do with neurodevelopment and 
maintenance of the nervous system; it plays a role in the survival and proliferation of 
neurons, especially in learning and memory (Ismail et al., 2015). There is numerous 
evidence that BDNF expression is decreased by experiencing stress and that a lack of 
neurotrophic support causes depression. 
Similarly to the NR3C1 gene the human and rat bdnf  genes have a complex gene 
structure, consisting of 11 exons (I–V, Vh, VI-VIII, VIIIh, IX), 9 of which (exon I–VII, IX) 
contain functional promoters. Epigenetic mechanisms have been shown to be very 
important for BDNF expression regulation (Zheleznyakova et al., 2016) Some rodent 
studies have shown that early-life stress can induce long-lasting changes in the 
methylation level of the bdnf promoter IV which and that this associates with 
lower bdnf expression level in the brain (Table 1.6). Furthermore, the offspring of 
stressed females showed increased of the bdnf in the brain prefrontal cortex and 
hippocampus, (Roth et al., 2009; Roth and Sweatt, 2011). 
 
Table 1.6. Rodent studies investigating the epigenetic regulation of the bdnf promoter following various prenatal, 
postnatal, early-life and adulthood stressors  
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Reference Animal  Form of stress Model Tissues Methylation  
(Roth et al., 2009) Rat Infant rats Abuse and neglect Cortex 
 
IV 
(Fuchikami et al., 2011) Rat PSTD Contextual fear 
conditioning 
Hipp IV 
(Roth et al., 2011) Rat Adult rats 
PSTD 
Stress manipulations (cat 
exposure. 
Hipp IV     
(Boersma et al., 2014) Rat Adult rat Prenatal stress Amy, Hipp IV 
(Wei et al., 2016) Mus Resveratrol Forced swim 
 
Amy, Hipp IV N/D 
(Blaze et al., 2015) Rat Adult rats 
 
Maltreatment 
Infant with a stressed 
caregiver 
cortex IV  ,  I      
(Mpofana et al., 2016) Rat ELS Maternal separation Blood IV N/D 
(Deng et al., 2017) Rat Adult rats 
ELS 
chronic mild stress Amy IV 
(Makhathini et al., 
2017) 
Rat Adult rats 
 
Repetitive restrain stress Hipp  IV N/D 
(Sagarkar et al., 2017) Rat Anxiety-like 
behaviours 
Minimal traumatic brain 
injury 
Amy IV    , I     , 
IX     
(Yamazaki et al., 2018) Rat ELS Maternal fructose 
consumption 
Hipp IV 
PSTD; Post-traumatic stress disorder, Hipp; hippocampus, Mus; mouse, Amy; amygdala, ELS; early life stress, N/D; not 
different. 
 
Another study by Boersma et al (Boersma et al., 2014) found that rats exposed to prenatal 
stress had increased bdnf methylation, and subsequently decreased bdnf mRNA 
expression, in the amygdala and hippocampus of their offspring. This suggests that stress 
can alter DNA methylation that relates to gene activity. In addition, this also supports that 
DNA methylation at bdnf can be inherited across generations. 
There are many human studies support these findings of increased bdnf methylation 
described in rats following stress (Table 1.7). Keller and colleagues were the first to 
investigate the BDNF DNA methylation changes in human brains. Investigating suicide 
victims in comparison with controls (Keller et al., 2010) and using bisulfite pyrosequencing 
and the authors analysed the methylation levels of CpG sites at BDNF promoter IV in the 
Wernicke area of the brain. They found significant increased methylation of the average 
levels of 4 CpG sites in suicide completers. Importantly, they also found an association 
between the average methylation level of these 4 CpG sites and the BDNF transcript IV 
levels supporting a role of methylation at these CpGs in regulating BDNF expression. 
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Table 1.7. Human studies investigating the epigenetic regulation of the BDNF promoter following various prenatal, 
postnatal, early-life and adulthood stressors  
MMD; major depression, PSTD; Post-traumatic stress disorder, Hipp; hippocampus. 
 
Fuchikami et al. were the first to examine blood DNA methylation changes in BDNF in 
relation to depression. Again using bisulphite pyrosequecning to look at two CpG islands 
in promoter I and promoter IV of BDNF gene they found in major depressive disorder 
patients compared with healthy individuals, various significant differences with some CpG 
sites showing increased and decreased methylation (Fuchikami et al., 2011). Several other 
studies have also examined BDNF methylation in relation to depression. Chagnon et al., 
found a significantly higher methylation level in promoter VI in elderly women with 
anxiety and depression compared with controls (Chagnon et al., 2015). Most other studies 
have also focussed on methylation at BDNF promoter VI or only found changes there. 
Reference Stress Study, Age collected Tissues Methylation 
(Tadić et al., 2009) MMD N=161 Borderline, 156 
healthy 
Blood IV 
(Keller et al., 2010) Suicide, MMD  N = 120  Wernicke brain 
area 
IV 
(Fuchikami et al., 2011) MDD N=20 Japanese, 18 
healthy  
Blood IV I  
(Roth et al., 2011) PSTD - Hipp IV     
(D'addario et al., 2012) childhood abuse N=154  Blood   I       
(D'Addario et al., 2013) MMD N=85, with healthy Blood   I        
(Kang et al., 2013) suicidal attempts N=108, age at onset  Blood VI 
(Perroud et al., 2013) childhood 
maltreatment 
N= 115 suicidal   Blood IV    I  
(Thaler et al., 2014) childhood abuse N=64 women, 32 normal Blood VI 
(Braithwaite et al., 
2015) 
Maternal depressive N=57 pregnant women, 
infant at 2 months of age. 
Buccal swabs IV 
(Chagnon et al., 2015) Anxiety, depression N=65 elderly women, no 
disorder 
Saliva VI 
(Kang et al., 2015b) depression 732 , ≥ 65 yrs Blood VI 
(Moser et al., 2015) Maternal separation. 
 PTSD 
N=46 women with 
violence and their young 
children 
 
Saliva, (fMRI) 
brains.  
 
IV    
(Stenz et al., 2015) Prenatal stress N=98 post-mortem by 
forensic physicians. 
Cortex, Hipp,  
blood    
IV    I  
(Unternaehrer et al., 
2015) 
Low/high maternal 
care 
A cross-sectional, 709,  
24 yrs 
 
Blood VI   
32 
 
Kang et al found increased methylation at BDNF promoter VI with a history of suicidal 
attempts (Kang et al., 2013), increased promoter VI methylation levels in late-life 
depression (Kang et al., 2015a) and increased methylation individuals with breast cancer 
and depression (Kang et al., 2015b). Perround et al. found increased methylation at 
both promoter I and promoter IV in for bipolar depression patients (Perroud et al., 2013) 
while D’Addario and colleagues found increased DNA methylation at BDNF promoter I in 
bipolar disorder patients. Tadic and colleagues found lower levels of the analysed in the 
BDNF promoter IV in major depressive patients than controls but this was only 1 CpG out 
of 12 CpGs they analysed.  
Looking at early life stress, Perround et al. (Perroud et al., 2013) in a study of bipolar 
depression that a larger number of childhood maltreatment was significantly associated 
with a higher methylation status of BDNF I and IV promoters. Thaler et al. found increased 
DNA methylation in the BDNF promoter IV (Fig. 1.8) in women with bulimic eating 
syndromes (Thaler et al., 2014) especially in those with a history of severe childhood 
abuse. 
A study at the University of Geneva Hospital looked at 46 women who had post-traumatic 
stress disorder following domestic violence, and their infant children. These children were 
separated from their mothers and the subsequent behaviour of both parties was 
observed. In addition, DNA samples were taken from maternal saliva, and functional 
magnetic resonance imaging (fMRI) was carried out on maternal brains.  
This revealed that maternal anxiety was significantly increased following separation from 
their child and that methylation of the BDNF gene was increased in the promoter region, 
causing BDNF expression to be decreased in the amygdala and hippocampus during 
separation, compared to during a non-stressful condition. In addition, there was 
significant correlation between the level of maternal anxiety, and the amount of BDNF 
methylation (Moser et al., 2015) An additional study of the influence of childhood 
maternal care on BDNF methylation level performed by Unternaehrer et al. 
(Unternaehrer et al., 2015) showed greater whole blood DNA methylation in the low 
versus high maternal care group in the BDNF exon VI.  
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These results all support the theory that depression relates to increased DNA methylation 
at BDNF and that stress and early life adversity may cause long term epigenetic changes 
to BDNF (Zheleznyakova et al., 2016) (Figure 1.8). However, it is unclear if BDNF 
methylation changes might show transgenerational inheritance between generations 
perhaps as a mechanism of transmission of anxiety between generations (Moser et al., 
2015). 
 
 
  
Figure 1.8. Human studies investigating the epigenetic regulation of BDNF 1.7 promoter following various prenatal, 
postnatal, early-life and adulthood stressors  
 
1.5.6 Inflammatory factors in depression  
There is much evidence in the literature that shows an increased activity of the innate 
immune system is patients with depression. This relates to an hypothesis of the social 
transduction theory of depression whereby exposure to social stress, particularly during 
early life, alters immune responses, which then can lead to risk for depression (Slavich 
and Irwin, 2014). Several studies have found higher levels of certain inflammatory 
cytokines in depressed people compared to non-depressed individuals including IL-1β, 
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IL-6, IFN-γ, TNF-α (Dowlati et al., 2010; Pike and Irwin, 2006). This increase in circulating 
cytokines has also been found in relation to increases in cytokine gene expression. For 
example, individuals with major depression had higher mRNA levels of TNF-α, IL-1β, IL-6 
and INF-α (Cattaneo et al., 2013; Tsao et al., 2006). 
Further studies have also linked increased levels of pro-inflammatory cytokines to 
increased severity of depression (Song and Wang, 2011), and poorer response to 
antidepressant therapies (Cattaneo et al., 2013). The links between increased cytokine 
levels and greater immune activation in patients with depression has also been 
demonstrated in the brains of depressed and suicide patients at post-mortem. For 
example, one study found increased levels of pro-inflammatory cytokines in depressed 
patients who had committed suicide, compared with controls (Shelton et al., 2011).  
 
1.5.6.1 Early life stress and programming inflammation 
Numerous studies show that exposure to prenatal and postnatal stress and depression 
can lead to long-term immune effects in the offspring, particularly increased 
inflammation, that can last into adulthood (Murgatroyd, 2018). One study showed 
immune changes in young adults who had previously been exposed to prenatal 
maternal stress (Entringer et al., 2015; Murgatroyd, 2018). A study by (Slopen et al., 
2015) found increased levels of the pro-inflammatory marker C-reactive protein (CRP), 
in adults who had increased levels of childhood social adversity (Slopen et al., 2015). 
Similarly, Danese et al. found a higher level of CRP in adults age 32 that had experienced 
adverse childhood experiences (Danese et al., 2009). A study by O’Connor et al found 
reduced immune function in infants of mothers who had exhibited prenatal stress and 
anxiety (O’Connor et al., 2013), low-grade chronic inflammation associates with reduced 
immune competence. In a study by Murgatroyd increased levels of the pro-
inflammatory cytokines CRP and IL-6 were found in adults who had experienced high 
levels of prenatal and early life stress (Murgatroyd, 2018) 
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1.5.7 Effect of stress on regulating factors in milk 
 
A further mechanism by which a mother might transfer her stress to her offspring is 
through milk during lactation. A mother’s stress might program stress-regulation in her 
offspring through lactation in several possible ways. For example, maternal stress might: 
1) impair mother’s lactation such as leading to reduced levels of milk production for the 
offspring in turn impacting postnatal development; 2) interfere with production of 
nutrients in the milk important for development; 3) alter levels of immune factors in the 
milk important for offspring immune development; 4) change quantities of hormones in 
the milk that the offspring uses in its development of its stress response circuits, known 
as lactocrine programming; 5) impact offspring behaviour such that the newborn is less 
able to suckle properly. 
 
1.5.7.1 Physiology of lactation 
 
 
The two main hormones involved in lactation are prolactin, which is secreted from the 
anterior pituitary, and oxytocin, which is secreted from the posterior pituitary in a 
pulsatile manner. Prolactin is released in response to stimulation of the nipple, and 
suckling of the infant, and is involved in milk synthesis. Oxytocin functions to regulate a 
neuroendocrine reflex called the milk ejection reflex in response to infant suckling. 
Oxytocin can also be released in response to various environmental factors such as 
hearing a baby cry or by preparing to breastfeed. Importantly, oxytocin is inhibited by 
stimuli such as stress, fear and anxiety (Sriraman, 2017; Leng et al., 2005). 
1.5.7.2 Milk constituents 
 
 
Breast milk is composed of numerous factors and cells such as T-cells, macrophages and 
stem cells (Ballard and Morrow, 2013). Factors include immune factors and endocrine 
hormones and steroids. These factors are thought to help regulate systems such as the 
endocrine and immune systems of the offspring, at least until they can function 
independently (Palmer, 2011). These factors exist in particularly high concentrations that 
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are greater than plasma concentrations, and they include hypothalamic releasing factors, 
pituitary hormones, thyroid hormones, growth factors and many others (Palmer, 2011; 
Polk, 1992) (Table 1.8). 
 
Table 1.8. Immune, endocrine and growth factors present in either rodent or human milk  
 
Together with nutrients such as fats, proteins, carbohydrates, vitamins and minerals 
found in breast milk the immune and endocrine factors are crucial in neurodevelopment. 
The World Health Organisation (WHO) recommends that infants should be exclusively 
breastfed for the first six months of life (Martin et al., 2016b). Several studies have shown 
that breastfeeding is important for neurodevelopment and cognition in the infant for 
example (Grantham-McGregor et al., 1999). 
 
1.5.7.3 Effect of environment on milk production and milk constituents 
 
Multiple factors, such as stress, depression, fatigue, or long periods of separation 
between the mother and infant can affect the production of milk possibly through 
oxytocin mechanisms. Therapies that reduce stress have been shown to increase milk 
production. For example one study found that mothers exposed to music-based, visual 
and verbal interventions over 6 days significantly increased volume of milk production 
(using a milk pump) and  milk fat concentration (Keith et al., 2012) (Figure 1.9). 
Class of factors Factors 
Pituitary hormones ACTH, Oxytocin, Prolactin, Growth hormone,  
Melatonin 
Steroids Corticosteroids, Oestrogen, Progesterone 
Thyroid hormones Thyroid stimulating factor, T3, T4 
Hypothalamic releasing hormones CRH,  GHRH, GnRH, TRH 
Metabolic hormones Insulin, Leptin, Adiponectin, Ghrelin 
Growth factors EGF, PDGF, VEGF, NGF, IGF, erythropoietin, calcitonin, 
lactoferrin 
Cytokines IL-6, IL-7, IL-8, IL-10, FNy, TNFα, TGFβ 
Imunoglobulins IgM, IgG, IgA 
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Some research shows that depression may decrease the prevalence of breastfeeding. One 
study has shown that a negative correlation between depression and breastfeeding at 6 
weeks after birth that no longer correlated at 12 weeks suggesting that depression  in the 
early postnatal period might lower the prevalence of breastfeeding (Hatton et al., 2005). 
Animal studies also show that stress can inhibit lactation, depending on the type of 
stressful stimuli (Dewey, 2001). One mechanism is that maternal stress has been shown 
to reduction oxytocin levels (Lau, 2001; Dewey, 2001) that in turn reduces milk ejection 
reflex. It is also possible that prolactin, may also be affected by stress (Torner, 2016) 
 
1.5.7.5 Effects of stress on cortisol/corticosterone levels in milk  
 
 
In a cross-sectional study by Benjamin et al. (Murgatroyd et al., 2015b) on maternal and 
infant cortisol levels and breastfeeding status in 54 mothers and their infants (20 partially 
or fully breastfed and 34 formula fed) found significant correlation of cortisol at bedtime 
between breastfeeding mothers and infants. Interestingly, this correlation was not found 
with formula fed infants and mothers. The authors suggested mechanisms might be that 
environmental factors of skin-to-skin contact and maternal-fetal physical interaction are 
typically increased in breastfeeding dyads compared with formula fed dyads (Mörelius et 
al., 2015), and there is increased correlation of cortisol in the former group. They further 
suggest the possibility of  a transfer of cortisol in human milk that may also contribute to 
the increased correlation observed (Neelon et al., 2015). 
Multiple rodent studies have found that the increased ingestion of cortisol (e.g. via 
mother’s milk or experimental supplementation) is beneficial to the offspring, as it 
improves spatial memory, reduces anxiety, and improves the function of the HPA axis 
(Casolini et al., 1997; Catalani et al., 2000). The opposite, however, has been described in 
human studies, where infants ingesting higher levels of cortisol are found to have greater 
anxiety and stress related behaviours  (Grey et al., 2013).  
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Figure 1.9. Schematic showing the effect of stress on milk corticosterone levels in cows. Stress caused a reduction in 
milk cortisol and lower milk volume compared to cows that received music therapy and showed a reduction in cortisol 
and increase in milk production.  
1.5.7.6 Effect of stress on BDNF levels in milk 
A study by Ismail et al looked at BDNF levels in infant serum and maternal breast milk in 
epileptic infants under 2 years of age, compared with healthy breastfed infants. They 
found significantly higher BDNF levels in the epileptic infants and in their mother’s breast 
milk, compared to the serum of healthy control infants and their mother’s milk (Ismail et 
al., 2015). 
 
1.5.7.7 Transgenerational milk  inheritance 
“lactocrine programming” a term first used by Bagnell describes the process by which 
hormones in the mother’s milk are able to influence behavioural, developmental and 
physiological processes within in the suckling offspring (Bagnell et al., 2009) Studies 
support the concept that the hormones within the mother’s milk, when ingested, are able 
to bind to receptors within the sucking offspring activating hormonal signaling cascades 
in the offspring. It is therefore important to understand the effect of depression and stress 
on the levels of these hormones in breastmilk, as these may in turn impact stress-
regulatory systems and behaviour in the offspring. 
 
In the previously mentioned three generational chronic social stress (CSS) rat model, to 
study the effect of stress on the inheritance of maternal depression, anxiety and care 
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behaviours, an intergenerational reduction in maternal care was found. In the study 
Murgatroyd et al. reported reduced milk intake in the first generation (F1) on days 9 and 
16, and reduced milk intake in the second generation (F1) on day 2 (Nephew et al., 2017) 
supporting that milk intake was reduced as a result of impaired maternal care observed 
in those generations. Interestingly, the female F1 dams also demonstrated reduced 
oxytocin receptor, vasopressin, and prolactin gene expression in the hypothalamus and 
amygdala.  
 
1.6 Summary of possible mechanisms underlying transgenerational inheritance 
of stress and maternal depression 
 
1.6.1 The role of maternal behaviour in programming transgenerational inheritance of 
infant behaviour 
Non-genomic transmission of behavioural traits has been shown for maternal care in rats. 
Several studies have shown that maternal care of offspring was highly correlated to the 
behaviour exhibited by their own mothers in the first postnatal weeks (Francis et al., 1999; 
Pan et al., 2014; Champagne, 2011; Nephew and Murgatroyd, 2013; Nephew et al., 2017). 
Behaviour in turn could alter endocrine and immune regulators of stress in the offspring. 
 
1.6.2 Transgenerational inheritance of epigenetic factors regulating maternal care 
It is hypothesised that maternal stress and the mother’s care determine offspring 
behavioural traits and their stress responses through epigenetic mechanisms 
(Murgatroyd and Spengler, 2011a). For example experiments in rodents show that 
experiences during sensitive periods of development influence DNA methylation patterns 
of several genes and that these patterns represent stable epigenetic modifications that 
alter gene transcription throughout the lifespan and promote specific behavioural 
outcomes (Murgatroyd et al., 2009). 
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Figure 1.10. Summary of the mechanisms underlying transgenerational inheritance of behavior 
 
 
1.6.3 Summary 
This chapter provides evidence from previously published studies that: 1, stress may be 
transgenerationally inherited in both rodent models and human cohorts; 2, epigenetic 
marking of key genes are modulated by early life stress and further associate with later 
life depression; 3, endocrine factors are effects by early life exposure to stress; 4, the 
immune system is sensitive to early stress; 5, factors in milk can be regulated by stress in 
the mother and may influence stress regulation in the offspring. 
 
 
1.6.4. Aims of all chapters  
The aim of this thesis is to test for mechanisms involved in transgenerationally inherited 
stress using both rodent studies and human cohorts: Study 1 (Chapter 3) we will 
investigate and identify stress-related hormones and immune factors involved in the 
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possible intergenerational transmission of maternal behavior and depression using a 
rodent model. Study 2 (Chapter 4) we will perform a hypothesis-free genomewide screen 
using RNAseq to identify genes that are transgenerationally inherited following maternal 
stress and depression. Study 3 (Chapter 5) we will test epigenetic regulation of candidate 
genes in human studies of maternal stress and infants exposed to early stress. Study 4 
(Chapter 6) we will explore the possible role of stress in the regulation of milk factors and 
identify key hormones that might be involved in the intergenerational transmission of 
maternal behavior and depression. 
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2 Chapter 2: METHODS AND MATERIALS 
2.1 Introduction 
This study uses a rodent model and two human studies to investigate, in a translational 
manner, the role of factors important in the intergenerational inheritance of stress 
through maternal depression (Figure 2.1). Stress-related, endocrine, immune and growth 
factors were measured in serum and milk using ELISA assays. Gene expression was 
measured in brains using real-time PCR and next generation sequencing, and DNA 
methylation studied using bisulphite sequencing.  
 
Figure 2.1. Timeline Flow chart of measurements  
2.1 CSS Animal Model 
The Sprague-Dawley rats were exposed to CSS and bred and behaviourally tested at Tufts 
University in collaboration with Dr Ben Nephew (Murgatroyd and Nephew, 2013). These 
animal experiments were performed in accordance with the guidelines of the Committee 
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of the Care and Use of Laboratory Animals Resources, National Research Council, and the 
research protocol was approved by the Tufts Institutional Animal Care and Use 
Committee.  
The intergenerational maternal depression model involved subjecting F0 dams to a 
Chronic Social Stress (CSS) procedure from the 2nd to the 16th day of lactation. The CSS 
consisted of introducing a novel male intruder (this was smaller than the female so could 
not hurt the dam) while controls were left undisturbed, (Carini et al., 2013). Twelve dams 
of CSS and control were produced. The offspring of the F0 control and CSS dams are the 
F1 control and F1 CSS animals. On day 23 after weaning all the F1 offspring were housed 
in groups of four until 70 days old when two from each litter were mated with other 
Sprague-Dawley males. The F2 control and CSS animals were treated identically 
throughout the study. The final F2 sample sizes were n=14 and n=14 for the control and 
CSS groups respectively. Importantly, and there were no significant treatment differences 
in litter size or number or bodyweights at the F2 juvenile or adult stage, (all p’s > 0.2) 
(Carini and Nephew, 2013). See (Figure 2.2) for an overview of the CSS model and the F0 
to F2 generations. Brains, milk and serum were shipped to the MMU for analysis as part 
of this project. Brain punches from the hippocampus were taken. 
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Figure 2.2. Schematic of the intergenerational model for chronic social stress. F0 Dams are exposed to stress (by 
introduction of novel male intruder) during lactation in specific days (d) for maternal behaviour and endocrine measures. 
Her offspring (F1) are then allowed to grow and then tested and these offspring (F2) then tested for maternal behaviour 
and endocrine and immune measures. 
 
2.2 Human Study Populations 
 
Two human cohorts were studied; the Wirral Child Health and Development Study 
(WCHADS), and the Latino Mothers Study. This was to allow testing DNA methylation with 
depression in 2 separate studies. It also allowed testing DNA methylation in children 
exposed to maternal depression in the WCHADS and the effects of stress (in the form of 
perceived discrimination) on DNA methylation in the Latino study. 
 
2.2.1 WCHADS 
 
The Wirral Child Health and Development Study (WCHADS) is a longitudinal study of 
prenatal and infancy origins of conduct disorders involving 1233 mothers with babies 
living in the Wirral area of the UK. A random subsample of 316 mothers were recruited 
as an intensive sample for which DNA was available from mothers and their offspring at 
multiple time points. The mothers at 20 and 32 weeks gestation were tested for prenatal 
depression and anxiety. The mothers and infants were then tested at 5, 9, and 29 weeks, 
and at 14 months for postnatal depression, depressive symptoms and anxiety. DNA was 
extracted from saliva obtained from the infants-children for 8 time points (within this 
study we used DNA collected at age 3). This DNA was used for methylation analyses.  
 
2.2.2 Latino study 
The Latino study is a longitudinal study of healthy pregnant Latina women (n = 150) living 
in North Carolina (NC) were enrolled in the study between May 2016 to March 2017. The 
mean age was 27.6 years old and exclusion criteria included those with severe depressive 
symptoms, a history of psychotic or bipolar disorder, or substance dependence to avoid 
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confounders and control for severe mood symptoms. Data collection was completed in 
English or Spanish, depending on participants preference, by a trained research assistant 
at the prenatal visit at 24-32-week gestation and a postnatal visit 4-6 weeks following 
birth. DNA was extracted from the mothers from blood samples by Hudson Santos from 
South Carolina and shipped to Manchester. This study was approved by the Institutional 
Review Board of the University of North Carolina at Chapel Hill (#15-3027). 
 
2.2.3 Measures of stress 
 
Perceived Discrimination: The Everyday Discrimination Scale (EDS), a nine-item 
questionnaire, was used to measure routine, day-to-day experiences of discrimination at 
prenatal and postnatal. The stem question is: “In your day-to-day life, how often do any 
of the following things happen to you?” Sample items include: “You are treated with less 
courtesy than other people are,” “People act as if they think you are dishonest” and, “You 
are called names or insulted.” Participants then link main reason for these discrimination 
experiences, including gender, race, ancestry, religion. In addition, participants were 
asked whether they have felt any type of ethnicity-based discrimination during their 
lifetime. The EDS is a widely used measure of subjective experiences of discrimination 
(Williams et al., 1997), with validated Spanish translation (Campo-Arias et al., 2016); It 
correlates with measures of institutional racial discrimination and interpersonal prejudice 
(Krieger et al., 2005) and does not prime the subjects to think about race, which limits 
cues to prejudice prior to responding to the questions (Deitch et al., 2003).  
 
2.3.4 Measure of maternal depression 
  
Inventory of Depression and Anxiety Symptoms - General Depression Scale (IDAS-GD): 
This was used in the Latino study to comprehensively assess depressive symptoms (O'hara 
et al., 2012) to account for negative mood prenatally and postnatally. A higher IDAS-GD 
scores indicates more severe symptoms. For control non-depressed women the Typical 
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IDAS-GD score is around 32.4 and for high-risk women it is 37.4. Scores between 44.6 and 
57.3 signify depression (Schiller et al., 2013; Medeiros et al., 2018; Fletcher et al., 2015) 
 
Edinburgh Postnatal Depression Scale (EPDS): This is a 10-item self-report questionnaire 
that was developed to identify women who have postnatal depression and is an 
established screening tool for monitoring depressive symptoms in the postnatal period, 
as well as parental. It is usually used as a single score and has been used in longitudinal 
research studies, in many cross-sectional studies on maternal wellbeing, as well as in 
clinical practice. Up to 3 points are given for each question with 0 – 8 points signifying low 
probability of depression, 8 – 12 points suggestive of mild most likely just dealing with a 
new baby or the baby blues, 13 – 14 points suggest signs leading to possibility of Postnatal 
Depression, and 15 + points signifies a high probability of experiencing clinical depression. 
Importantly, this test is not diagnostic (Cox et al., 1987). 
 
2.3.4 Analysis of serum proteins 
 
ELISA was used to measure the concentration of specific factors in the serum using single-
plex assays or customisable multiplex assays (MILLIPLEX MAP, Millipore) (Table 2.1). ELISA 
allows the detection of specific proteins by specific antibodies, as part of an 
immunoassay. Through a series of incubation and washing steps, these antibodies, which 
are linked, to an enzyme, will detect protein coating the bottom of a well on a microtiter 
plate. When exposed to a substrate, antibody-bound enzyme will cause a color change, 
indicating the presence of the protein-of-interest in the sample. A variation of this 
procedure is Luminex xMAP Technology where a microsphere (bead) array is used 
enabling multiple assays to be simultaneously performed from a single samples, i.e. 
multiplexing (Baker et al., 2012). 
Three assay panels were used to measure of pituitary hormones (ACTH, bdnf, TSH and 
prolactin), neuropeptides (α-MSH, β-Endorphin, Neurotensin, Orexin A, Oxytocin, 
Substance P), and anti-inflammatory cytokines (GM-CSF, sIcam-1, IFNγ, IL-2, IL-4, IL-6, IL-
10, TNFα and VEGF). Three assay panels were used to measure of cytokine (IL-1β, IL-4, IL-
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6, IL-10, IL-14, TNFα, IFNγ, VEGF and GM-CSF), vascular injury, (Timp-1), and cardiac injury 
(Icam-1) were purchased from Millipore and R&D Systems (R&D Systems, UK) was 
conducted on a Luminex 200 Bio-Plex Platform. Immediately prior to the initiation of the 
study, the Bio-Plex platform underwent a complete on-site maintenance cycle. Samples 
were thawed directly on the day of analysis. Working wash solutions and protein 
standards were prepared within 1 hour of beginning the assay by reconstituting the 
standard in assay diluent and performing serial dilutions according to manufacturer 
specifications. A magnetic plate washer was utilized during the plate washing stages. 
Following processing, protein concentrations were calculated and analyzed with the 
xPONENT software (Luminex, v.3.1.871). The majority of samples were run in duplicate in 
an individual assay to eliminate interassay variation. 
 
Table 2.1. List of endocrine and immune factors measured in rat plasma using (ELISA) single-plex and multiplex 
immunoassays 
ELISA kit (Supplier) Supplier 
Oxytocin ELISA kit (ENZO) Oxytocin 
Corticosterone ELISA kit (ENZO) Corticosterone 
GXR ELISA kit Cat no: 80-0060 
(ENZO) 
GxR 
bdnf, OXT, GR, ICAM-1, CORT (single) 
MILLIPLEX R MAP RAT 
Neuropeptides Magnetic Bead Panel 
(Millipore) 
α-MSH, β-Endorphin, Neurotensin, Orexin A, Oxytocin, 
Substance P 
MILLIPLEX R MAP RAT Pituitary 
hormones Magnetic Bead Panel 
(Millipore) 
ACTH, bdnf, TSH and prolactin 
MILLIPLEX R MAP RAT Anti-
inflammatory cytokines Magnetic 
Bead Panel (Millipore) 
GM-CSF, sICAM-1, IFNγ, IL-2, IL-4, IL-6, IL-10, TNFα 
and VEGF 
MILLIPLEX R MAP RAT 
Cytokine/Chemokine) Magnetic 
Bead Panel (Millipore) 
IL-1β, IL-4, IL-6, IL-10, TNFα, IFNϒ.  
and  L1B,4,6,10,12,18  
fromTNFα, INFYα, GM-CSF, VEGF. 
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MILLIPLEX R MAP RAT Cardiac 
Injury Magnetic Bead Panel 1 
(Millipore) 
Timp-1 
MILLIPLEX R MAP RAT Vascular 
Injury Magnetic Bead Panel 2 
(Millipore) 
ICAM-1 
 
 
3.2.3 Microdisection of hippocampus using brain punches 
 
Frozen rat brains were sectioned using a LEICA cryostat at -18°. A scalpel was used to cut 
off the cerebellum and the rest of the brain sample was stuck to a chuck using Neg50 glue 
and placed in the pre-chilled LEICA cryostat to freeze. 
The brain was sectioned cronally until the hippocampus was arrived at. A section was 
placed on a frosted slide and melted to the slide before staining for 2 minutes in cresyl 
violet fast (company). This was then washed in ethanol for 2 minutes and water for 1 
minutes. The brain slice was visualized using a light microscope. Once the hippocampus 
is seen brain punches were taken across the hippocampus using a tissue borer (1 mm 
diameter) (Figure 2.3). Two punches were taken from both sides of the hippocampus. The 
punches were then placed in a pre-frozen Eppendorf tube and stored at -80° until 
extracted for DNA and RNA.  
 
Figure 2.3. A cresyl violet stain of rat hippocampus and a frozen brain with a punch taken to show the diameter of 
the punch in relation to the hippocampus. 
 
3.2.3 Simultaneous RNA and DNA extraction from brain punches 
 
Brain punches were extracted for both RNA and DNA (see Figure 2.3 for the scheme). This 
allowed to reduce the number of animals needed and allowed to correlate RNA 
expression and DNA methylation within the individual animals. The frozen brain punches 
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were digested in 800 μl of Trisure (Bioline) using a vortexer and a 23-gauge needle. This 
was incubated for 5 minutes at RT followed by adding of 160 μl of chloroform. Samples 
were then shaked vigorously for 15sec and incubated for 5 minutes at RT. Samples were 
then centrifuged at 12,000xg for 15 minutes at 4°C. Three phases appeared: the upper 
colorless portion that contains RNA, the lower portion containing the solvent and the 
middle layer containing the DNA and protein. The upper phase (RNA) was transferred into 
clean into Eppendorf tubes and the RNA precipitated by adding 500 µl of ice-cold 
isopropanol followed by sample incubation for 10 minutes at room temperature. This was 
then centrifuged at 12,000xg for 10 minutes at 4°C. The supernatant was removed and 
RNA wash was performed by adding 1ml of 75% ethanol to the pellet and vortexed then 
centrifuged at 7500xg for 5 minutes at4°C. Finally, the pellet was air dried and dissolved 
in 25 µl DEPC-treated water. 
The middle layer (DNA and protein) was taken and DNA extracted following a DNA 
extraction kit (Bioline). 180 μl of the lysis buffer GL was added, followed by 200 μl of G3. 
After  incubation for 10 minutes at 70°C in a heat block (Labnet or Grants), 210 μl of 100% 
ethanol was used to wash the sample, and the resulting sample transferred to a spin 
column and centrifuged (SIGMA 3-16K) to allow DNA binding. Subsequent column washes 
were applied to remove unwanted proteins and salts. 30 μl of elution buffer G was added 
to the spin column to elute the DNA.  
The DNA and RNA quality and quantity was measured by using the NanoDrop 1000 
spectrophotometer (ThermoScientific). The RNA concentrations and purity were 
determined by assessing the ratio of absorbance at 260/280 nm and 260/230 nm. Ratios 
of 260/280 nm of ~1.8 and ~2.0 were accepted as “pure” for DNA and RNA, respectively, 
with 260/230 values in the range of around 2.0-2.2 and similar in all samples. 
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Figure 2.4.  Flowchart of the Simultaneous RNA and DNA extraction from brain punches  
 
3.2.3.2 Bisulfite conversion of DNA 
 
200ng of extracted DNA, for each sample, was bisulfite treated and purified using the 
EpiTect Fast DNA Bisulfite Kit 200 (QIAGEN). See (Figure 2.5) for scheme. In summary, 
sodium bisulfite solution and sodium hydroxide (DNA protection buffer) were both mixed 
with the samples, before incubation in a thermocycler (SureCycler 8800; Agilent 
Technologies Inc., Santa Clara, USA) with the following settings: 95°C (5 minutes), 60°C 
(20 minutes), 95°C (5 minutes), 60°C (20 minutes) to ensure denaturation of the DNA and 
optimal deamination. The DNA was added to a spin column following and desulfonation 
buffer added followed by wash buffer and finally, elution buffer to dissolve the DNA from 
the spin column membrane and elute the bisulfite DNA.   
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Figure 2. 5.  Flowchart of the Bisulfite treated DNA 
 
 
3.2.3.3 Bisulphite PCR  
 
Bisulfite DNA was amplified by Polymerase chain reaction (PCR) with primers specific to 
bisulphite converted DNA and modified with a Biotin for the pyrosequencing method (see 
table 2.4). The total volume of reaction mixture was 20 μl: 10 μl myTaqHS, 1 μl Forward 
primer (10 μM), 1 μl Reverse primer (10 μM), 6 μl water MiliQ H2O. Reaction mixtures 
were made up as a master mix and plated out in a 96-well plate before additon of 2 μl of 
bisulfite DNA (which equals about 10 ng) DNA to each tube of the plate. The plate was 
placed in a thermocycler (PCR Agilent Technologies SureCycler 8800; Agilent)  with the 
following program: 95°C (30 minutes), 58°C (30 minutes), 72°C (30 minutes) (45 cycles) 
that worked for both PCRs. A number of programs with different annealing temperatures 
from 55°C -60°C were tried, together with various primer concentrations and the products 
tested by gel electrophoresis, and the best program was recorded (Table 2.2). 
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Table 2.2. Primer sequences, locations and sequences of regions targeted by bisulphite pyrosequencing 
Gene 
(location) 
Species Primers; Forward (F), Reverse (R), 
Sequencing (S),  
Biotinylation (B) 
PCR cycle Sequence analysed (CpGs 
numbered) 5’–3’ 
Nr3c1 Rat F-TTGGTTTGGGAGGGAAAT; 
R-(B)AACTATCCCCTCCAAAACTCTAACTAC 
S-CCCTCCAAAACTCTAACTACC   
94°C 30sm 
56°C 30s 
72°C 30s 
50 cyc. 
(CpG1)CR(CpG2)AAACTAAACR(
CpG3)AAAACR(CpG4) 
AAAAAAAAATAAC 
bdnf Rat  F-AAAGGGGGTTTAGGGAGTTAT 
R-(B)ACTATCATATAATACCTCCTCTACC 
S-AGGTTTGGTTTTTGTG 
94°C 30sm 
56°C 30s 
72°C 30s 
50 cyc. 
(CpG1)CR(CpG2)AAACTAAACR(
CpG3)AAAACR(CpG4) 
AAAAAAAAATAAC 
NR3C1 
(hg19;chr5:
143,404,04
4- 
143,404,07
6) 
Human  F-(B)AATTTTTTAGGAAAAAGGGTGG 
F-AACCCCTTTCCAAATAACACACTTC 
S-AACTCCCCAATAAATCTAAAAC 
94°C 1m 
60°C 1m 
72°C 1m 
50 cyc. 
CR(CpG1)CR(CpG2)AAACTAAAC
R(CpG3)AAAACR(CpG4) 
AAAAAAAAATAAC 
BDNF (hg 
19; 
chr11:27,70
1,578- 
27,701,672) 
Human  F-GATTTTGGTAATTCGTGTATTAGAGTGTT 
R-(B)AATGGAGTTTTCGTTGATGGGGTGCA 
S-AGATTAAATGGAGTTTTCGTTGAT 
 
94°C 1m 
56°C 1m 
72°C 1m 
50 cyc. 
Y(CpG1)GTAY(CpG2)GTTAAGGT
ATY(CpG3)GTGGAGTTTTTTY 
(CpG4)GTGGATTTTTATTTATTTT
TTTATTTATY(CpG5)GY 
(CpG6)GGAGAGGGTTGTTTTY(C
pG7)GTTGTYGTTTTTTTYGGYG 
FKBP5 
(hg19; 
Chr6: 
35,558,48-
35,558,567) 
Human  F-GGATTTGTAGTTGGGATAATAATTTGG  
R-(B)TCTTACCTCCAACACTACTACTAAAA 
S-GGAGTTATAGTGTAGGTTT 
94°C 1m 
60°C 1m 
72°C 1m 
50 cyc. 
TTTY(CpG1)GTGATTTTTGTGAA
GGGTATAATTY(CpG2) 
GTTTAGTTTTGAAAAG 
 
3.2.3.4 Bisulfite Pyrosequencing 
 
Bisulfite pyrosequencing was done to measure the degree of DNA methylation at 
individual CpG sites. It was carried out on the PyroMark Q24 system (Qiagen, Hilden, 
Germany) using the PyroMark Q24 Advanced CpG reagents following the manufacturer’s 
instructions. In rat samples, promoter IV of the bdnf gene and promoter 1.7 of the Nr3c1 
gene were analyzed. In human samples, BDNF promoter 1.4, NR3C1 promoter 1.F and the 
FKBP5 promoter were analysed.   
For each 10 μl of PCR product, 1 μl of Streptavidin Sepharose High Performance beads 
(GE Healthcare), 40 μl of binding buffer, and 29 μl of ddH2O were added in a 24-well PCR 
plate. The plate was placed on a shaker for 10 minutes at 1400rpm at room temperature. 
The samples were then treated using the PyroMark Q24 workstation (Qiagen) as follows: 
5 seconds in 70% ethanol, 5 seconds in denaturation buffer, and 10 seconds in wash 
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buffer. Following this, the samples were added to 25 μl of 0.3μM diluted sequencing 
primer in a Q24 sequencing plate, and heated for 2 minutes at 80°C before setting aside 
at room temparature. The PyoMark Q24 advanced CPG Reagents (Qiagen) were added to 
the sequencing cartridge, using the volumes determined by the PyroMark Q24 Advanced 
software. Both the cartridge and the Q24 sequencing plate were placed in the Q24 
sequencer (Qiagen), and the methylation levels determined using the PyroMark Q24 
advanced software. See (Figure 2.6) for a scheme. 
 
Figure 2.6.  Flowchart of Bisulfite Pyrosequencing  
Using the PyroMark Q24 Advanced CpG reagents system 
For each 10 μl of PCR 
product, 
1 μl of Streptavidin 
Sepharose beads, 40 
μl of binding buffer, 
and 29 μl of ddH2O 
were added in a 24-
well PCR plate 
The plate was placed on 
a shaker for 10 minutes 
at 1400rpm at room 
temperature 
The samples were then 
treated using the 
PyroMark Q24 
workstation (Qiagen) as 
follows: 
5 seconds in 70% 
ethanol, 5 seconds in 
denaturation buffer, 
and 10 seconds in wash 
buffer 
The samples were added 
to 25 μl of 0.3μM diluted 
sequencing primer in a 
Q24 sequencing plate 
It heated for 2 minutes 
at 80°C before setting 
aside at room 
temparature 
Nuclotoids were added 
to the sequencing 
cartridge, using the 
volumes determined by 
software 
  
Both the cartridge and the Q24 sequencing plate were placed in the Q24 sequencer and the methylation 
levels determined using the PyroMark software.  
  
  
  
  
  
  
    
  
    
F S A 
T 
G 
C 
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3.2.4 RNA reverse transcription 
 
The quality and quantity of the RNA was measured using the NanoDrop 2000 
spectrophotometer (ThermoScientific). The RNA concentrations and purity were 
determined by assessing the ratio of absorbance at 260/280 nm and 260/230 nm. 
The GoScript Reverse Transcription system was used to convert the RNA to cDNA by 
reverse transcription. Reaction mixtures (5 μl) were made as follows: total RNA (200ng), 
Hexamer primer (1 μl), and nuclease free water. The reaction mixtures were added to a 
new PCR plate and then incubated at 70°C for 5 minutes, before 10 seconds of 
centrifugation. Each 5 μl RNA reaction mix was added to 15 μl of reverse transcription 
reaction mix (20 μl). The total 20 μl was placed in a thermocycler (PCR Agilent 
Technologies SureCycler 8800) with the following settings:  95°C (5 minutes), 60°C (1 
hour), 72°C (15 minutes). 
 
3.2.4.2 Real-time polymerase chain reaction (RT-PCR) 
The cDNA from the previous step, was then amplified using RT-PCR. Briefly, the following 
reaction mixture was made up in each well of a PCR plate for 60 samples (30 bdnf, 30 GR): 
3 μl sample of cDNA, 15 μl SyBR (Bioline, UK), 1.5 μl of bdnf/GR Forward primer, 1.5 μl of 
bdnf/GR Reverse primer and 9 μl of nuclease free water. The PCR plate was placed in a 
real-time PCR system (Stratagene Mx3000P): 95°C (30 seconds), 60°C (30 seconds), 72°C 
(30 seconds) (40 cycles).  
Expression levels for oxt, oxt receptor (oxtr), avp, avp V1a receptor, the long form of the 
prolactin receptor, GR (Nr3c1) and MR (Nr3c2) were normalized against three combined 
housekeeping genes, β-actin, hypoxanthine phosphoribosyltransferase (hprt) and 
glyceraldehyde-3-phosphate dehydrogenase (gapdh). Sequences of primers for real-time 
PCR are given in (Table 2.3). 
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Table 2.3. Primer sequences for real-time PCR 
Primers Species Sequence (5’-3’) PCR cycle 
B-actin Rat -TTGCTGACAGGATGCAGAA;  
R-ACCAATCCACACAGAGTACTT 
94°C 2m  
94°C 5s 
62°C 5 
72°C 10s 
45cyc 
Hprt Rat F-CATCACCATCTTCCAGGAGC;  
R-TAAGCAGTTGGTGGTGCAGG 
94°C 2m  
94°C 5s 
58°C 5 
72°C 10s 
45cyc 
Gapdh Rat F-TGGTCAAGCAGTACAGCCCC;  
R-TACTGGCCACATCAACAGGA 
94°C 2m  
94°C 5s 
60°C 5 
72°C 10s 
45cyc 
Nr3c1 Rat F-AGGGGAGGGGGAGCGTAATGG;  
R-CCTCTGCTGCTTGGAATCTGC 
94°C 2m  
94°C 5s 
58°C 5 
72°C 10s 
45cyc 
Bdnf Rat  F-AGGGGAGGGGGAGCGTAATGG;  
R-CCTCTGCTGCTTGGAATCTGC 
 
94°C 2m  
94°C 5s 
58°C 5 
72°C 10s 
45cyc 
 
3.2.4.2.1 Gel electrophoresis 
 
Gel electrophoresis (Bio_RAD) was used to confirm that the PCR products were 
adequately amplified, using 2% agarose gel and Midori Green. 
3.2.4.2.1 Statistical analysis 
 
The cytokine and hormone levels were analysed with either 2-tailed or 1-tailed t-tests 
(these were not corrected for multiple comparisons), following tests for distribution. 
The use of a 1-tailed t-tests for the ICAM-1 analysis in the F1 rats was justified in the 
case of a priori results indicating direction in previous studies of the F2 adults. 
Pearson correlations were used to test for associations with DNA methylation in the 
human studies, following tests for distribution. All graphical results are presented as 
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mean + SEM, and the level of statistical significance was p ≤ 0.05. Excel was used for 
t-tests and graphs and SPSS for correlations.  
 
3.2.3.4 RNASeq 
RNASeq was performed according to methods provided as part of Chapter 4. Briefly, RNA 
was used to make a cDNA library prep and sequenced using an Illumina NextSeq Next 
Generation Sequencer. 
 
3.2.3.4 Analysis of rat milk 
ELISA was performed on rat milk according to methods provided as part of Chapter 6. 
Breifly, multiplex ELISA plates were used that were read using the Luminex Multiplex plate 
reader. 
 
2.1 Materials 
2.1.1 Equipment  
 
Table 2.4. Equipment used for laboratory 
Equipment Supplier Use 
NanoDrop 2000 
spectrophotometer 
ThermoScientific Quantification and purity of DNA 
and RNA samples 
Bioanalyzer 2100 Agilent Qualification of DNA and RNA 
samples 
Nanod Qubit 3 Flurometer Invitrogen Quantification and purity of DNA 
and RNA samples 
Thermocycler, SureCycler 8800; Agilent Technologies Inc., Santa 
Clara, USA 
PCR amplification, with 
Stepdown option 
Stratagene Mx3000P Stratagene Real-time PCR for cDNA 
expression and Genotyping 
Eppendrof PCR Mastercycler Eppendorf Bisulphite PCR amplification 
PyroMark Q24 system Qiagen, Hilden, Germany Pyrosequencing for CpG 
methylation 
Gel electrophoresis BIORAD Separation of DNA according to 
their size 
NextSeq® Sequencer system Illumina Next-generation sequencer 
Luminex XMAP TM Technology Millipore Multiplex ELISA analysis. 
57 
 
Bio Tek ® INSTRUMENTS elX405 
#250371 (U.S.A) 
Bio Tek Magnetic plate washer for ELISA 
Chemi/UV/Stain-tray & 
ChemiDoc UV (Bio-RAD) 
BIORAD Ultraviolet radiation touch 
imaging system 
Centrifuge SIGMA 3-16K Sigma 
 
For DNA extraction 
Centrifuge 5415 Eppendorf A non-refrigerated bench-top 
centrifuge for bisulphite DNA 
conversion 
Heater Techne Dri-Block DB-2D Sigma heater for denaturation of DNA 
prior to bisulphite 
pyrosequencing 
Shaker Thermo PeQlab 
 
For bisulfite sequencing 
Adjustable Pipette with Tips 
capable of delivering 25 μl to 
1000 ul. Lot 16271071 
Gilson- Thermo scientific For all experimental analyses. 
Multichannel Pipettes capable of 
delivering 5 μl to 50 μl or 25 μl to 
200 μl. 
BIORAD For pipetting multiple DNA 
samples. 
Laboratory vortexemixer VortexGenie mix small vials of liquid, attached 
to a rubber piece 
Sonicator (Grant  Ultrasonic 
cleaner # XUBA1) 
Grant Ultrasonic vibration so as to 
fragment 
Titer plate shaker (IKA MTS 2/4 
digital) 
IKA Assay and run plates, timed 
Automatic plate washer for 
magnetic beads 
Bio Tek Wash of magnetic microspheres 
with automatic buffer switching 
Microwave Sigma Melting of agarose 
PyroMark Q24 Workstation 
Qiagen- Q24 biomark tray 
Qiagen Washing and denaturing of PCR 
products for pyrosequencing 
Image/Gel doc  system BIORAD Imaging and documentation of 
agarose gels 
Cytostat LEICA CM3050S Brain sectioning and dissection 
 
 
2.1.2 Molecular biology kits 
 
Table 2.5.  Kits used for laboratory 
Kit Supplier Use 
EpiTect Fast DNA Bisulfite Kit 200  QIAGEN Conversion and purification of 
DNA 
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ISOLATE ll Genomic DNA kit  Bioline Isolation of high-quality total 
cellular RNA 
PyoMark Q24 advanced CPG 
Reagents 
Qiagen Advance quantitative CpG 
methylation to improve 
quantification of sequence 
RNA 6000 Nano Reagents part 1 
Kit-no 5067-1511 RNA 7000 
Nano Chips 
Agilent RNA quality and quantity 
Bisulphite Kit Qiagen Conversion of DNA for 
methylation analysis 
GoScript Reverstranscripase Kit Bioline Reverse transcriptase for 
efficient synthesis of first-strand 
cDNA optimized in preparation 
for PCR amplification 
Library Prep kit 
NEBNext Ultra RNA Library Prep 
Kit for Illumina  E7530S BioLabs 
no.: 0111612 
NEB input for libraries to be 
sequence on the Illumina 
RNA module 
NEBNext poly(A) mRNA Magnetic 
Isolation Module (BioLabs) 
NEB Isolation of poly(A)+ RNA. 
based on Oligo beads for binding 
of poly(A)+ RNA 
NEBNext Multiplex Oligos for 
Illumina kit- Biolab  E7335S No.: 
0121610, (set 1, NEB E7335); (set 
2, NEB E7500) 
NEB Library production 
base index primers with 
universal primer 
RNATURBO DNA-FREE TM Kit- 
Invitrogen by Thermo Fisher 
Scientific Lot: 00505703 
Thermo Fisher Single- and double-stranded 
DNA 
Luminex 100/200 Calibration Kit Illumina Calibration and verification 
DNA extraction kit Bioline Rapid purification of high-quality 
DNA to be ready for PCR, 
sequencing 
cDNA via the iScript cDNA 
Synthesis kit 
BIORAD  First-strand cDNA synthesis kit 
for gene expression analysis 
using real-time PCR 
High sensitivity DNA Reagents 
(Agilent Technologies) Lot No. 
1749 
Agilent Separation, sizing and 
quantification 
 
2.1.3 Glass and Plastics  
Table 2.6.  Glass and Plastics used for laboratory 
 
Glass and Plastics Supplier Use 
Conical flask Pyrex Agarose gel preparation 
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Reagent reservoirs Starlabs ELISA 
Polypropylene microfuge tubes 
(0.5m., 1.5ml) 
Starlabs Most experiments 
96 well PCR plates 
PCR plate consumables STARLAB 
lot.15189- caps strip MicroAmp 
GIAGENS lot. No.154038416 
Mat.No. 1071591  
UNSKIRTED SKIRTED for the Eppendorf PCR 
UNSKIRTED for the Stratagene 
Optical film- Lot no: 112571 BIORAD For sealing 96 Well PCR plate 
seals 
25G needle Starlabs DNA and RNA extraction 
Q24 plate holder  Qiagen For Pyrosequencing 
Filter RNA and RNase-free tips. 
(10 μl, 200 μl, 1ml) 
Starlabs For all DNA work and PCRS 
Non-Filter tips (10 μl , 200 μl, 
1ml) 
Starlabs ELISA and non-contamination 
risk experiments 
Brain micropunches  F.S.T For brain microdissection 
Magnetic rack 15 ml Tube- 2408 
– DYNAL Invitrogen bead 
separations 
Invitrogen For RNA library prep 
Parafilm 4 in. X125 FT.roll 
Pechirvey WI 54952 
Heathrow Scientific For loading agarose gels 
Pyromark Sequencing cartridge Qiagen For Pyrosequencing 
 
2.1.4 Chemicals  
Table 2.7. Chemicals used for laboratory 
Chemicals Supplier Use 
Trisure 38033  Bioline isolation of RNA, DNA 
Chloroform Sigma substances dissolve 
Isopropanol Sigma Dissolve, as cleaning fluid 
Ethanol (70% ,75%,80%, 100%) Sigma denaturing and dissolving 
RNAse free H2O Mat. No. 
1012888  
QIAGEN high purity 
MyTaqHS Mix,2x Cat No.Bio-
25046 Bioline 
Bioline Enzyme for PCR amplification 
Agarose  MELFORD MBI 200 
Cas:9012-36-6 No.20509- TBEx1 
MELFORD diagnostic tool to visualize the 
fragments to move the DNA 
across 
DNA stain madiore green 
advance 1ml Cat. No MG04  
NippoN Genetics EuRopE GMBH detecting nucleic acid in agarose 
gels 
DNA loading buffer  Bioline Mix with DNA samples for 
prepare DNA markers for  
loading on agarose  
hyperladder 25bp. 50bp  Bioline mass determination of DNA 
throughput agarose gels to 
determine the size of DNA 
fragments. 
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Bead (streptavidin sepharQse)  GE Healthcare (protein) 
Streptavidin strong interact with 
biotin used to purify antigens  
SYBR (Bioline, UK) 
 
Bioline binds to all dsDNA used in 
combination with a primer to 
detect PCR products in real-time.  
Richard-Allan Scientific NeG 50 
glue 
Thermo Scientific to prevent tissue separation 
from the slide 
Sheath Fluid (XMAP®) 
#B64487(U.S.A) 
 
Thermo Fisher Scientific the delivery medium that carries 
the sample to the optics 
component of Luminex 
 
2.1.5  Software  
Table 2.8. Software used to process Experiments 
Software Supplier Use 
PyroMark Q24 Advanced 
software 
Qiagen used with the QIAGEN kits 
PrimerDesign…for PCR product 
to seq 
Qiagen Check for validated designs on 
pyrosequencing 
Design primer/past 
seq/generate primer/ 
GraphPad GraphPad Software Inc.  
(through MMU) 
Table data for ELISA analysis 
SPSS SPSS Inc. 
(through MMU) 
correlation, regression, tables, 
scatter plot 
Exel Microsoft (through MMU) Makes figures  
Quantify-one programme 
softwere- UV light box BIO-RAD –
printer Sony 100V 1.5A 50/60H2 
BioRad For image calibration for 
quantify DNA/RNA 
Bacespace Illumina allows to use the apps to analyze 
RNASeq analysis data  
Babrahm bio. RNAseq analysis. 
Fast QC. Top HAT Alignment. 
Desseq2. HISAT2 
 
Babrahm Bioinformatics Analysing RNA sequence data in 
sequencing for analysis for 
(trimming, mapping and gene 
expression) 
SeqMonk BaseSpace mapped next generation 
sequence data of genomic  
Gene expression -RNASeq 
luminex 200 TM with XPONENT ®  
SOFTWARE 
Millipore assay workflow 
graphical user 
for Elisa data 
link program for automatic plate 
washer for magnetic beads of Bio 
Tek ®  
Bio Tek For wash plate of ELISA 
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Agilent high sensitivity DNA 
Assay- 2001 expert - Bioanalyzer 
system   
Agilent RNA quality, total 
RNA with RNA Integrity Number 
(RIN) and graphs 
DAVID protein pathway. analyses DAVID bioinformatics Gene ontology analyses and 
pathways 
PANTHER (protein analysis 
through evolutionary 
relationships)  
Thomas lab at the University of 
Southern California 
Gene ontology analyses 
Gene Ontology enrichment 
analysis and visualization tool 
UniProtKB-GOA, European 
Bioinformatics Institute, 
Cambridge, UK 
Gene ontology analyses 
 
2.1.6  Solutions 
 
Table 2.9. Solutions used for laboratory 
Solutions Recipe Use 
Pyrosequencing denaturation 
buffer 
0.2 M NaOH Pyrosequencing 
Pyrosequencing wash buffer PH 7.6 (10 Mm Tris-Acetate) Pyrosequencing 
10xTBE Dissolve 108 g Tris and 55 g 
Boric acid in 900 ml distilled 
water, add 40 ml 0.5 M 
Na2EDTA (pH 8.0) Adjust 
volume to 1 Liter., 
DNA and RNA gel 
electrophoresis 
Sheath Fluid (XMAP®) 
#B64487(U.S.A) 
 
(XMAP®)  Luminex 
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3 Study 1: Inheritance of endocrine, immune and epigenetic changes in a rat model 
showing inter-generational transmission of maternal depression 
3.1 Introduction 
Early adversities such as exposure to prenatal and postnatal stress such as maternal 
depression and reduced maternal care can produce long-lasting physiological and 
behavioural effects on offspring and future generations. In a rat model, exposure of dams 
to chronic social stress (CSS) during lactation reduces their levels of maternal care (Carini 
et al., 2013; Carini and Nephew, 2013; Murgatroyd et al., 2015b; Nephew and Bridges, 
2011). Interestingly, stress-related behaviours are increased and levels of maternal care 
reduced in their F1 offspring (Carini and Nephew, 2013; Murgatroyd and Nephew, 2013; 
Murgatroyd et al., 2015b). Furthermore, the F2 generation show even further 
exaggerated increases in maternal stress and reductions in maternal care behaviour 
supporting an intergenerational transmission of increasing maternal depression. 
Factors governing such transmission of maternal depression across the generations could 
include stress-regulatory factors important in the HPA axis, as discussed. Importantly in 
the CSS animal model the F1 animals were exposed to postnatal depressed maternal care 
while the F2 were exposed to both prenatal and postnatal maternal stress. Perhaps this 
might be reflected in an altered regulation of key factors between the generations. This 
could include ACTH and corticosterone that together with the glucocorticoid receptor are 
important in regulating the HPA axis (See Fig. 2.1) and prenatal and postnatal depression. 
Importantly, the HPA axis becomes differently regulated during pregnancy in the mother 
as the placenta, a transient endocrine gland, is formed; the placenta is also able to 
regulate the levels of corticosterone passing through to the developing offspring. Some 
studies have suggested interactions between HPA axis regulation across the prenatal and 
postnatal period (Murgatroyd and Spengler, 2011b; Laurent et al., 2013). Postnatally, the 
HPA axis exerts strong control over maternal behaviour through the regulation of stress-
response. 
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It is possible that hormones important in the regulation of maternal behaviour could also 
be important. For example, oxytocin and prolactin are crucial in regulating maternal care, 
as well as milk production (Nephew and Murgatroyd, 2013). The dysregulation of oxytocin 
in maternal depression is well described and further studies have shown that altered 
maternal care and maternal depression can in turn influence infant’s oxytocin together 
with behavioural changes (Priel et al., 2019). 
Serum levels of bdnf have been strongly linked to maternal depression (Fung et al., 2015) 
and studies have found associations with the regulation of bdnf in adulthood following 
variations in maternal care received as an infant (see Table 1.5). A number of other 
neuropeptides linked to depression include Substance P (Schwarz and Ackenheil, 2002), 
B-endorphin (Hegadoren et al., 2009), alpha-MSH (Kokare et al., 2010) and Orexin (Shariq 
et al., 2018) are also important candidates that could exert changes in behaviour 
postnatally or influence stress prenatally. Luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) are crucial in regulating the ovarian cycle and pregnancy. 
Additionally, these hormones are associated with stress and regulation of mood with 
studies reporting altered levels of these among women with depression (Huerta et al., 
1995). These hormones, important in the hypothalamic–pituitary–gonadal axis, are 
suppressed by the HPA axis and stress. Indeed low postnatal serum LH/FSH ratio has been 
shown to be a robust predictor of postnatal depression (Pillai et al., 2017). Therefore, 
measure of these factors could allow us to understand the role of stress in regulating 
depression in offspring. 
Alterations in the regulation of the thyroid during pregnancy through thyroid stimulating 
hormone (TSH) abnormalities have been associated with adverse neuropsychological 
function and behaviour problems in infants (Andersen et al., 2017) as with Growth 
hormone (GH) (Devesa et al., 2011). These factors, important in metabolism are also 
important for neurodevelopment, particularly in cognition but also in behaviour. One 
possibility is that metabolic pathways might be impacted by maternal depression that 
consequently impact neurodevelopment of behaviour in the offspring. There are further 
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growth factors with additional links to immune modulation, such as VEGF and GM-CSF. It 
appears that early neurodevelopment and immune development, as well as development 
of the HPA axis, are tightly linked. So perhaps there are factors linking these processes 
that might become dysregulated through exposure to depression prenatal and 
postnatally. Another factors important in neurodevelopment is ICAM-1 that is also linked 
to inflammation. For example, one study has shown that increased concentration in this 
factor in children born preterm associated with increased risks of cognitive dysfuction 
(Leviton et al., 2018). This factor is also important in regulating the blood-brain barrier 
that could be important in allowing peripheral inflammatory factors to impact 
neuroinflammation.  
Finally, there are immune factors to consider in the context of inflammation and its role 
in modulating the stress-response together with depression and its regulation during 
early prenatal and postnatal stress (Murgatroyd, 2018). Alterations in the levels and 
regulation of the interleukins IL-2, IL-4, IL-6, IL-8, IL-and 10 have all been clearly linked to 
risk for depression (Talarowska et al., 2016) as have interferons (Franscina Pinto and 
Andrade, 2016) and Tumour necrosis factors (TNFs) (Postal et al., 2016).   
The involvement of epigenetic mechanisms in the regulation of maternal depression and 
its transmission through the generations would be a plausible hypothesis supporting an 
intergeneration epigenetic process. Numerous studies have investigated DNA 
methylation at key candidate genes involved in stress regulation through prenatal and 
postnatal stress. As the F1 and F2 animals were exposed to postnatal and prenatal plus 
postnatal maternal stress this might be reflected in altered epigenetic regulation of key 
genes between the generations, or perhaps epigenetic marks are directly inherited 
through the generations. Importantly, we also test the for sex-specific effects in endocrine 
and immune studies to determine if transgenerational effects might differentially targets 
female offspring.  
This chapter looks to investigate the regulation of the above key factors linked to 
maternal behaviour, stress response, depression, neurodevelopment and inflammation 
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to investigate their possible roles in the generational transmission of maternal depression 
and stress-related changes. 
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3.2 Aims  
The aim of this part of the project is to investigate whether specific stress, endocrine and 
immune factors, together with epigenetic changes are differently regulated in response 
to maternal depression and whether any possible changes might be inherited. 
To do this, the CSS rat model of transgenerational changes in maternal care is studied 
using ELISA to investigate endocrine and immune markers, real-time PCR to test gene 
expression and bisulphite sequencing to measure DNA methylation. 
 
3.3 Objectives  
1. Measure endocrine markers of HPA regulation in generations of the CSS rat model. 
2. Measure endocrine factors important in maternal care in generations of the CSS rat 
model.  
3. Measure immune regulatory factors markers in generations of the CSS rat model.  
4. Measure epigenetic regulation of specific stress-related genes in generations of the CSS 
rat model.  
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3.4 Results 
Serum levels of hormones involved in the endocrine regulation of HPA axis 
(Corticosterone and ACTH) and the endocrine regulation of lactation and maternal care 
(Oxytocin and Prolactin) together with bdnf and TSH were firstly measured in the F2 
animals to check for transgenerational changes.  
LH, FSH, GH together with Orexin A were then also measured together with the above 
analytes in F1 and F0 animals to test whether they were inherited through the 3 
generations. Finally, Immune measures were also made of key inflammatory markers in 
F2 and then F1 and F0 animals of key factors. 
 
3.4.1 Endocrine regulation 
Serum levels of endocrine factors important in HPA axis regulation, Prolactin, bdnf, TSH 
and related to stress, were measured in the F2 animals. Specifically, F2 Dams from F0 CSS 
and control were compared at day 23 of lactation. 
 
3.4.1.1 HPA regulation in F2 
Serum levels of Corticosterone and ACTH were measured in the F2 animals as a function 
of HPA axis regulation at 2 timepoints: as a pup and as a lactating dam. This revealed 
significantly lower levels in the CSS F2 Dams compared to the controls at day 23 of 
lactation and significantly lower levels in F2 pups (Figure 3.1). 
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Figure 3.1. HPA axis function in F2 CSS and control dams. Mean + SEM of serum levels of corticosterone (CORT) in F2 
pups (d16) (A) and Dams (lactation d23) (B) and ACTH in Dams (lactation d23) (C) in CSS and control dams. * Indicates 
a significant effect of treatment (2-tailed t-test, p < 0.05). n= 11 control and 13 CSS Dams and 12 control and 12 CSS 
pups. 
 
3.4.1.2 Regulation of Maternal-related hormones in F2 
Serum levels of Prolactin and Oxytocin were measured in the F2 Dams animals. This 
revealed no significant differences between CSS and controls at day 23 of lactation in 
Oxytocin (p= 0.54) and Prolactin (p= 0.69) (Figure 3.2). 
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Figure 3.2. Oxytocin and Prolactin levels. Mean + SEM of serum levels of Oxytocin (A) and Prolactin (B) in CSS and 
control Dams (lactation d23). * Indicates a significant effect of treatment (2-tailed t-test, p < 0.05). Oxytocin n= 11 
control and 13 CSS Dams; Prolactin n=7 control and 8 CSS pups. 
 
3.4.1.3 bdnf and TSH regulation in F2 
Serum levels of bdnf were measured in the F2 Dams together with TSH. This revealed no 
significant differences between CSS and controls at day 23 of lactation in bdnf (2 –tail t-
test p=0.1) and TSH (2 –tail t-test p=0.35) (Figure 3.3).  
 
 
Figure 3.3. bdnf and TSH levels. 
Mean + SEM of serum levels of bdnf (A) and TSH (B) in CSS and control Dams (lactation d23). * Indicates a significant 
effect of treatment (2-tailed t-test, p < 0.05). n= 11 control and 13 CSS Dams and 11 control and 13 CSS pups. 
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3.4.1.4 HPA regulation in F1 
Serum levels of ACTH were measured in the F1 animals as a function of HPA axis 
regulation as a lactating mothers. This revealed no significant differences between CSS 
and controls at day 23 of lactation (2–tail t-test p=0.35) or in the adults (male, p=0.93; 
female, p=0.45) (Figure 3.4).  
 
 
Figure 3.4. Corticosterone and ACTH levels in F1 Dams and adults. Mean + SEM of serum levels of ACTH (A) in CSS and 
control mothers (lactation d23) and male and female adults (B). * Indicates a significant effect of treatment (2-tailed t-
test, p < 0.05). n= 11 control and 13 CSS Dams and 13 male and 12 female control and 12 male and 11 female CSS pups. 
. 
3.4.1.5 Regulation of Maternal-related hormones in F1 
 
Serum levels of Prolactin and Oxytocin were measured in the F1 Dams animals. 
Importantly, the Oxytocin assay was performed by a different method (Radio-Immuo-
Assay) in the lab of Dr Ben Nephew as our oxytocin ELISA assay did not work in the dams. 
When calculating the results this revealed no significant differences between CSS and 
controls at day 23 of lactation in Oxytocin (p= 0.28) and Prolactin (p= 0.78). There were 
also no differences in CSS and control adults for Oxytocin (male p= 0.88, female p= 0.92), 
but significantly reduced Prolactin in females but not males (p= male 0.45, female 0.04) 
(Figure 3.5). 
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Figure 3.5. Oxytocin and Prolactin levels. Mean + SEM of serum levels of Oxytocin (A) and Prolactin (B) in CSS and 
control Dams (lactation d23) and Oxytocin (C) and Prolactin (D) in CSS and control adults. * Indicates a significant effect 
of treatment (2-tailed t-test, p < 0.05). n= 12 control and 13 CSS Dams and for Prolactin n= 7 control and 8 CSS pups. 
 
3.4.1.6 bdnf and TSH regulation in F1 
 
Serum levels of bdnf were measured in the F2 Dams together with TSH. This revealed no 
significant differences between CSS and controls at day 23 of lactation in bdnf (2–tailed t-
test p=0.78) and TSH (2–tailed t-test p=0.36). In F1 adults bdnf and TSH also did not differ 
in either females or males (bdnf, 2–tailed t-test male p=0.45; female = 0.93; TSH, male 
p=0.48; female = 0.48) (Figure 3.6). 
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Figure 3.6. bdnf and TSH levels in F1. Mean + SEM of serum levels of BDNF (A) and TSH (B) in CSS and control Dams 
(lactation d23) and BDNF (C) and TSH (D) in CSS and control adults. * Indicates a significant effect of treatment (2-tailed 
t-test, p < 0.05). n= 12 control and 13 CSS Dams and for Prolactin n= 7 control and 8 CSS adults. 
 
3.4.1.7 Regulation of LH, GH and FSH in F1 adults 
 
Serum levels of LH, GH and FSH were measured in the F1 adults. This revealed no 
significant differences between males and females in either (LH, 2–tailed t-test male 
p=0.72; female = 0.24; GH, male p=0.91; female = 0.27; FSH, male p=0.4; female = 0.31) 
(Figure 3.7). 
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Figure 3.7. LH, GH and FSH levels in F1 adults. Mean + SEM of serum levels of LH (A) GH (B) and FSH (C) in CSS and 
control adults. * Indicates a significant effect of treatment (2-tailed t-test, p < 0.05). n= 12 control and 9 CSS female pups 
and n= 12 control and 12 CSS male adults. 
 
3.4.1.7 Regulation of Alpha-MSH, Substance P, Beta-endorphin and Orexin A in F1  
 
Serum levels of Alpha-MSH, Substance P, Beta-endorphin and Orexin A were measured in 
the F1 adults. This revealed no significant differences between males and females in 
either Alpha-MSH, Substance P, Beta-endorphin and Orexin (Figure 3.8). 
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Figure 3.8. Alpha-MSH, Substance P, Beta-endorphin and Orexin A levels in F1. Mean + SEM of serum levels of alpha-
MSH (A) Substance P (B) Beta-endorphin (C) and Orexin A (D) in CSS and control adults. * Indicates a significant effect 
of treatment (2-tailed t-test, p < 0.05). n= 12 control and 9 CSS female and n= 12 control and 12 CSS male rats. 
 
3.4.2 Regulation of immune markers 
 
A number of immune markers were measured to the effects of CSS and inheritance of 
different components of the immune system, namely Interferons (specifically, IFN-γ), 
Interleukins (specifically, IL-2, IL-4, IL-6 and IL-10), Tumour Necrosis Factors (specifically 
TNF-α). We also tested other immune-regulatory factors such as: GM-CSF, that functions 
as a cytokine and important in neuronal differentiation of adult neural stem cells and 
neuroprotection; VEGF, important in blood vessel growth in the CNS and together with 
neurogenesis, neuroprotection and inhibition of inflammation; Icam-1/CD54 a cell 
surface protein important in activation of inflammation and blood brain barrier. 
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3.4.2.1 Inheritance of IFNγ in F1 and F2  
 
Levels of IFNg were too low to measure in all serum samples two different assays on F1 
and F2 samples with different concentrations of serum tested and both gave values below 
the detection level for over 90% of the samples. 
 
3.4.2.2 Inheritance of TNFα in F1 and F2  
 
Levels of IFNg were too low to measure in around 80% of the samples in two different 
assays with different concentrations of serum used, leaving not enough samples for 
statistical analyses. 
 
3.4.2.3 Inheritance of Interleukins in F1 and F2  
 
Serum levels of interleukins were measured in F1 and F2 dams. This revealed no 
significant differences in IL-6 between CSS and controls dams at day 23 of lactation in F1 
(2–tailed t-test p=0.73) and F2 (2–tailed t-test p=0.91). There were no significant 
differences in Il-10 between CSS and controls dams at day 23 of lactation in F1 (2–tailed 
t-test p=0.64) and F2 (2–tailed t-test p=0.11) (Figure 3.9).  
For the Il-2 and IL-4 and ELISAs all serum samples produced values below the standard 
curve so could not be tested (data not shown).  
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Figure 3.9.  IL-6 and IL-10 levels in F1 and F2 dams. Mean + SEM of serum levels of IL-6 in F1 (A) and F2 (B) dams and 
IL-10 in F1 (C) and F2 (D) dams between CSS and control. * Indicates a significant effect of treatment (2-tailed t-test, p 
< 0.05). F1 n= 6 control and 8 CSS female and n= 11 control and 17 CSS mal. 
 
3.4.2.4 Inheritance of VEGF, GM-CSF, Icam-1 in F1 and F2 animals 
 
Serum levels of VEGF, GM-CSF, Icam-1 were measured in F1 and F2 dams. This revealed 
no significant differences in VEGF between CSS and controls dams at day 23 of lactation 
in F1 (2–tailed t-test p=0.66) and F2 (2–tailed t-test p=0.56). There were no significant 
differences in GM-CSF between CSS and controls dams at day 23 of lactation in F1 (2–
tailed t-test p=0.69) and F2 (2–tailed t-test p=0.89) (Figure 3.10).  
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Figure 3.10. VEGF and GM-CSF levels in F1 and F2 dams. Mean + SEM of serum levels of VEGF in F1 (A) and F2 (B) dams 
and GM-CSF in F1 (C) and F2 (D) dams between CSS and control. * Indicates a significant effect of treatment (2-tailed t-
test, p < 0.05). F1 n= 6 control and 8 CSS female pups and n= 11 control and 17 CSS male pups. 
 
There were no significant differences in Icam-1 between CSS and controls dams at day 23 
of lactation in F1 (2–tailed t-test p=0.45) and F2 (2–tailed t-test p=0.1).  However, if one 
considers the direction of Icam-1 in the F1 animals and uses a 1-tailed t-test, then there 
is a significant (p=0.05) decrease in CSS F2 animals (Figure 3.11). 
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Figure 3.11. Icam-1 levels in F1 and F2 dams. Mean + SEM of serum levels of VEGF in F1 (A) and F2 (B) dams, GM-CSF 
Mean + SEM of serum levels of ICAM-1 in F1 (A) and F2 (B) dams between CSS and control. * Indicates a significant effect 
of treatment (2-tailed t-test, p < 0.05). # Indicates a significant effect of treatment (1-tailed t-test, p < 0.05), n= 6-10 F1 
group and 11-13 F2 group). F1 n= 6 control and 8 CSS female pups and n= 11 control and 17 CSS male pups. 
 
Considering the reduced levels of Icam-1 in F2 CSS rats, and the direction of a reduction 
in the F1 CSS animals, F0 dams were also studied This revealed no significant differences 
(1-tailed t-test, p= 0.45) (Figure 3.12). 
 
 
 Figure 3.12.  Icam-1 levels in F0. Mean + SEM of serum levels in F0 CSS and control dams of Icam1. n= 10 control, 11 
CSS 
 
Considering the reduced levels of Icam-1 in F2 CSS rats, and the direction of a reduction 
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if those levels in the F1 dams associated with subsequence levels in their F2 offspring 
(Figure 3.13). This revealed no significant correlation 
 
Figure 3.13. Inheritance of I-cam1 between F1 and F2 dams. Serum levels of I-cam1 in F2 dams (y axis) were plotted 
against serum levels of I-cam1 in F1 dams.  
 
3.4.3. Epigenetic regulation of stress related genes in F1 and F2 dams. 
 
The hypothalamus was investigated for the regulation of Nr3c1 (GR) and bdnf in the CSS 
and control rat dams from the F1 and F2 generations to determine if the differentially 
regulation HPA axis, judging from the corticosterone changes related to alterations in GR 
and bdnf. 
 
3.4.3.1 Preparation of DNA and optimization of methods 
 
DNA from hypothalamus from F1 and F2 CSS and control rat dams were extracted 
together with RNA. Tissue punches were extracted and DNA and RNA quantities and 
quality measured. DNA concentrations were around 30-50ng/ml in 20 μl volume, 
therefore around 600ng-1ug (Table 3.1). However, the first 8 were lower – this is because 
learning the procedure increased its efficiency. The RNA levels were around 100-
300ng/ml in 20 μl volume, therefore around 2-6ug total RNA. 
The RNA was reverse transcribed to cDNA for measurement using real-time PCR. 
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Table 3.1. Comparisons of total DNA and RNA isolated from rat brain punches using Nanodrop 
                   DNA                                                                        RNA 
  
Sample 
  
  
Total 
conc. 
ng 
Conc. 
ng/ml 
260/280 
purity 
ng/ml 
260/230 
purity 
ng/ml 
Total conc. 
ng 
Conc. 
ng/ml 
260/280 
purity 
ng/ml 
260/230 
purity 
ng/ml 
1:5-1-1 261 8.7 1.77 1.00 2732 136.6 1.55 0.27 
2:25-1-1 270 9.0 1.87 0.18 10.614 530.7 1.37 0.31 
3:26-1-1 75 2.5 34.06 0.31 4292 214.6 1.60 0.34 
4:20-2-1 123 4.1 3.40 1.43 4274 213.7 1.57 0.90 
5:21-1-2 24 0.8 -1.87 -1.23 9772 488.6 1.97 0.67 
6:10-2-2 108 3.6 2.28 1.38 8330 416.5 1.90   
7:26-1-2 39 1.3 1.87 3.62 6982 349.1 1.71 0.52 
8:4-1-1 42 1.4 2.00 1.77 8772 438.6 1.82 0.73 
9:1-2-2 12 4.3 2.00   2088 104.4 1.64   
10:1-1-1 420 14.0 1.97 3.39 1766 88.3 1.61 0.31 
11:27-2-2 400 20.0 1.53 1.43 956 47.8 1.55 0.25 
12:22-2-1 784 39.2 1.46 2.0 119.6 99.6 1.61 0.25 
13:27-1-1 1362 26.1 1.61 1.48 6954 347.7 1.66 0.53 
14:26-2-1 1292 64.6 1.57 1.40 2672 133.6 1.61 0.30 
15:25-2-1 834 41.7 1.46 1.21 1494 74.7 1.46 0.30 
16:18-1-1 2114 105.7 1.35 0.07 3094 154.7 1.49 0.31 
17:14-1-1 1394 69.7 1.43 0.84 4398 219.9 1.70 0.33 
18:17-2-1 550 27.5 1.51 1.15 2172 108.6 1.61 0.29 
19:22-1-2 1162 58.1 1.50 1.20 2734 136.7 1.61 0.27 
20:27-2-1 800 40.0 1.57 1.40 4312 215.6 1.65 0.35 
21:18-2-1 1052 52.6 1.61   1906 95.3 1.47   
22:2-1-2 710 35.5 1.55   5226 261.3 1.62   
23:15-1-1 2668 133.4 1.23   4166 208.3 1.49   
24:21-1-1 1068 36.2 1.53   4026 201.3 1.58   
25:3-1-1 758 37.9 1.79   7810 390.5 1.57   
26:2-1-1 1346 67.3 1.46   4508 225.4 1.44   
27:17-1-1 926 46.3 1.49   2782 139.1 1.57   
28:24-1-1 604 30.2 1.42   8610 430.5 1.77   
29:24-1-2 328 16.4 1.50   2722 136.1 1.53   
30:25-2-1 574 28.7 1.47   8366 418.3 1.75   
31:22-1-1 1152 57.6 1.36   4432 221.6 1.68   
32:11-1-1 306 15.3 1.47   16482 824.1 1.48   
33:11-1 2052 82.1 1.40 -0.90 2464 123.2 1.61   
3426-2 1255 50.2 1.57 -0.42 2760 138.0 1.58   
35:14-2 1237 49.5 1.52 -0.41 2646 132.3 1.66   
36:30-1 1080 43.2 1.48 -0.34 3524 176.2 1.70   
37:16-1 1315 52.6 1.49 -0.44 3148 157.4 1.57   
38:20-1 1437 57.5 1.83 -0.96 3042 152.1 1.71   
39:22-1 795 31.8 1.71 -0.27 10920 546.4 1.49   
40:27-1 710 28.4 1.64 -0.23 4420 221.0 1.70   
41:17-2 447 17.9 1.67 -0.16 4376 218.8 1.69   
42:22-2 627 25.1 1.80 -0.19 2788 139.4 1.69   
43:3-1 927 30.9 1.75   5088 254.4 1.60   
44:24-1 741 24.7 2.03   8322 416.1 1.61   
45:2-1 1245 41.5 1.54   5558 277.9 1.49   
46:24-1 1218 40.6 1.52   7512 375.6 1.54   
47:15-1 1572 52.4 1.54   4844 242.2 1.61   
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48:1-2 1662 55.4 1.51   6982 349.1 1.49   
49:17-1 1125 37.5 1.74   7948 397.4 1.71   
50:25-2 1335 44.5 1.52   8470 423.5 1.63   
51:26-1 1344 44.8 1.75   4320 216.0 1.52   
52:5-1 2313 77.1 1.43   5778 288.9 1.35   
53:4-1 963 32.1 1.61   9350 467.5 1.86   
54:27-1 1188 39.6 1.65   4708 235.4 1.61   
55:14-1 2130 71.0 1.58   10142 507.1 1.36   
56:18-2 2013 67.1 1.49   5416 270.8 1.65   
57:20-1 918 30.6 1.90   11458 572.9 1.47   
58:1-1 1506 50.2 1.49   8064 403.2 1.74   
59:25-1 1179 39.3 1.69   15332 766.6 1.41   
60:21-1 1380 46.0 1.57   6934 346.7 1.67   
 
 
 
 
Bisulphite pyrosequencing was used for DNA methylation and real-time PCR for gene 
expression measurements. Primers for both were optimised. PCR was performed using a 
“practice” rat bisulphite treated DNA samples at varying temperatures together with 
negative controls. These were run on 2% agarose gels (Figure 3.14). This confirmed that 
the PCR products were adequately amplified for the bdnf (195bp) and the Nr3c1 (132bp) 
promoter sequences. 
 
 
Figure 3.14. Optimisation of PCR for bisulphite pyrosequecning. PCR products for Bdnf exIV and Nr3c1 run on a 2% 
agarose gel together with a DNA ladder (Hyperladder 50 bp) and negative.  
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Bisulphite pyrosequencing was performed on the PCR products to check that the 
bisulphite conversion is of high quality and that the sequencing produced readable results. 
The Pyromark sequencer software gives % methylation at each CpG and colour codes the 
“calls” depending on its confidence. This can be affected by the quality of the read and 
the sequencing reaction. Blue is highest confidence and red is the lowest. However, in 
some reactions such as the rat Nr3c1 and Bdnf, CpGs consistently called as red in repeat 
experiments still gave highly repeatable results.  
Examples of the Nr3c1 (Figure 3.15A) and Bdnf (Figure 3.15B) pyrosequencing results are 
shown highlighting when some bases are labeled red. 
 
 
 
 
 
 
Figure 3.15. Pyromark sequencing of the rat Nr3c1 (A) and bdnf (B) promoters. 
A 
B 
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Real-time PCRs were performed on cDNAs to check that the cDNA products produced 
clear melting curves and bands of appropriate sizes to allow measurement of Nr3c1 
expression. The Nr3c1 primers gave clear results however the bdnf primers constantly 
gave primer dimers and multiple bands which would interfere with the experiment. Three 
further primers were designed and tested, however the same problems arose. 
Housekeeping genes (Beta-actin, Hprt and Gapdh) were also measured to allow relative 
gene expression to be determined (Figure 3.16) 
 
Figure 3.16. Example of a melting curve for relative cDNA expression of Beta-actin. 
 
3.4.3.2 Epigenetic regulation of Nr3c1 in the transgenerational CSS rat model:  
RNA expression and DNA methylation of Nr3c1 were measured between CSS and control 
animals form the F1 and F2 generations. 
Nr3c1 expression Comparing expression of Nr3c1 in the hippocampus of F1 CSS and F1 
control dams it as found that there was significant increased expression in the CSS (2-
tailed t-test, p= 0.02) (This was after removing one control value that was 2.5 times higher 
than the next highest sample in the controls) (Figure 3.17). 
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Figure 3.17.  Relative expression of Nr3c1 between F1 CSS and control dams. Mean + SEM of hippocampal Nr3c1 
relative expression in F1 CSS and control dams. Significant effects of treatment using a 2-tailedt-test are indicated *P< 
0.05. n= 14 control, 14 CSS  
 
Comparing expression of Nr3c1 in the hippocampus of F2 CSS and F2 control dams there 
were no significant changes in expression found (2-tailed t-test, p= 0.56). Removing any 
outliers did not change the significance (Figure 3.18). 
 
 
 
Figure 3.18. Relative expression of Nr3c1 between F1 CSS and control dams. Mean + SEM of hippocampal Nr3c1 
relative expression in F1 CSS and control dams. n= 11 control, 13 CSS  
 
Nr3c1 methylation: DNA methylation was measured at the promoter 1-7 Nr3c1 gene 
(Figure 3.19) levels of methylation across the 7 CpG sites in the hippocampus of F1 and 
F2 CSS and controls.  
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Figure 3.19.  A schematic representation of the rat Nr3c1 promoter region. This contains 9 untranslated 1st exons and 
promoter regions. Within the exon 1.7 promoter region 7 CpG sites were investigated. 
 
 
Measuring DNA methylation within the F1 dams comparing controls and CSS dams 
significantly lower levels of methylation were found at six of the seven CpGs tested in the 
CSS compared to the control (2-tailed t-test, CpG1 p= 0.004; CpG2 p=0.009; CpG3 p= 
0.004; CpG4 p= 0.003; CpG5 p= 0.001; CpG6 p=0.038; CpG7 p = 0.12). The average 
methylation off all CpGs was also significantly lower in the F1 CSS group compared to the 
F1 control dams (2-tailed t-test, p= 0.003) (Figure 3.20). 
 
 
Figure 3.20. Glucocorticoid receptor methylation in F1 CSS and control dams. Mean + SEM of DNA methylation and at 
Nr3c1 promoter 1.7 in F1 control and CSS dams. Significant effects of treatment using a 2-tailedt-test are indicated *P< 
0.05.n= 14 control, 14 CSS.  
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Measuring DNA methylation within the F2 dams comparing controls and CSS dams 
significantly lower levels of methylation were found at six of the seven CpGs tested in the 
CSS compared to the control (2-tailed t-test, CpG1 p= 0.74; CpG2 p=0.25; CpG3 p= 0.88; 
CpG4 p= 0.59; CpG5 p= 0.98; CpG6 p=0.32; CpG7 p = 0.38). The average methylation of all 
CpGs was also not significantly different between the groups (2-tailed t-test, p= 0.6) 
(Figure 3.21). 
 
 
 
 
Figure 3.21.  Glucocorticoid receptor methylation within F2 control and CSS. Mean + SEM of DNA methylation and at 
Nr3c1 promoter 1.7 in F2 control and CSS dams. n= 13 control, 13 CSS. 
 
 
Correlation between methylation and expression: DNA methylation at a promoter 
usually represses gene expression. To test whether promoter 1-7 methylation associates 
with gene expression, correlations were plotted between F1 and F2 data points this 
revealed no association using a Pearson’s correlation (Figure 3.22).  
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Figure 3.22. Scatter plot of Nr3c1 methylation and expression. Average methylation and expression from each animal 
were plotted. n= 53. 
 
Correlation between Corticosterone and Nr3c1 methylation: DNA methylation at a 
promoter usually represses gene expression. To test whether promoter 1-7 methylation 
associates with gene expression, correlations were plotted with all F1 and F2 data points 
(Figure 3.23). 
 
 
 
Figure 3.23. Scatter plot of Nr3c1 methylation and corticosterone levels. Average methylation and serum 
corticosterone levels from each animal were plotted. N=27. 
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3.4.3.3 Epigenetic regulation of Bdnf  in the transgenerational CSS rat model:  
The epigenetic regulation of Bdnf in the hippocampus of F1 and F2 CSS was then 
examined. 
Bdnf expression: Expression of Bdnf in the hippocampus of F1 and F2 CSS and Control 
samples was tried, however optimization using three sets of primers still did not give clear 
enough signals to allow quantification of expression levels (data not shown) 
Bdnf methylation: DNA methylation was measured at the promoter IV of the Bdnf gene 
(Figure 3.24).  
 
 
 
Figure 3.24.  A schematic representation of the rat Bdnf promoter region. This contains 8 untranslated 1st exons and 
promoter regions. Within the exon IV promoter region 6 CpG sites were investigated. 
 
Measuring levels of Bdnf  exon IV DNA methylation within the F1 dams comparing controls 
and CSS dams revealed significantly lower levels of methylation at one of the six CpGs 
tested in the CSS compared to the control (2-tailed t-test, CpG1 p= 0.078; CpG2 p=0.025; 
CpG3 p= 0.25; CpG4 p= 0.8; CpG5 p= 0.86; CpG6 p=0.58). The average methylation off all 
CpGs was not significantly different (2-tailed t-test, p= 0.13) (Figure 3.25).  
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Figure 3.25. Bdnf methylation in F1 CSS and control dams.  Mean + SEM of DNA methylation and at bdnf promoter IV 
in F1 control and CSS dams. Significant effects using a 2-tailed t-test are indicated *P< 0.05. n= 13 control, 13 CSS. 
 
 
Measuring bdnf  DNA methylation within the F2 dams comparing controls and CSS dams 
significantly lower levels of methylation were found at six of the seven CpGs tested in the 
CSS compared to the control (2-tailed t-test, CpG1 p= 0.69; CpG2 p=0.01; CpG3 p= 0.79; 
CpG4 p= 0.34; CpG5 p= 0.87; CpG6 p=0.71; CpG7 p = 0.57). The average methylation of all 
CpGs was also not significantly different between the groups (2-tailed t-test, p= 0.57) 
(Figure 3.26). 
 
 
 
Figure 3.26. bdnf methylation in F2 CSS and control dams. Mean + SEM of DNA methylation and at bdnf promoter IV 
in F1 control and CSS dams. n= 12 control, 13 CSS (F1 group). 
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3.5 Discussion: 
In the CSS intergenerational depression model there are increasingly reduced maternal 
care-associated behaviours at increasing durations of lactation from F0 to F2, i.e. reduced 
nursing at days 2, 9 and 16 in F2, compared to day 9 and day 2 only in the F0 and F1 dams 
respectively (Figure 1.2). This gives the pattern of an increasing accumulation of 
reductions in maternal care through the three generations. There was a similar pattern in 
maternal anxiety behaviour. As the F2 animals were never in direct contact with the CSS 
intruder male suggest that it is either the reduced maternal care of the F1 dams that 
mediate the effects on the F2 maternal care and anxiety behaviour, changes in serum 
markers that impacted development of the offspring or the inheritance of epigenetic 
marks.  
 Testing HPA axis activity revealed reduced corticosterone in the F2 animals as 
dams and also earlier in life at the pup stage suggesting a permanent reduction in the 
basal levels of this stress steroid. Interestingly, previous research on the F1 dams showed 
increased corticosterone levels (Murgatroyd and Nephew, 2013). That we find reduced 
corticosterone in the F2 dams that showed the reduced maternal care and increased 
anxiety seems contrary to the idea of increased corticosterone levels and stress and 
depression. However, numerous studies are now showing increased corticosterone to be 
associated with more chronic maternal stress and depression (Groer and Morgan, 2007), 
with increases in corticosterone more confined to women with immediate postnatal 
stress or shorter lasting depression (Seth et al., 2015). If we consider that the F2 dams 
showed more prolonged changes in reduced maternal care and anxiety, than the F1s, this 
would support our finding. Why the corticosterone is reduced may be hypothesized that 
a possible initial stress-induced corticosterone release form the HPA activation may over 
time during chronic stress become reduced in order to protect the brain and other 
physiological processes from prolonged exposure to excess cortisol levels that can be 
damaging (Fries et al., 2005). This would suggest that the regulation of the HPA axis 
activity during early life depends on the duration of the stress exposure: in the CSS 
generations, this may relate to the duration of depressed maternal care and increased 
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anxiety-related behaviour the pups receive, that is gradually lengthened though the 
generations. One might therefore expect even stronger stress phenotype in the F4 
generation if this were studied, as those pups would have received reduced care and 
increased maternal stress across the whole of the lactational period. 
The importance of maternal care during early life is supported by other studies. For 
example Capitanio et al. showed that in nursery reared Rhesus monkeys those that were 
denied access to maternal care have decreased levels of cortisol compared to those 
monkey raised by their mother (Capitanio et al., 2005) In a human study, infants exposed 
maternal depression stress showed lower cortisol levels when compared to control 
populations exposed to moderate levels of early life stress (Essex et al., 2011). 
When studying levels of ACTH in the F2 dams and F1 however there were no significant 
differences. Though ACTH regulates corticosterone they did not correlate. Several studies 
have shown that the basal levels of these factors often do not directly correlate and are 
more a measure of acute stresses as cortisol levels may remain after the ACTH stimulation 
(Christ-Crain et al., 2007; Bruder et al., 2008). Testing the maternal behaviour related 
hormone prolactin revealed no difference in F2 dams. However, in the F1 adults the 
stressed females showed significantly reduced serum prolactin. Though this difference 
did not reach statistical significance in the F1 dams in this study (the study here only had 
group sizes of 6 for the F1 CSS and control dams), previous findings with larger group sizes 
of 12 F1 dams did show a significant of decrease in plasma prolactin levels (Carini and 
Nephew, 2013). F1 dams have also been shown to have reduced Prolactin gene 
expression in the hypothalamus. (Murgatroyd and Nephew, 2013). Together this all 
suggests long-lasting prolactin changes in the F1 animals that are not carried to the F2 
generation. This supports the importance of prolactin in regulating stress response 
(Torner, 2016) and a human study has found lower levels in women suffering from 
postnatal depression (Abou-Saleh et al., 1998). 
It is interesting that the F2 dams also lacked changes in oxytocin. But again, only groups 
of 6 animals were used in the analysis. Previous findings from the F1 dams showed 
reduced levels of Oxytocin and Oxytocin receptor gene expression in the hypothalamus 
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and amygdala (Murgatroyd and Nephew, 2013) while F0 dams showed also lower 
amygdala Oxytocin expression (Murgatroyd et al., 2015b) (Table 1). The normalisation of 
oxytocin in the F2s seem to suggest the prolactin and oxytocin endocrine factors do not 
explain the F2 dam’s increased levels of depressed maternal care. This would suggest that 
these neuroendocrine systems play less of a role in the F2 dam behaviour in contrast to 
the F1 and F0 dams. Finally, it should be noted that the F1 and F2 values for oxytocin and 
prolactin do vary considerably. The first multiplex pituitary ELISA plates run during this 
study had issues with the plate-washer that did not remove all wash buffers, even though 
the machine registered that it had. It was only later that this was properly serviced and 
repaired. However, results between samples on the same plate did have relatively 
uniform values so can be compared. 
Other neuropeptides important in behaviour and stress regulation were also tested. This 
revealed no changes in bdnf in F1 or F2 animals. Substance P, alpha-MSH, Beta-endorphin 
or Orexin A also did not differ when tested in F1 adults. This suggests these factors have 
no role in the maternal behavioural changes in the CSS dams. 
Thyroid stimulating hormone (TSH) levels did not differ in F1 or F2s and neither did with 
growth hormone (GH) in F1 adults suggesting these important metabolic regulatory 
factors are not also important for the generational changes seen. The further growth 
factors VEGF and GM-CSF also did not significantly differ in either F1 and F2 dams.  
Luteinizing hormone (LH) and follicle-stimulating hormone (FSH), important in the 
hypothalamic–pituitary–gonadal (HPG) axis, did not significantly differ in the F1s. Though 
there were some HPA differences in the F1s, it appears that the HPG axis was not 
impacted or that these factors are involved in the decreased maternal care behaviour.  
Early stress can induce lasting changes in the immune system that may be important in 
programming the adverse effects of early life stress on mental health (Carpenter et al., 
2010). Analysis of cytokines including IL-6, IL-10, and immune regulatory factors GM-CSF 
and VEGF in F2 adults revealed no differences in either F1 or F2 dams. However, reduced 
levels of Icam-1 were found in the F2 CSS dams serum (using a 1-tail t-test), though this 
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no longer differed in F1 or F0 dams. The 1-tail t-test was justified as reduced Icam-1 levels 
have been previously reported in the F2 adults (Nephew et al. 2017). Increased Icam-1 
levels have been associated with increased stressed-induced cortisol levels (Heinz et al., 
2003) which may relate to the lower corticosterone in the F2 animals. A marker of 
inflammation, I-CAM-1 plays a role in regulating blood-brain-barrier function with 
reduced levels found in schizophrenia (Schwarz et al., 2000) and depression and suicide. 
However, another study contrarily found a significant increase in Icam-1 in the 
dorsolateral prefrontal cortex in major depression in the elderly (Thomas et al., 2002). 
This reduction in only the F2 dams and adults would support the accumulation of stress 
theory through the F0 to F2 dams with more chronic behavioural phenotypes and rescued 
HPA regulation and increased immune components. Further work would be important to 
investigate the regulation of Icam-1 in the brain of the F0 to F2 dams. 
Epigenetic changes were investigated in stress-regulatory genes between the F1 and  F2 
dams to test whether this mechanism has a role in the intergenerational inheritance of 
the depressed maternal care and maternal stress behaviours. In the F1  hippocampus 
there were significant reductions in DNA methylation at most of the CpGs measured in 
the Nr3c1 gene in the CSS hippocampi. These F1 CSS dams also has significantly reduced 
Nr3c1 RNA expression supporting the role of the DNA methylation in recuing gene 
expression (though these did not directly negatively correlate). In the F2 dams there were 
no longer any differences in Nr3c1 DNA methylation or expression. This suggests that 
Nr3c1 methylation is not maintained through the generations or that it is important in the 
maternal behavioural changes. 
Investigation of Bdnf epigenetic regulation showed reduced methylation at CpG2, one 
CpG out of six tested, in the hippocampi of the F1 CSS dams. Interestingly, this same CpG2 
showed significant increased methylation in the F2 CSS dams again supporting little level 
of heritability in CpG methylation between the generations. 
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There are some limitations to this study. The multiplex ELISA results seems to give 
variations between plates in overall reads, especially the first runs. It is thought that this 
may relate to the plate washer that did not seem to remove all the wash buffers before 
adding the second antibody. This was repaired and the results became more comparable. 
Therefore, sample values were not compared across plates, only within plates. Regarding 
the F1 dams, there were group sizes of only 6, compared to 12-14 in the F2 dams and F1 
adults. Some of the analytes did not measure so well. For example, IL-2 and IL-4, TNF-
alpha, while others did not produce results for all samples. This considerable reduced the 
numbers for some statistical analyses. 
Overall, this study, taken together, reveals decreases in HPA axis dysregulation and 
increases in the levels of a marker of inflammation through the generations F0-F2 of the 
CSS. This suggests adaptive mechanisms functioning in regulating of chronic and acute 
stress, through inheritance of a chronic stressor. 
 
 
 
        
 
 
  
95 
 
4 CHAPTER 3: RNA seq 
4.1 Introduction 
The above results from the Study 1 suggest that Nr3c1 gene is upregulated following 
stress in the F1 dams but not the F2 dams. Conversely, levels of I-cam1 protein were 
upregulated following stress in the F2 dams but not the F1 animals. This suggests 
variations in gene regulations between the generations, possibly switching from stress to 
immune regulatory pathways. Genomewide studies allow gaining a bigger picture of the 
circuits and mechanism in the brain important in the regulation of depression and its 
heritability across generations. 
Numerous studies have shown transcriptome (i.e. genomewide gene expression) changes 
in brains of animal models following acute (Stankiewicz et al., 2015)and chronic stress 
(Muhie et al., 2015). For example, Stankiewicz et al. studying hippocampus 
transcriptomes of mice exposed to chronic social stress found altered regulation in genes 
involved in the functioning of the vascular system (Alas2, Hbb-b1, Hba-a2, Hba-a1), injury 
response (Vwf, Mgp, Cfh, Fbln5, Col3a1, Ctgf) and inflammation (S100a8, S100a9, Ctla2a, 
Ctla2b, Lcn2, Lrg1, Rsad2, Isg20) supporting that stress may impact the vascular system 
(Stankiewicz et al., 2015) 
However, one finding across many of these studies is that there seem to be relatively little 
correlation between findings in regards to particular genes that are differentially 
regulated. This is contrary to the epigenetic studies that focus on candidate genes in 
which we see many complementary and supporting findings (e.g. Tables 2.4, 2.5, 2.6). 
One reason might be that the genomewide approaches, in having to account for multiple 
analyses, do not have the statistical power to identify common genes changes that might 
not be at large magnitudes. Technical limitations such as tissue heterogeneity and the 
fact that major depression is a complex disorder involving numerous systems of 
interacting genes, and single-gene associations of expression that may not reach genome-
wide significance. Added to this, is that in human studies there is widespread genetic 
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difference that further influences gene expression. To combat this, a number of studies 
looking at the types and functions of differentially regulated genes are beginning to 
identify common patterns in genes belonging to particular pathways of functions such as 
immune regulation and neurotransmission.  
For example, using RNA-seq, Pantazatos et al. (Pantazatos et al., 2017) examined 
transcriptomes in the frontal cortex of suicides with major depression, non-suicides with 
major depression and non-psychiatric controls revealing 35 genes differentially expressed 
between groups that in the depressed groups consisted of lower expression of immune-
related pathways such as chemokine receptor activity, chemotaxis and cytokine 
biosynthesis, and lower expression of genes involved in oligodendrocyte differentiation, 
regulation of glutamatergic neurotransmission, and oxytocin receptor expression. Further 
studies on genomewide expression in lymphocytes have found stress-related alterations 
in expression levels of immune response genes with various environmental adversities, 
such as childhood abuse and neglect and post-traumatic stress disorder (Schwaiger et al., 
2016; O’Donovan et al., 2011). One of the largest RNAseq study on bloods from 463 major 
depression and 459 controls people (Mostafavi et al., 2014), when investigating the 
impact of childhood trauma found no significant results. However, a more recent study 
on blood transcriptome of childhood trauma combining with gene-set enrichment 
analyses identified genes and pathways differentially expressed in adults who had 
experienced emotional abuse and neglect. Specifically, there was a dysregulation in the 
expression of genes involved in cytokine system pathways including interferon (IFN) α/β 
and γ signaling (Minelli et al., 2018). 
No study has yet investigated heritable transcriptional changes between generational 
showing transmission of depressive behaviour. It is unclear if key pathways or genes 
might be passed to subsequent offspring. Perhaps the expression of particular genes 
might be maintained between generations, maybe highlighting possible epigenetic 
inheritance mechanisms. Here we investigate hippocampal changes in rats with 
intergenerational inheritance of depression that allows us to control of genetic 
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differences and the environmental exposure. Finally, it also allows us the first 
investigation of possible heritable changes in gene expression following depression. 
4.2 Aims  
The aim of this chapter is to investigate whether genomewide changes in gene expression 
occur following CSS in the F1 and F2 dams. This is done using Next generation sequencing 
to perform RNAseq on hippocampus RNA from F1 and F” CSS and control dams. This will 
test whether specific genes are regulated or if there are specific functions of genes or 
shared pathways that might be transgenerational affected by stress. In sum, we hope to 
find if changes in the regulation of specific key genes are transgenerationally inherited in 
the brain following stress. 
 
4.3 Objectives  
1. Perform RNASeq on 24 hippocampus samples from CSS and control F1 and F2 
dams. 
2. Test if specific genes are differentially regulated or specific pathways or groups of 
genes differ between CSS and control. 
3. Determine if there are transgenerationally inherited differences in gene expression 
between the F1 and F2 generation of CSS dams compared to control. 
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4.4 Methods 
Transcriptome changes were measured in the F1 and F2 CSS and control hippocampus. 
To do this RNA sequenced using next generation sequencing (RNAseq). 
 
4.4.1 RNA samples 
The previously extracted RNA (Table 3.1) was tested for RNA quality prior to performing 
RNASeq to allow us to select on the highest quality RNA. The RNA was firstly measured 
for quality using the bioanalyser (Figure 4.1 and Table 4.1). Those samples with high RIN 
values and concentrations were selected for RNAseq (add Table 4.1), these included 6 of 
each group of F1 CSS, F1 Control, F2 CSS and F2 Control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Example bioanalyser results of hippocampal RNAs  
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Table 4.1.  RNA quality and quantity analyses. Bioanalyser and Nanodrop results of hippocampal RNAs to give RIN 
values and concentrations.  
 
 
 
 
5.1.11 8.3 136.6 21 150 
25.1.1 2 8.4 530.7 23 581 
26.1.1 3 7.9 214.6 30 263 
20.2.1 4 8.2 213.7 15 218 
21.1.2 5 8.3 488.6 33 496 
10.2.2 6 8.4 416.5 26 416 
26.1.2 7 8 349.1 25 351 
4.1.1 8     N/A 438.6 5 462 
1.2.2 9 7.8 104.4 36 102 
1.1.1 10 7.8 88.3 21 90 
27.2.2 11 7.4 47.8 15 49 
22.2.1 12 7.8 99.6 50 95 
27.1.1 13 6.9 347.7 11 355 
26.2.1 14 7.5 133.6 37 137 
25.2.1 15 8 74.7 21 77 
18.1.1 16 7.4 154.7 17 154 
14.1.1 17 7.6 219.9 29 231 
17.2.1 18 7.9 108.6 29 117 
22.1.2 19 6.8 136.7 28 139 
27.2.1 20 7.3 215.6 23 221 
18.2.1 21 7.4 95.3 19 100 
2.1.2 22 7.4 261.3 20 267 
15.1.1 23 7 208.3 26 223 
21.1.1 24 7.2 201.3 44 213 
3.1.1 25 6.4 390.5 57 395 
2.1.1 26 5.6 225.4 24 227 
17.1.1 27 5.7 139.1 69 212 
24.1.1 28 6.7 430.5 30 475 
24.1.2 29 5.8 136.1 46 141 
25.2.1 30 6.6 418.3 34 446 
22.1.1 31 6.3 221.6 58 222 
11.1.1 32 4.6 824.1 33 825 
11.1 33 5.7 123.2 65 125 
26.2 34 6.6 138 113 130 
14.2 35 6.9 132.3 91 140 
30.1 36 7.5 176.2 210 177 
16.1 37 7.9 157.4 67 162 
20.1 38 7.4 152.1 34 140 
22.1 39 6.5 546.4 35 589 
                  
Sample 
             
RIN values 
                                
Nano-drop Conc. 
ng/ μl 
  Bioanalyzer 
Conc. 
ng/ μl 
                 
Nano-drop 
Conc. 
ng/ μl 
100 
 
27.1 40 6.5 221 56 226 
17.2 41     N/A 218.8 17 222 
22.2 42     N/A 139.4 11 139 
3.1 43     N/A 254.4 6 386 
24.1 44     N/A 419.1 43 455 
2.1 45     N/A 277.9 1 307 
24.1 46     N/A 375.6 17 440 
15.1 47 7.9 242.2 44 254 
1.2 48     N/A 349.1 160 375 
17.1 49 8.2 397.4 31 419 
25.2 50 7.9 423.5 14 450 
26.1 51 1 216 20 230 
5.1 52     N/A 288.9 94 4.5 
4.1 53     N/A 467.5 76 4.2 
27.1 54 8.6 235.4 52 34.4 
14.1 55 9.1 507.1 65 571 
18.2 56 8.7 270.8 44 285 
20.1 57 8 572.9 72 623 
1.1 58 9 403.2 33 425 
25.1 59     N/A 766.6 6 859 
21.1 60 8.6 346.7 57 354 
 
 
Results from the RNA quality and quantity allowed us to select 48 samples to RNA 
sequence. We firstly started with 24 and would then perform another 24. However, the 
library preps for the second run of 24 were not so efficient and so only 24 samples were 
finally sequenced. Samples selected are shown in (Table 4.2). 
 
Table 4.2. RNA samples selected for RNAseq. Six samples were selected for each of the 4 groups of F1 control, F1 CSS, 
F2 control, F2 CSS.  
Groups RNA number (Animal number) 
F1 Control 3, 4, 11, 12, 19, 20  
F1 CSS 7, 8, 15, 16, 23, 24 
F2 Control 1, 2, 10, 17, 18 
F2 CSS 5, 6, 13, 14 , 21 , 22  
 
 
4.4.2 Library preparation and Next Generation Sequencing 
 
The outline of the RNAseq involved DNase treatment of RNA samples, cDNA library 
preparation, sequencing using the Illumina NextSeq and bioinformatics analyses. 
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DNase treatment 
 
Turbo DNA-free DNase treatment and removal reagents (Ambion) were used to remove 
any contaminating DNA from the 48 RNA samples, and to also remove the DNase and 
divalent cations from the samples (Figure 4.2).  
 
 
 
 
Figure 4.2. Flowchart of DNase treatment 
For each reaction, 200μg  of nucleic acid was used per ml. 5.5 μl of TURBO DNase Buffer 
and 1 μl of TURBO DNase was added to 50 μl of RNA, and the resulting mixture incubated 
at 37°C for 30 minutes. Briefly, 9 μl of resuspended DNase inactivation reagent was added, 
mixed and the supernatant was transferred to a fresh tube.  
 
4.3.2.1 RNA library Preparation 
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In order to carry out the RNA sequencing, the RNA library first had to be prepared for 
Illumina using the NEBNext Ultra RNA Library Prep kit (New England Biolabs). This 
involved RNA enrichment, RNA fragmentation, cDNA synthesis, end prep, adaptor 
ligation, and PCR amplification (Figure 4.3). 
 
 
Figure 4.3. Step involved in the RNA Library preparation for illumine Next Generation Sequencing. a) RNA enrichment 
(mRNA isolation/rRNA depletion). Poly-A selection using poly-(T) oligo-attached magnetic beads. b) RNA Fragmentation 
and Random Priming c) First strand cDNA synthesis d) Second strand cDNA synthesis e) End repair and 5’ 
Phoshphorylation e) End repair and 5’ Phoshphorylation f) A-tailing i.e. 3’ ends adenylated g) Adaptor Ligation followed 
by PCR amplification 
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RNA enrichment 
Firstly, the mRNA had to be isolated from the total RNA and bound to the NEBNext Oligo 
d(T)25 beads. The beads were washed with 100μl of RNA binding buffer, and the tubes 
containing the beads were placed on a magnetic rack. The supernatant was discarded and 
50μl of RNA binding buffer was added to the beads along with 50μl of total RNA sample. 
Eppendrof PCR for 5 minutes at 65°C was used to allow the poly-mRNA to bind to the 
beads. The resulting samples were washed, and following this, 50μl of Tris buffer was 
added and the samples placed in PCR for 2 minutes at 80°C. Another 50μl of RNA binding 
buffer was added and the samples resuspended and placed on the magnetic rack, to 
further ensure adequate binding of the poly-mRNA to the beads. The beads were 
rewashed and all supernatant removed. 
RNA fragmentation 
The poly-mRNA underwent a fragmentation process to elute the mRNA from the beads. 
Briefly, 17μl of First Strand Synthesis Reaction Buffer and Random Primer mix (2X) was 
added to the samples and PCR was carried out at 94°C for 15 minutes. The purified mRNA 
was collected by transferring 15 μl of supernatant to fresh tubes. 
cDNA synthesis 
First strand cDNA was synthesized from the fragmented and primed mRNA (15μl). 0.5μl 
of Murine RNase inhibitor, 1μl of ProtoScript II Reverse Transcriptase, and 3.5μl of 
nuclease-free water were added to each tube. The resulting samples underwent PCR with 
the following program: 25°C (10 minutes), 42°C (15 minutes), 70°C (15 minutes). 
Second strand cDNA was synthesized by adding the following reagents to the first strand 
synthesis reaction (20μl): 48μl of nuclease free water, 8 μl of second strand synthesis 
reaction buffer, 4 μl of second strand synthesis enzyme mix. The resulting 80μl sample 
underwent PCR for 1 hour at 16°C. 
The resulting double stranded cDNA was purified using 1.8X Agencourt 1AMPure XP 
Beads. 144μl of 1.8X 1AMPure XP Beads was added to the second strand synthesis 
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reaction, and the sample microcentrifuged before discarding the supernatant. 200μl  of 
80% ethanol was used to wash the beads. 60μl of 10 mM Tris-HCI PH 8.0 was then added, 
and 55.5μl of the supernatant was transferred to a clean PCR plate. 
End preparation 
End Prep of cDNA library was carried out. 6.5 μl of NEBNext end repair reaction buffer 
and 3 μl of NEBNext end prep enzyme mix were added to each 55.5 μl sample of purified 
double stranded cDNA. PCR was carried out with the following program: 20°C (30 
minutes), 65°C (30 minutes).  
Adaptor ligation 
Adaptor ligation was then performed. This started by diluting the NEBNext Adaptor for 
illumina (15 uM) to 1.5 uM with a 10-fold dilution with 10 mM Tris-HCl. 1ul of the diluted 
NEBNext Adaptor was added to the 65ul end prep reaction, along with 15ul of Blunt/TA 
ligase master mix and 2.5ul of nuclease free water. The resulting samples underwent PCR 
at 20°C for 15 minutes. After this, 3μl of USER Enzyme was added and the mixture 
incubated at 37°C for 15 minutes. 
Next the ligation reaction was purified using AMPure XP beads. Firstly, 17μl of nuclease 
free water was added to each sample. 100μl of resuspended AMPure XP  beads was added 
to each sample, this was mixed and then placed on a magnetic rack, and the supernatant 
discarded. The samples were washed twice with 200μl of 80% ethanol each time. After 
this, 52μl of 10 mM Tris-HCl was added to elute the DNA target from the beads. 50μl of 
supernatant was transferred to a clean PCR tube, and the beads discarded. 50μl of 
resuspended AMPure XP beads was then added to each 50μl sample, this was mixed and 
then placed on a magnetic rack, and the supernatant discarded. 200μl of 80% ethanol was 
used to wash the samples twice. 22 μl of 10 mM Tris-HCl was added to elute the DNA 
target from the beads. Finally, 20 μl of the supernatant was transferred to a new PCR 
tube, ready for PCR enrichment of the adaptor ligated DNA. 
PCR amplification 
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2.5μl of an individual appropriate index primer (NEBNext Multiplex Oligos for Illumina 
Set1 and Set 2) was added to each sample i.e. each sample had a different primer used. 
Following this, 2.5μl of universal PCR primer was added to each sample, along with 25μl 
of NEBNext Q5 Hot Start HiFi PCR Master Mix. Samples underwent 13 cycles of PCR as 
follows: 98°C (30 seconds), 98°C (10 seconds), 65°C (75 seconds), 65°C (5 minutes). It was 
important to limit the number of PCR cycles to avoid overamplification. 
Lastly, the PCR reaction was purified using Agencourt AMPure XP beads. 45 μl of beads 
was added to each sample and mixed before supernatant discarded. 200 μl of 80% 
ethanol was then used to wash the samples twice. The DNA target was eluted from the 
beads by adding 23 μl of 0.1xTE. 20 μl of supernatant was transferred to a clean PCR tube 
and stored at 20°C.  
Validation and quantification 
Fragment sizes were evaluated via using a Bioanalyzer. The quality of the samples was 
assessed using a Bioanalyzer (Agilent high sensitivity assay). 32 μl of nuclease free water 
was added to each of the samples from the previous step, and they were re-cleaned using 
Agencourt AMPure XP beads and ethanol as described above. The concentration of DNA 
in each sample was assessed using the Quibit 3 Fluorometer (Invitrogen).  
A scheme of the whole method is given in (Figure 4.4). 
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Figure 4.4. Flow chart of RNA lib preparation 
 
4.4.2.2 Next Generation Sequencing  
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 ( invitrogen), after re-cleaning the sample with  the beads. 
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The prepared DNA libraries were denatured and diluted to a target concentration of 
20pM, before sequencing on the Illumina® NextSeq® system. Firstly, 20 μl of 1nM DNA 
library was prepared, and added to 20 μl of freshly diluted 0.2 N NaOH. The resulting 
mixture was centrifuged at 280 x g for 1 minute. After 5 minutes incubation at room 
temperature, 200 mM Tris-HCL (pH 7) was added, and the resulting mixture centrifuged 
at280 x g for 1 minute. The mixture now contains denatured DNA library. To dilute this to 
20pM, 940 μl of prechilled hybridization buffer was added and centrifuged for 280 x g for 
1 minute. 
After denaturing and dilution, the libraries were loaded onto the reagent cartridge and 
the sequencing run set up. To do this we used the Illumina NextSeq® 500/550 High Output 
Kit v2 (150 cycles). 
 
Cluster generation 
Before sequencing could occur, the single stranded DNA templates were bridged-
amplified, forming clonal clusters within the flow cell. To achieve this, the double 
stranded DNA from the PCR amplification step had to be broken down into single strands.  
Firstly, the DNA templates were hybridized to a slide containing a high-density of 
immobilized forward and reverse primers. 3’ extension with DNA polymerase was then 
used to copy the templates from the hybridized primers. The original templates were 
broken down, and only the immobilized copies on the flow cell surface remained. Next 
the immobilized copies looped over to hybridize to adjacent primers, and double stranded 
DNA bridges formed by DNA polymerase copying the templates. The DNA bridges were 
then denatured to form two single stranded molecules with the same information as the 
initial DNA template. Lastly, specific base cleavage was used to remove the reverse DNA 
strand, and the 3’ ends of the immobilized forward strand were blocked to stop them 
from interfering in the sequencing process. Dense clonal clusters with over 1000 
molecules per cluster were made by repeating this procedure on each template through 
cycles of isothermal denaturation and amplification (Figure 4.5). 
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Figure 4.5. Flow chart of Cluster generation 
 
4.4.2.3 Quality Control Analysis 
Sequencing data from the Illumina NextSeq run was firstly analysed for sequence quality 
of reads. The sequences were then aligned to the rat genome and coverage of the reads 
and assayed to determine the quality of the data and uniformity of the coverage. RNA 
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expression differences were then tested for between CSS and control samples from the 
F1 and F2 hippocampi. Any differently regulated RNAs were then analysed for shared 
ontologies and pathways. 
 
 
Quality control of sequence reads 
The FastQC program was used for quality control (QC) of the reads of RNA sequence for 
each library sample to check that the sequence data does not have errors or biases, and 
that it is of a good standard. This gives the following information: per base sequence 
quality, per sequence quality scores, per base sequence content, per base GC content, 
per sequence GC content, per base N content (N=unread bases), sequence length 
distribution, sequence duplication level, and kmer content for levels of duplication.  
 
Per Base Sequence Quality: The FastQC program gives a quality score, which can be 
interpreted as the statistical probability of an error in base calling occurring: the higher 
the quality score, the lower the error probability and hence the more reliable a base call 
is likely to be. For example, Q40 quality score implies 1 base call out of 10,000 is likely to 
be incorrect, while a Q30 score means one base call out of 1,000 is likely to be incorrect.  
This was done for each sample individually and a graph was generated that reports quality 
scores based on position, for every read. The ideal score is over 28 at each position and a 
quality score dropping much below 28 should be trimmed at that point as this indicates a 
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high probability of error that could influence biological conclusions when performing the 
alignments in the following steps. Using sample 1 as a representative example it can be 
seen that most of the sequence falls into good to reasonable quality scores (Figure 4.6). 
The quality calls do decrease towards the end of the sequence which is common to see.  
 
Figure 4.6. Per base Sequence Quality. Sample 1 is shown as a representative example. For each position in read length 
a BoxWhisker type plot is shown where the central red line is the median value, the yellow box is the inter-quartile range 
(25-75%) and the upper and lower whiskers represent the 10% and 90% points. The blue line shows the mean quality. 
On the y-axis are the quality scores divided into very good quality calls (green), reasonable quality (orange), and poor 
quality (red). 
 
Per sequence quality scores: In addition to going over each base one can average the 
quality of each read instead and show a cumulative plot of the sequence quality of these. 
Using sample 1 as a representative example this revealed that most reads have an average 
quality of 34. This is to be considered very good (Figure 4.7). All 23 other samples had 
similar scores 
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Figure 4.7.  Per base quality score over all sequences. Sample 1 is shown as a representative example. The red line 
shows the mean sequence against the y-axis of the number of sequences. 
 
Per base sequence content: The quality of the reads were then again assessed for 
sequence content with a graph produced for the percent of bases called for each of the 
four nucleotides at each position across all reads. The proportion of each of the four bases 
should remain relatively constant over the length of the read, i.e. A (%) = T (%) and G (%) 
= C(%). For the first 10 nucleotides there is non-normal distribution but this is normal and 
expected with RNA-Seq. Importantly though our samples show a uniform distribution for 
the rest of the sequence again supporting that the sequencing data from all the samples 
are of good quality (Figure 4.8). 
 
Figure 4. 8.  Per base sequence content: Sample 1 is shown as a representative example. The percent of bases called for 
each of the four nucleotides (y axis) is plotted against at each position across all reads (x axis). 
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Per sequence GC content: The sequences were then tested for GC content. A graph was 
produced comparing the theoretical distribution of GC content with the observed GC 
content. These two plots should be very similar: large variation between these 2 plots 
could signal contamination from another organism with higher GC content: if the 
distribution is shifted it could mean a systematic bias not dependent on base position of 
A/T rich sequences: a very low GC content could signal only the mRNA poly-A tails have 
been sequenced. All of our samples all showed similar theoretical and observed plots with 
good GC content supporting high quality sequencing (Figure 4.9). 
 
Figure 4.9. Per sequence GC content: Sample 1 is shown as a representative example: A graph of %  Mean GC content 
(x axis) and number of sequences (y axis) was used to plot Mean GC count per read (red line) and theoretical GC 
distribution (blue line). 
 
GC content across all bases: Plotting GC content across all bases supported the previous 
graph that the sequecnes have a good uniform level of GC at around 50%. The fluctuation 
in the first 8bp reflect the sequcning of the adaptors which have defined sequecnes 
(Figure 4.10). 
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Figure 4.10. GC content across all bases: Sample 1 is shown as a representative example: A graph of position in read 
across the sequence (x axis) and % of GC (y axis) was used to plot % mean GC count per read across all the sequences 
(red line). 
 
Per base N content: the quantity of unclear base calls (N’s) were measured across the 
sequences in all samples. A plot was produced that shows the fraction of 
indistinguishable bases as a function of the base position in the reads (Figure 4.11). 
In high quality sequence data this is should be close to zero: increases in these values 
indicate problems during the sequencing. All our sequences showed close to zero. 
 
 
Figure 4.11. Per base N content: Sample 1 is shown as a representative example: A graph of position in read across the 
sequence (x axis) and % of unclear base calls (N) (y axis) was used to plot %N per read across all the sequences (red line). 
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Sequence Length Distribution: The Sequence length distribution was plotted which 
showed the distribution of read lengths with a peak at 150 bp as expected (Figure 4.12). 
 
 
 
Figure 4.12. Sequence length distribution: Sample 1 is shown as a representative example: A graph of the number of 
sequences (y axis) and sequence length was used to plot the sequence across all the sequences (red line). 
 
Sequence Duplication Levels: The levels of duplicated sequences were then tested for in 
the sequencing reads. There are generally two sources of duplicate reads: PCR duplication 
in which library fragments have been over represented due to biased PCR enrichment or 
truly over represented sequences such as very abundant transcripts in an RNA-Seq library. 
The former is a concern because PCR duplicates misrepresent the true proportion of 
sequences in your starting material. The latter is an expected case and not of concern 
because it does faithfully represent your input. In RNAseq data there is expected to be 
some duplication due to possibly highly expressed genes but too much of over 10+ could 
suggest a problem with the experiment. All our samples showed relatively low duplication 
levels (Figure 4.13). 
 
115 
 
 
 
Figure 4.13. Sequence duplication levels: Sample 1 is shown as a representative example: A graph of the number of % 
of sequences against the sequence duplication levels (y axis) was used to plot the sequence duplication  across all the 
sequences (red line). 
 
Kmer content: As a further test for sequence duplication the occurrence of kmers - 
nucleotide sequences of fixed k length were measured. This plot tests that a small 
fragment of sequence is not biased to any position as it appears in a library that is diverse. 
If a certain Kmer is enriched or depleted overall due to a biological reason, and not an 
error, then any bias should affect all positions equally without any positional bias. The 
FastQC plots the top 6 most biased Kmers to relay their distribution. Testing the samples 
these revealed similar patterns across all samples (Figure 4.14).  
116 
 
 
Figure 4.14. Kmer distribution over read length: Sample 1 is shown as a representative example: A graph of the number 
of % of sequences(y axis) against position in read (x axis) for 4 Kmers across all the sequences (different colours lines 
represent different Kmers). 
 
The FastQ Toolkit program was used to trim all the sequences in all samples to 100 bp.  
 
4.4.2.4 Sequence alignment: 
The previous FASTQ files that contain the nucleotide sequence of each read that contain 
the quality scores etc. were then aligned to a reference rat genome. This produces BAM 
files. This was done using the TopHat2 spliced alignment software in combination with 
the Bowtie index available at the Illumina Basespace. 
 
The sequences were then analysed for Length of reads, Number of Reads (Total number 
of reads passing filter for this sample), percentage of reads passing filter that aligned to 
the reference (% Total Aligned), percentage of reads that do not align to the reference (% 
Unaligned), percentage of reads that align to abundant transcripts, such as mitochondrial 
and ribosomal sequences (% Abundant) and the median coefficient of variation of 
coverage of the 1000 most highly expressed transcripts. The Ideal value = 0. (Median CV 
Coverage Uniformity). (See Table 4.3) for the summary of these factors for all samples. 
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Table 4.3. Read length, number of reads, % aligned, % abundant, % unaligned and median CV coverage uniformity 
for all samples.  
Sample 
ID 
Read 
Length 
Number of 
Reads 
% Total 
Aligned 
% 
Abundant 
% 
Unaligned  
 Median CV 
Coverage 
Uniformity 
Sample1 100 19,328,365 88.21% 7.94% 11.79%  0.45 
Sample10 100 22,932,906 85.73% 7.36% 14.27%  0.54 
Sample11 100 22,339,745 78.33% 26.46% 21.67%  0.51 
Sample12 100 26,643,711 81.36% 9.23% 18.64%  0.55 
Sample13 100 21,677,960 80.48% 8.71% 19.52%  0.53 
Sample15 100 32,068,201 86.82% 15.90% 13.18%  0.47 
Sample16 100 25,620,016 77.47% 6.44% 22.53%  0.49 
Sample17 100 23,711,773 77.74% 9.66% 22.26%  0.48 
Sample18 100 29,515,133 70.87% 9.55% 29.13%  0.60 
Sample19 100 23,574,288 84.78% 9.98% 15.22%  0.49 
Sample2 100 16,569,892 87.76% 9.43% 12.24%  0.45 
Sample20 100 34,179,124 84.53% 8.22% 15.47%  0.50 
Sample21 100 30,304,456 84.93% 9.32% 15.07%  0.48 
Sample22 100 21,494,834 90.68% 10.06% 9.32%  0.48 
Sample23 100 20,487,688 83.47% 7.22% 16.53%  0.46 
Sample24 100 20,804,246 80.62% 14.08% 19.38%  0.46 
Sample3 100 23,399,765 86.26% 6.70% 13.74%  0.45 
Sample4 100 17,060,348 87.03% 8.30% 12.97%  0.48 
Sample5 100 21,214,979 88.32% 7.39% 11.68%  0.45 
Sample6 100 15,034,051 88.26% 8.44% 11.74%  0.44 
Sample7 100 24,907,150 89.15% 10.59% 10.85%  0.49 
Sample8 100 21,944,435 89.32% 6.98% 10.68%  0.46 
 
 
Insert Length Distribution: A Histogram was plotted for all samples (these are from  paired 
reads so from 100bp each read from each end) to show the full distribution of insert sizes 
determined from the alignments. Importantly, this shows relatively similar pattenrs 
across all sampels anfd all sampels have insert lengths of around 150-300bp (Figure 4.15) 
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Figure 4.15. Insert Length Distribution Histogram:  The full distribution of insert sizes determined from the alignments 
for all samples is shown. 
 
The sequences were analysed using an alignemnt distribution histogram where the 
numbers of bases (%) are graphed accoring to genomic regions; either coding, 
untranslated regions (UTR), intronic or intergenic. Importantly all the sampels show a 
similar distribution and a good coverage of coding and UTR and intergenic. There is less 
intronic, though there will be some, dependent on intronic splicing (Figure 4.16). 
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Figure 4.16. Alignment distribution: All Samples were aligned and plotted for the distribution across coding, UTR, 
exonic, intronic and intergenic reads. 
 
Transcript coverage was then plotted for all samples. This produces a graph showing the 
coverage of a transcript position by that transcript position as reported by 
CollectRnaSeqMetrics utility from Picard tools. The coverage is normalized for the 
coverage of that transcript.  It is important that a similar pattern is seen for all samples 
and that there is a clear bell-shaped curve (Figure 4.17). 
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Figure 4.17. Alignment distribution: All Samples were aligned and plotted for the distribution across coding, UTR, 
exonic, intronic and intergenic reads. 
 
The samples were all checked across read lengths, duplicates, aligned reads coverage and 
numerous other criteria to ensure uniformity across all samples. This did revealed that all 
samples were indeed comparable, supporting the previous graphs (Table 4.4) (Table 4.5). 
 
 
Table 4.4. Alignment distribution: All Samples were aligned and plotted for the distribution across coding, UTR, exonic, 
intronic and intergenic reads. 
 Definition  
Read Length Length of reads 100 
Number of Reads Total number of reads passing filter for this sample 19,328,365 
Bases (GB) The total number of bases for this sample 1.93 
Q30 Bases (GB) The total number of bases with a quality score of 30 or higher 1.75 
Insert Length Mean Mean length of the sequenced fragment. The fragment length is 
calculated based on the locations that a read pair aligns to the 
reference. The read mapping information is parsed from the BAM 
files. 
207.33 
Insert Length S.D. Standard deviation of the sequenced fragment length. 67.85 
Duplicates (% Reads) Percentage of paired reads that have duplicates, from a sub-sampled 
set of 4 million reads. If a panel is selected, only 0.5 million reads are 
sampled. 
16.65% 
Total Aligned Reads 
(% Reads) 
Percentage of reads passing filter that aligned to the reference. 89.40% 
Abundant Reads (% 
Reads) 
Percentage of reads that align to abundant transcripts, such as 
mitochondrial and ribosomal sequences. 
7.98% 
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Unaligned Reads (% 
Reads) 
Percentage of reads passing filter that are not aligned to the 
reference. 
10.60% 
Reads with spliced 
alignment (% 
Aligned Reads) 
Percentage of aligned reads with a spliced alignment. 26.68% 
Reads aligned at 
multiple loci (% 
Aligned Reads) 
Percentage of aligned reads to multiple loci. 3.37% 
Median CV The median coefficient of variation of coverage of the 1000 most 
highly expressed transcripts, as reported by the CollectRnaSeqMetrics 
utility from Picard tools. Ideal value = 0.0 
0.46 
Median 3' The median uniformity of coverage of the 1000 most highly expressed 
transcripts at the 3' end, as reported by the CollectRnaSeqMetrics 
utility from Picard tools. 3' bias is calculated per transcript as: mean 
coverage of the 3' most 100 bases divided by the mean coverage of 
the whole transcript. 
0.35 
Median 5' The median uniformity of coverage of the 1000 most highly expressed 
transcripts at the 5' end, as reported by the CollectRnaSeqMetrics 
utility from Picard tools. 5' bias is calculated per transcript as: mean 
coverage of the 5' most 100 bases divided by the mean coverage of 
the whole transcript. 
0.39 
Reads aligned to 
correct strand 
Percentage of reads that align to the correct strand, as reported by 
the CollectRnaSeqMetrics utility from Picard tools. 
0.00% 
Homozygous 
Reference 
Number of homozygous reference calls. 4,165,100 
Heterozygous Number of heterozygous variant calls. 12,052 
Homozygous variant Number of homozygous variant calls. 17,991 
SNVs Total number of SNVs (single nucleotide variants) detected for the 
sample. 
28,011 
Indels The number of indels (insertions and deletions) detected for the 
sample. 
2,092 
Tn/Tv Transition rate of SNVs that pass the quality filters divided by 
transversion rate of SNVs that pass the quality filters. Transitions are 
interchanges of purines (A, G) or of pyrimidines (C, T). Transversions 
are interchanges of purine and pyrimidine bases (for example, A to T). 
3.00 
 
 
Table 4.5. Coverage uniformity information: All Samples were aligned and plotted for the distribution across coding, 
UTR, exonic, intronic and intergenic reads. 
Statistic Definition 
Fold Coverage The total number of bases in the category divided by the size of the entire category. 
% Bases The total number of bases aligned to this region relative to the total number of aligned bases. 
Region Fold Coverage % Bases 
Coding 49.63x 41.56% 
UTR 61.93x 26.82% 
Intron 0.34x 7.62% 
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Intergenic 0.35x 23.99% 
 
 
GENE-L 
L COVERAG 
Statistic Definition 
Coverage Gene level coverage. 1X: At least 1X; 10X: At least 10X; 30X: At least 30X; 100X: At least 100X. 
Number of Genes Number of genes covered at the mean base coverage level or deeper. 
Coverage Number of Genes 
1X 11,283 
10X 7,831 
30X 4,719 
100X 1,733 
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4.5 Results 
 
 
4.5.1 RNA expression analysis: 
The aligned data in the BAM files were imported into a program called SeqMonk that is 
able to run r analysis statistical determination of expression differences and DESeq 
software for visualization of expression analyses. Though this could have been done in 
the same BaseSpace package as above (which also runs DESeq), Illumina charge costs, 
whereas SeqMonk is free version of the package. 
Within SeqMonk the data from the alignments, were imported and again aligned to the 
rat genome (Rattus 5.0) in the form of raw counts, were then Log2 transformed to allow 
better visualization. Preliminary QC analysis was then performed to confirm the quality 
assessments verified in Basespace and the BAM files. Firstly, a plot was performed to 
check the proportion of reads in genes falling into exons and the strand-specificity of the 
library – as we ran a bidirectional sequencing, we need to be certain that both read 
directions are uniform and that they are uniform across samples. (Figure 4.18) shows that 
all samples show similar percent in gene and exons and 50% on sense strand. They also 
show 0% rRNA (we purified only for mRNA prior to sequencing) and 0% in Mitochondria 
that we again selected against. 
 
 
 
Figure 4.18.  Alignment distribution: All Samples were aligned and plotted for the distribution across percent in gene, 
percent in exons, percent in rRNA, percent genes measured, percent of max data size, Percent in MT and percent on 
sense strand. 
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Duplication levels within the samples were then also re-checked. This was done by 
plotting duplication against read density over all exons. This revealed an association with 
read density and duplication with low density exons having low duplication, which. 
Importantly it showed that everything was not high duplication or non-continuous 
duplication (Figure 4.19). 
 
 
 
Figure 4.19.  Duplication plot: Sample 1 as representative example is shown. Sequences were plotted for % duplication 
(y axis) against Log2 reads per KB (x axis). 
 
Duplication levels within the samples were then also re-checked. This was done by 
plotting duplication against read density over all exons. This revealed an association with 
read density and duplication with low-density exons having low duplication. Importantly 
it showed that everything was not high duplication or non-continuous duplication (Figure 
4.20). 
A distribution plot was then performed to make sure all the log2 counts from the samples 
were similarly distributed. The idea is that overall distributions of counts should be similar 
but different individual genes might change. (Figure 4.20) shows that the samples are 
generally similar. 
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Figure 4.20. Distribution plot of reads across samples: Numbers of sequences (y axis) were plotted against percentage 
(x axis) for each sample. 
 
Finally, a cluster tree of the samples was performed to test that certain samples might 
not be highly unrelated to the others. This revealed that the samples were generally 
related (Figure 4.21). 
 
Figure 4.21.  Cluster tree analysis of the samples: A cluster tree was performed of the different samples. 
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All the samples were then placed into set groups for F1 control, F1 CSS, F2 control, F2 CSS 
(Table 4.2) to allow comparison for RNA expression changes using DESeq, an R program 
for expression analysis.  
 
4.5.2 Differences in expression between F1 control and F1 CSS: 
DESeq was used to compare F1 control with F1 CSS. Intensity-difference statistics were 
used, using a p-value cutoff of 0.05 and applying multiple testing correction. All genes 
significantly different are given in (Table 4.6). 
 
Table 4.6. Gene significantly different between F1 control and F1 CSS: Probe names and gene names together with 
significant differences are given. 
Probe Gene name Location Diff – p-value Function of coded protein 
ApoE apolipoprotein E Chr1:43236641-
43269644 
0.001783995 packaging cholesterol & fat 
through blood stream with 
fat. 
Slc6a5 solute carrier family 6 
(neurotransmitter 
transporter, glycine), 
member 5 
Chr1:81878373-
81881182 
1.1460418E-8 neurotransmitter 
Map3k11 mitogen-activated 
protein 11 
Chr1:106335558-
106385226 
0.021159545  
Fth1 ferritin heavy 
polypeptide 1  
Chr1:227978441-
227991739 
5.5415276E-4 Hemochromatosis, CNS 
Fam111a family with sequence 
similarity 111, member 
A  
Chr1:232979054-
232981410 
0.0026425656 Gracile bone dysplasia 
Scd stearoyl-coenzyme A 
desaturase 4,key 
enzyme 
Chr1:271502294-
271515353 
0.032811735 Fatty acid metabolism 
Map1b microtubule-associated 
protein 1B  
Chr2:48837124-
48930483 
0.032811735 Neurogenesis,  
Car3 carbonic anhydrase 3 Chr2:107900583-
107909291 
3.4972896E-8 Normal growth 
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Sertm1 serine rich and 
transmembrane domain 
containing 1 
Chr2:163721932-
163741483 
0.0029803626  
Sfrp2 secreted frizzled-
related protein 2 
Chr2:202136233-
202143777 
0.0037722779  
S100a10 S100 calcium binding 
protein A10 (calpactin) 
Chr2:210966310-
210975004 
0.03962063 Cell-cell progression & 
differentiation  
Celsr2 cadherin, EGF LAG 
seven-pass G-type 
receptor 2  
Chr2:230654782-
230677391 
0.0057067005 Bind cells, growth factors. 
Ak1 adenylate kinase 1 Chr3:16995039-
17002961 
0.001783995 Energy metabolism 
homeostasis 
Fjx1 four jointed box 1  Chr3:98940094-
98941443 
0.004252445 Growth & differentiation 
Snhg11 Small Nucleolar RNA 
Host Gene 11 
Chr3:160736978-
160743135 
0.0026595236 Host gene 
Cebpb CCAAT/enhancer 
binding protein (C/EBP), 
beta 
 
Chr3:170577777-
170578880 
0.001783995 Transcription factor, 
inflammation 
Cadps2 Ca2+-dependent 
activator protein for 
secretion 2  
Chr4:50109970-
50640382 
0.042915583  
Iqub IQ motif and ubiquitin 
domain containing 
Chr4:51258446-
51365176 
0.029059142 Formation & maintenance 
Retsat retinol saturase (all 
trans retinol 13,14 
reductase) 
Chr4:165235748-
165244511 
2.497757E-5 Vitamin –A 
Metabolism pathways 
Tmsb10 thymosin, beta 10 Chr4:165645783-
165646842 
0.0334597 Infection bacterial disease  
Ccdc77 coiled-coil domain 
containing 77 
Chr4:219949770-
219972305 
0.009776219 TF & gene expression 
Pnisr PNN interacting 
serine/arginine-rich  
Chr5:40646030-
40672914 
0.0015030955 Splicing factors 
Rnf11l RING finger protein 11 Chr5:133132389-
133132853 
5.1929953E-4  
Ncdn Neurochondrin Chr5:148539983-
148549743 
0.014347231 Transcription 
Antigen-process 
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Ptpru protein tyrosine 
phosphatase, receptor 
type, U 
Chr5:153601583-
153675513 
0.011278439 Early neurodevelopment & 
cell growth 
Plch2 phospholipase C, eta 2  Chr5:175842863-
175871527 
0.03259342 Phospholipase pathways & 
phosphyt metabolism 
Eml5 echinoderm 
microtubule associated 
protein like 5 
Chr6:131991613-
132118730 
0.034290496 CNS expression & glial cells 
Calm1 calmodulin 2  
neurotransmitters 
Chr6:133444274-
133454391 
0.0046323547 Binding to calciumions 
growth cell 
Serpina3n calmodulin 3, 
proteinase inhibitor 
Chr6:137283364-
137292168 
0.0028383373 Cancer, 
Alzheimer’s disease 
Hsp90aa1 Heat shock protein 90α Chr6:144182014-
144187540 
8.0430077E-4 Interacting with co-
chaperone 
Cancer  growth 
Nts Neurotensin Chr7:44140236-
44150124 
7.497003E-12 Enodcrine fat luteinizing 
Nov nephroblastoma 
overexpressed 
Chr7:95015159-
95022176 
0.003180026 Cardiovascular 
Cancer Skeletal 
development 
Mpped1 metallophosphoesteras
e domain containing 1 
Chr7:124671298-
124740991 
3.674019E-4 Transport & post protein 
Aniridia 
Mettl7a Methyl transferase like 
7 a 
Chr7:139783755-
139790601 
0.019388966 Innate immune system 
Nr4a1 Nuclear receptor 4 
group a member 1, 
steroid thyroid 
Chr7:140713176-
140721070 
6.482955E-4 Cancer fetal disease 
endocrine disease 
Vps13c Vascular protein sorting 
13C 
Chr8:78012253-
78174561 
0.0037190893 Parkinson disease 
autosomal recessive 
Plscr4 Phospholipid 
scramblase 4 
Chr8:99364963-
99403085 
0.00829274 Binding calcium ions 
Trank1 tetratricopeptide 
repeat and ankyrin 
repeat containing 1 
Chr8:118916156-
118993803 
0.005603083 Hydrolase activity 
Cmc1 Cox assembly 
mitochondrial protein 1 
Chr8:125679760-
125737762 
0.036573105 Metocondorial enzyme 
copper chaperon 
Lyzl4 Lysozyme like 4 Chr8:129406685-
129411111 
0.005825823 hydrolasis 
129 
 
Nktr natural killer tumor 
recognition sequence 
Chr8:129548839-
129572815 
0.003918177  
Slc5a7 Soluble carrier family 5 
choline transporter, 
member 7 
Chr9:4343096-
4379724 
0.012006678 Neuronal disease fetal eye 
muscle 
Aox1 Aldehyde oxidative 1 Chr9:64726637-
64804786 
0.031017216 Nephrological metabolism 
disease 
Hba2  Hemoglobin alpha, 
adult chain 1 
Chr10:15484461-
15485305 
0.046643484 Blood endocrine 
Hba-a2  Hemoglobin alpha, 
adult chain 2 
Chr10:15497886-
15498744 
0.031017216 Blood fetal immune liver 
Dnah9 Dynein heavy chain 9 Chr10:52103139-
52465432 
0.034090836 Fetal ear respiratory 
cardiovascular  
Wsb1 WD repeat & SOCS box- 
containing 1, atigen 
Chr10:65046088-
65062151 
0.027572677 Innate & adaptive immunity 
Luc7l3 LUC7- like 3 
(s.cerevisiae) 
Chr10:81823960-
81859932 
0.0051783216 mRNA binding 
Spp1 Osteopontin Chr14:6653093-
6658953 
6.1179094E-6 Cytokines upregulated bone 
muscles cancer disease 
Rasl11b  RAS-like, family 11, 
member B 
Chr14:36378166-
36382381 
0.00829274 Transmembrance & 
transporter activity 
Cc2d2a  Coiled-coil and C2 
domain-containing 
protein 2A, calcium 
binding 
Chr14:71922811-
71997340 
0.012006678 Fetal respiratory endocrine 
bone liver eye 
Wfs1 wolframin ER 
transmembrane 
glycoprotein 
Chr14:78613738-
78630689 
0.0 Wolframe, metabolism. 
Fetal ear Endocrine. 
 bbb. NS 
Sncg synuclein, gamma,  
nurogenerative  
Chr16:9049951-
9054488 
1.9992008E-11 Alzheimer tumors breast 
Fam129c Family with sequence 
similarity 129, member 
C 
Chr16:19887776-
19899604 
4.153117E-4 Immune system 
Tenm3 Teneurin-3 , 
transmemberance 
glycoprotein 
Chr16:46462637-
46657495 
0.0029803626 Eye disease, NS  
Dctd Deoxycytidylate 
deaminase 
Chr16:46903570-
46933233 
0.01870843 Nucleotides metabolism, 
Glass syndrome fetal 
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Kbtbd11  Kelch repeat & BTB 
domain containing 11 
Chr16:79275079-
79276980 
0.045282472 Endocrine, bone, lung, liver, 
muscles, skin 
Rgs14 A member of the 
regulation of G- protein 
signaling 
Chr17:11887270-
11901352 
0.0014981425 Long memory & learning in 
Hippocampus 
Rreb   Chr17:29453342-
29579484 
0.025306202 Zinc thyroid 
Rock1 Coiled-coil- containing 
protein Kinase 1  
Chr18:1292383-
1432455 
0.027572677 Angiogenesis 
cancer 
Grp gastrin releasing 
peptide 
Chr18:60759080-
60772845 
0.011574095 CNS binding receptors gast 
trac lung disease 
Mbp myelin basic protein Chr18:78473296-
78504226 
0.032811735 Bone marrow immune 
neuronal disease 
RT1-M6-2 RT1 class, Locus M6, 
gene 2,  
peptide antigen 
signaling receptor  
binding 
Chr20:4113595-
4116511 
4.681462E-10 Immune & process 
endogenous 
RT1-N2 ras responsive element 
binding protein 1  
Chr20:5245094-
5248485 
0.027572677 germlines 
Col11a2 Collagen type X1 alpha 2 
chain 
Chr20:5909495-
5938415 
0.017659966 Found between cells in 
space surrounding to make 
muscles  
Col6a1 Collagen type V1 alpha 1 
chain 
Chr20:14817563-
14835866 
1.3494605E-10 strength & growth 
Tmsb4x Thymosin beta-4 ChrX:28985069-
28987071 
0.006946334 Polymerization cell 
proliferation homeostasis 
bone endocrine cancer 
immune 
Klhl34 Kelch Like Family 
Member 34 
ChrX:40264786-
40266723 
0.034739614  
Ccnt Cylcin T1 ChrX:114723350-
114993826 
2.5451824E-5 Endocrine  
Immune regulation 
TF &chromatin acetylation 
regulation 
tumor growth 
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To visualize the significantly expressed genes in table data a scatter plot was made 
plotting F1 control expression against F1 CSS expression. Genes that were significantly 
differentially expressed are highlighted (Figure 4.22). 
 
 
 
Figure 4.22. Scatter plot of expression count differences between F1 control and F1 CSS. Genes significantly differently 
expressed between F1 CSS (y axis) and F1 control (x axis) are highlighted. 
 
To visualize the significantly expressed genes in table a heat map was produced that 
allowed to see if the CSS and control groups clearly differ across all genes (Figure 4.23). 
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Figure 4.23. Heat plot of differentially regulated genes between F1 control and F1 CSS. A heat map shows expression, 
low (red) too high (green), of all significantly expressed genes in the control (highlighted by blue line) and the CSS. 
 
4.5.3 Differences in expression between F2 control and F2 CSS: 
DESeq was used to compare F2 control with F2 CSS based. Intensity-based statistics were 
used, using a p-value cutoff of 0.05 and applying multiple testing correction. This revealed 
a number of differentially regulated genes (Table 4.7) (Figure 4.24). 
 
Table 4.7. Gene significantly different between F2 control and F2 CSS: Probe names and gene names together with 
significant differences are given. 
Probe Gene name Location Function of coded 
protein 
Diff – p-value 
Apoe apolipoprotein E Chr1:81878373-81881182 Packaging cholesterol 
and other fats for 
transport 
0.0 
Hbb Beta-globin Chr1:175134674-
175136088 
Component of 
hemoglobin in red 
blood cells 
0.0033 
Smg1 SMG1 homolog, 
phosphatidylinositol 3-
kinase-related kinase (C. 
elegans)  
Chr1:194739745-
194836241 
Involved in Nonsense 
Mediated MRNA 
Decay 
0.0088 
Fth1 ferritin heavy polypeptide 1  Chr1:232979054-
232981410 
Component of 
ferritin, the 
intracellular iron 
storage protein 
1.416E-10 
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Mpeg1 macrophage expressed gene 
1 
Chr1:235887051-
235889195 
membrane protein of 
macrophages, 
thought to be 
involved in the killing 
of intracellular 
bacteria 
0.0088 
Fam111a family with sequence 
similarity 111, member A 
Chr1:236163691-
236179257 
Promotes S-phase 
entry and DNA 
synthesis 
0.0039 
S100a9 S100 calcium binding protein 
A9 (calgranulin B)  
Chr2:209531412-
209533744 
Plays a prominent 
role in the regulation 
of inflammatory 
processes and 
immune response. 
0.0157 
Nktr natural killer tumor 
recognition protein 
Chr8:129548839-
129572815 
A tumor-recognition 
complex involved in 
the function of NK 
cells 
0.0256 
Slc5a7 Solute Carrier Family 5 
Member 7 
Chr9:4343096-4379724 Transmembrane 
transporter that 
imports choline from 
the extracellular 
space into the neuron 
2.3322E-8 
Hba-a2 Hba-a2 hemoglobin alpha, 
adult chain 2 
Chr10:15497886-15498744 Component of 
haemoglobin 
2.5722E-4 
Sncg Synuclein gamma  Chr16:9049951-9054488 Plays a role in 
neurofilament 
network integrity. 
0.0 
Fam129c family with sequence 
similarity 129, member C 
Niban-like protein 2 
Chr16:19887776-19899604 Expressed in early 
stages of B-cell 
differentiation, 
4.5840E-7 
RT1-M6-
2 
RT1 class I, locus M6, gene 2 Chr20:4113595-4116511 Predicted antigen 
binding and immune 
processes 
2.572E-4 
Pcsk1n Proprotein convertase 
subtilisin/kexin type 1 
inhibitor  
ChrX:16104506-16107925 May function in the 
control of the 
neuroendocrine 
secretory pathways. 
0.0346 
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Figure 4.24.  Scatter plot of expression count differences between F2 control and F2 CSS. Genes significantly differently 
expressed between F1 CSS (y axis) and F1 control (x axis) are highlighted. 
 
4.5.4 Gene ontology analysis 
To test whether certain classes of proteins, coded by the genes differentially expressed 
between CSS and Control software was used. The PANTHER 
(Protein ANalysis THrough Evolutionary Relationships) Classification System is able to 
classify proteins (and their genes) according to family of evolutionarily related proteins or 
subfamilies of related proteins that also have the similar function. Gene coding proteins 
can aso be related by molecular function, their biological processes or if they are involved 
in a same pathway suggesting relationships between the interacting molecules (Mi et al., 
2016). 
Inputting the genes identified as differentially expressed between the F1 control and F1 
CSS groups it appears that most of the genes code for proteins involved in biological 
regulation (Figure 4.25A), are receptors and calcium binding proteins (Figure 4.25B) and 
have a molecular function as binding (Figure 4.25C). 
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Figure 4.25. Gene Ontology analysis of the genes differentially expressed between F1 CSS and Control. Genes 
significantly differently grouped according to Biological Processes (A) Protein class (B) and molecular function (C). 
 
When testing the genes identified as differentially expressed between the F2 control and 
F2 CSS groups it appears that most of the genes code for proteins involved in metabolic 
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processes (Figure 4.26A). There is no clear protein class (Figure 4.26B) but again have a 
molecular function as binding (Figure 4.26C). 
 
Figure 4.26. Gene Ontology analysis of the genes differentially expressed between F2 CSS and Control. Genes 
significantly differently grouped according to Biological Processes (A) Protein class (B)  and molecular function (C). 
 
Gene ontology analysis was performed using another software called GProfiler. (Reimand 
et al., 2016) Inputting the genes identified as differentially expressed between the F1 
control and F1 CSS groups it appears that most of the genes code for proteins involved in 
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biological regulation (Figure 4.27A), are receptors and calcium binding proteins (Figure 
4.27B) and have a molecular function as binding (Figure 4.27C). 
 
Figure 4.27. Gene Ontology analysis using GProfiler. Was used to investigate genes differentially expressed between 
F1 CSS and Control (A) and F2 CSS and Control (B).   
B A 
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4.6 Discussion 
 
The results of Study 1 suggest that between F1 and F2 generations there is a shift from 
HPA dysregulation to more immune changes. To investigate genomewide changes in gene 
expression in the F1 and F2 CS dams hippocampi were tested using RNASeq. Groups of 6 
each of F1 CSS and controls and F2 CSS and controls were tested. A further 6 of each group 
were also prepared for RNAseq, to increase numbers to 12, however the library preps 
were not efficient and a repeat of the method again led to low yield.  Reasons included a 
malfunctioning PCR machine and using ice at the wrong step. However, the results for the 
first 24 samples revealed high quality sequencing across the samples that allowed 
comparisons of differential gene regulation across the samples and groups. 
Gene expression differences between the F1 CSS and control animals were compared 
using intensity differences and treating the groups as replicates using a p-value cut-off of 
0.05 and applying multiple testing correction. This revealed 75 genes differentially 
regulated between CSS and control (Table 4.6). Investigating the genes using gene 
ontology analyses revealed that most of the genes were receptors and calcium binding 
proteins that had molecular functions as binding. Calcium binding proteins are 
particularly important in neuronal functioning and depression (Rajkowska et al., 2007). 
This family of proteins found in a variety of tissues particularly the brain and neurons that  
use calcium-mediated signaling functions and calcium influx as part of depolarisation. The 
most well described calcium binding proteins are parvalbumin, calbindin-D28K, calretinin, 
calmodulin, calcineurin, and the S100 family (Eyles et al., 2002) and these have well-
described roles in stress and depression, for example (Uher and Bob, 2012). Genes 
differentially regulated include S100 calcium binding protein A10 (calpactin, S100A), 
Ca2+-dependent activator protein for secretion 2 (Cadps2), calmodulin 1, calmodulin 2, 
S100 calcium binding protein A9 (Nktr, calgranulin B). S100, for example has been found 
to be reduced in the cerebral spinal fluid in linked to increasing symptoms of depression 
(Seo et al., 2017). Calmodulin 1 and 2 have been linked to neurodevelopmental 
disorders e.g. (Fillman et al., 2014) , and calgranulin to depression and stress (Fillman et 
al., 2014). 
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There are also a high number of hydolases including Dnah9, Mpped1, Ptpru, Dctd, Spp1 
and Plch2. Hydrolases are one of the largest enzyme classes and play crucial roles in many 
developmental processes including. One of the other important groups are the receptors 
including Col6a1, Nr4a1 nuclear receptor, Ptpru protein phosphatase receptor and the G-
protein coupled receptors Celsr2 and Sfrp2. G Protein-Coupled Receptors have well-
described roles in psychiatric disorders (Catapano and Manji, 2007). 
Regarding pathways, the main pathway in which most genes fitted was the 
Cholecystokinin (CCKR) signaling map, including Nr4a1, Rock1, Map3k11 and Calm1. 
Though important in control of the intestine, CCK has been strongly linked to depression 
and suicide with one study finding 22 times higher levels of this hormones in suicide 
attempters (Jahangard et al., 2018). There are also genes linked to Inflammation 
mediated by chemokine and cytokine signaling pathways including Col6a1, Rgs14 and 
Rock1, supporting the role of inflammation in the CSS model. Finally, it is interesting when 
comparing the previously mentioned study of Stankiewicz et al. on hippocampus 
transcriptomes of mice exposed to chronic social stress, that we also found altered 
regulation of proteins involved in the vascular system (i.e. Hba1 and Hba-a2), injury 
response (e.g. Col6a1) and inflammation (e.g. S100 proteins Rgs14 and Rock1) supporting 
their conclusions that stress may impact the vascular system (Stankiewicz et al., 2015). 
Of other interest are the roles of Calmodulin and Neurotensin in the control of prolactin 
secretion. Considering that prolactin was reduced in the F1 dams it is important that 
Calmodulin is altered in expression. Calmodulin is highly important in the regulation of 
the Prolactin gene expression (White and Bancroft, 1987; Merritt et al., 1983) as is  
Neurotensin (Enjalbert et al., 1982) suggesting perhaps there are gene pathways 
disrupted in the regulation of this hormone.  
Comparing F2 CSS and control dams only 15 genes were found to be differently regulated. 
This included genes involved in metabolic processes, such as Smg1, Slc5a7, Pcsk1n, Hbb, 
Apoe and S100a9. Such metabolic processes are highly important in brain function and 
development. Importantly, there are also genes involved in inflammation regulation 
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including Fam111a, S100a9 and calcium binding (Nktras and S100a9) as in the F2 animals 
suggesting some similar pathways. 
Finally, when comparing genes differently expressed between F1 and F2 CSS and control 
dams we find a startling number of genes similarly regulated in both. In fact 9 of the 15 
genes differently regulated in the F2 animals were also differently regulated between the 
F1 CSS and control dams. This included ApoE, Hba-a2, Fam111a, Fth1, Nkt1, SLc5a7, Sncg, 
Fam129c and RT1-M6-2. A related S100 protein, S100a10, was also differently regulated. 
This suggests some level of inheritance of the differently expressed genes in the F1 
animals. Importantly, many of these genes have also been linked to stress and depression. 
ApoE, an important marker for Alzheimer’s disease, has been shown in a meta-analysis of 
major depression to be a susceptibility gene (López-León et al., 2008). The Hba-a2 gene 
has been found to be differently expressed in prefrontal cortex of rats showing increased 
levels of depression (Yamamoto et al., 2015). Polymorphisms in the SLC5A7 gene have 
been associated with infant stress responsivity (Jones et al., 2018). Gamma-Synuclein 
(Sncg) expression in the hippocampus has been linked to depressive-like behaviour in a 
rat model of depression (Jeannotte et al., 2009).  
Finally, alterations in S100A10 (also known as p11) are linked to major depression and in 
the therapeutic actions of antidepressants (Svenningsson et al., 2013; Svenningsson et al., 
2006) with a decrease in mRNA and protein in the brains of humans with depression, 
suicide victims, and a mouse model of depression (Dwivedi et al., 2005; Svenningsson et 
al., 2006; Anisman et al., 2008; Alexander et al., 2010). (Leckman et al., 2004; Dwivedi, 
2009) suggesting a crucial role for this gene in the development of depression.  
The major limitations in this study are that the numbers of animals in each group could 
be increased. It was planned to perform 48 RNAseq experiments, but the final 24 library 
preparations could not be performed as firstly a PCR machine failed to run properly and 
then there was a mistake with putting samples on ice at the wrong step. Due to the costs 
of the library prep kits and associated chemicals we could not re-perform these. However, 
the high quality of the first 24 samples has allowed analysis. 
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Overall, the results show that in F1 CSS and control animals there are a relatively larger 
number of genes differentially regulated than between the F2 CSS and control dams. In 
the F1s there are genes involved in calcium binding and protein-coupled receptors 
whereas in the F2s there are genes involved in inflammation. The most striking finding is 
that two-thirds of the genes (if you include S100a10) differently regulated in the F2 were 
also changes in the F1s. Many of these genes have been previously linked to the stress 
and the development of depression. This seems to suggest a level of inheritance of 
expression of key genes involved in the regulation of depression from F1 to F2 dams 
supporting a possible mechanism for the intergenerational inheritance of the maternal 
anxiety and depressed maternal care. 
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5 Study 4: Investigation of epigenetic changes in stress-related genes in mothers and 
infants exposed to stress and maternal depression.  
5.1 Introduction 
Results from the Study 1 of the transgenerational CSS rat study highlighted epigenetic 
regulation of Nr3c1 and BDNF with maternal depression. Specifically, Nr3c1 and BDNF 
methylation and expression were differentially changed in F1 exposed to postnatal 
depression in comparison to the F2 animals exposed to prenatal and postnatal expression. 
Results from the literature review in Chapter 1 shows that these two genes are widely 
regulated has identified key stress-related genes that are epigenetically regulated by 
stress and associated with depression. 
Studies on Nr3c1 DNA methylation at promoter 1-7 have shown that stress in prenatal 
and postnatal stages both induce increased methylation in the offspring. Interestingly, 
(Table 2.1) (*prenatal stress) reveals do differences between prenatal and postnatal in 
this methylation change. However, a study by Murgatroyd et al. were the first to show an 
interaction between prenatal and postnatal maternal depression on infant methylation. 
Specifically, they showed that prenatal and postnatal maternal depression individually 
increased Nr3c1 methylation. Importantly though, exposure to prenatal depression 
protected the infant from the effects of postnatal depression in terms of increased 
methylation and anxiety and depressive symptoms (Murgatroyd et al., 2015a). 
Studies on FKBP5 DNA methylation, as previously described, again highlight similar 
epigenetic changes, namely increases in DNA methylation at intron 7 in human studies, 
of stress exposure and depression (Table 1.4). However, there are few studies on prenatal 
stress and few studies contrast pre and postnatal stages. Similarly, in the BDNF studies 
there is only one report on prenatal stress and child methylation (Table 1.5). However, 
no studies have yet tested methylation in mothers suffering maternal depression in either 
NR3C1, FKBP5 or BDNF. 
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One consideration is the difference between studying epigenetic changes in blood and 
brain. The rodent studies, including in Chapter 3 Study 1, generally investigate brain 
material. However, the majority of the human studies have focused on blood. If one 
considers that epigenetic changes alter gene expression and the depression should 
involve gene expression changes in the brain, the question is how relevant is blood to 
study. Considering that many of the findings in (Tables 1.3, 1.4, 1.5)  detailing the result 
from studies of DNA methylation and stress report their measures in blood and that many 
of the findings support each other, the importance of using blood DNA for the 
investigation of stress-related epigenetic changes is important. 
Using two individual human studies this study will be the first to test whether DNA 
methylation in mothers at NR3C1, FKBP5 and BDNF associate with their level of either 
prenatal or postnatal depression. Testing in two different studies will allow us to test the 
robustness of any associations. We then test the role of perceived stress at prenatal and 
postnatal period on the methylation of the above genes in the mothers using 
discrimination and pregnancy anxiety. 
Finally, we test to what extent either prenatal or postnatal maternal depression impacts 
DNA methylation at NR3C1, FKBP5 and BDNF in their offspring. 
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5.2 Aims:  
This study will investigate epigenetic changes at candidate genes in a human study 
mothers with maternal depression and stress and infants exposed to maternal 
prenatal and postnatal depression. Specifically we hypothesis that epigenetic changes 
in candidate stress-related genes, highlighted from the rat studies, are similarly 
regulated in human studies. 
 
5.3. Objectives: 
1. Investigate epigenetic changes in stress-related genes in mothers exposed to stress.  
2. Investigate epigenetic changes in stress-related genes in mothers suffering from 
prenatal and postnatal maternal depression 
3. Test whether infants exposed to maternal depression or maternal stress show 
epigenetic changes in stress-related genes 
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5.4 RESULTS 
5.4.1 Epigenetic regulation of stress-related genes with stress and in depression during 
pregnancy in a Latio cohort 
 
Latino mothers living in the US were asked to complete a questionnaire for depression 
(IDAS-GD) and perceived discrimination (EDS). Blood DNA was measured for methylation 
at NR3C1, FKBP5 and BDNF. 
 
5.4.1.1 NR3C1 methylation in the Latino mothers study 
PCRs were performed on bisulphite-treated DNA from the Latino mothers study. This was 
pyrosequenced and 4 CpG sites were investigated (Figure 5.1), identical to those CpGs 
studied in previous studies (Table 1.3, Figure 1.7). 
 
 
Figure 5.1. A schematic representation of the human the NR3C1 exon 1-F promoter region  showing sequence 
analysed by bisulphite sequencing and the numbered CpGs. 
 
An example of a pyrosequencing run demonstrating methylation levels across the 4 CpG 
sites in the NR3C1 promoter is shown in (Figure 5.2). 
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Figure 5.2. Bisulphite pyrosequencing of NR3C1 
 
Levels of methylation across the mothers at the 4 CpG sites in the NR3C1 promoter in the 
Latino mothers cohort were: CpG1, 1.36%; CpG2, 3.608%; CpG3, 4.615%; CpG4, 5.32% 
and average methylation across the CpGs was 2.48% (Figure 5.3). 
 
Figure 5.3. NR3C1 methylation in the Latino mothers study. Percentage average + Standard Deviation of DNA 
methylation at each of the 4 CPGs are shown together with the average methylation of all CpGs within an individual. 
 
5.4.1.2 NR3C1 methylation and discrimination  
A correlation was performed between DNA methylation across the CpGs for average 
methylation and EDS (Everyday discrimination scale, see 2.2.3) during pregnancy (eds1) 
and postnatally (eds2) and across pre- and postnatal periods (eds total) to determine if 
there is an association between methylation and stress in the form of discrimination. This 
revealed a negative correlation between NR3C1 methylation and total EDS score, i.e. the 
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higher the amount of average methylation at NR3C1 the higher the level of perceived 
discrimination (Table 5.1). 
 
Table 5.1. Correlation of average NR3C1 methylation and EDS in the Latino mothers study.  
  GR_AVG eds_1 eds_2 eds_total 
GR_AVG Pearson 
Correlation 
1 -0.111 -0.116 -.163* 
Sig. (2-
tailed) 
  0.176 0.157 0.046 
N 150 150 150 150 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
A correlation was then done between DNA methylation at the individual CpGs and EDS 
determine if there is an association between methylation and stress at particular CpGs. 
This revealed there was a negative correlation between CpG1 methylation and prenatal, 
postnatal and total EDS scores, with higher levels of methylation and higher levels of  
stress 
 
Table 5.2. Correlation of NR3C1 methylation at individual CpGs and EDS in the Latino mothers study.  
  GR_cpg1 GR_cpg2 GR_cpg3 GR_cpg4 eds_1 eds_2 eds_total 
GR_cpg1 Pearson 
Correlation 
1 .272** .285** .306** -.171* -.167* -.176* 
Sig. (2-
tailed) 
  0.001 0.000 0.000 0.037 0.041 0.032 
N 150 150 150 150 150 150 150 
GR_cpg2 Pearson 
Correlation 
.272** 1 .616** .398** -0.074 -0.086 -0.132 
Sig. (2-
tailed) 
0.001   0.000 0.000 0.370 0.295 0.107 
N 150 150 150 150 150 150 150 
GR_cpg3 Pearson 
Correlation 
.285** .616** 1 .445** -0.033 -0.039 -0.126 
Sig. (2-
tailed) 
0.000 0.000   0.000 0.689 0.634 0.126 
N 150 150 150 150 150 150 150 
GR_cpg4 Pearson 
Correlation 
.306** .398** .445** 1 -0.048 -0.044 -0.038 
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Sig. (2-
tailed) 
0.000 0.000 0.000   0.560 0.593 0.646 
N 150 150 150 150 150 150 150 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
A scatter plot was produced to show the significant negative correlation between NR3C1 
CpG1 methylation and EDS (Figure 5.4). 
 
Figure 5.4. A scatter plot of percentage DNA methylation at CpG1 and EDS 
 
5.4.1.3 NR3C1 methylation and depression 
A correlation was performed between DNA methylation and IDAS (Inventory of 
depression and anxiety scale, see 2.3.4) to determine if there is an association between 
methylation and prenatal (IDAS1) and postnatal (IDAS) or total depression. This revealed 
no significant a negative correlation between average methylation at NR3C1 methylation 
and IDAS score (Table 5.3) or methylation at individual CpGs (Table 5.4). 
 
Table 5.3. Correlation of NR3C1 methylation and prenatal (idas1) and postnatal (idas2) or total (idas total) maternal 
depression in the Latino mothers study 
 
  GR_AVG idas1 idas2 idas_total 
GR_AVG Pearson 
Correlation 
1 -0.055 0.010 -0.057 
Sig. (2-
tailed) 
  0.507 0.902 0.486 
149 
 
N 150 150 150 150 
 
 
Table 5.4.  Correlation of NR3C1 methylation at specific CpGs and prenatal (idas1) and postnatal (idas2) or total (idas 
total) maternal depression in the Latino mothers study 
  GR_cpg1 GR_cpg2 GR_cpg3 GR_cpg4 idas1 idas2 idas_total 
GR_cpg1 Pearson 
Correlation 
1 .272** .285** .306** -0.051 0.056 -0.034 
Sig. (2-
tailed) 
  0.001 0.000 0.000 0.538 0.495 0.682 
N 150 150 150 150 150 150 150 
GR_cpg2 Pearson 
Correlation 
.272** 1 .616** .398** -0.032 0.022 -0.048 
Sig. (2-
tailed) 
0.001   0.000 0.000 0.698 0.788 0.558 
N 150 150 150 150 150 150 150 
GR_cpg3 Pearson 
Correlation 
.285** .616** 1 .445** -0.062 -0.080 -0.033 
Sig. (2-
tailed) 
0.000 0.000   0.000 0.449 0.329 0.690 
N 150 150 150 150 150 150 150 
GR_cpg4 Pearson 
Correlation 
.306** .398** .445** 1 -0.006 0.038 -0.047 
Sig. (2-
tailed) 
0.000 0.000 0.000   0.938 0.642 0.566 
N 150 150 150 150 150 150 150 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
5.4.1.4 FKBP5 methylation in the Latino mothers study 
DNA methylation was measured at two sites within a regulatory region in intron 7 of the 
FKBP5 gene. These sites were found by Klengel and colleagues (Klengel et al., 2013) to 
exhibit lower levels of methylation in adults with a history of childhood adversity and have 
been investigated in several previous studies (See Table 1.5, Figure 1.8) (Figure 5.5). 
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Figure 5.5. A schematic representation of the human FKBP5 intron 7 region showing sequence analysed by bisulphite 
sequencing and the numbered CpGs. 
 
An example of a pyrosequencing run demonstrating methylation levels across the 2 CpG 
sites in the FKBP5 promoter is shown in (Figure 5.6). 
 
 
Figure 5.6. Bisulphite pyrosequencing of FKBP5 
 
Levels of methylation across the mothers at the 2 CpG sites in the FKBP5 intron 7 in the 
Latino mothers cohort were: CpG1, 98.98%; CpG2, 92.18%. Average methylation across 
the CpGs was 95.58% (Figure 5.7). 
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Figure 5.7. FKBP5 methylation in the Latino mothers study. Percentage average + Standard Deviation of DNA 
methylation at each of the 4 CPGs are shown together with the average methylation of all CpGs within an individual. 
 
5.4.1.5 FKBP5 methylation and discrimination  
A correlation was performed between average DNA methylation across the CpGs and EDS 
prenatal (eds1) and postnatally (eds2) to determine if there is an association between 
methylation and discrimination. This revealed no significant correlations (Table 5.5). 
 
Table 5.5.  Correlation of average FKBP5 methylation and EDS in the Latino mothers study  
  FKBP5_AVG eds_1 eds_2 eds_total 
FKBP5_AVG Pearson 
Correlation 
1 -0.056 -0.105 -0.033 
Sig. (2-
tailed) 
  0.493 0.203 0.691 
N 150 150 150 150 
 
A correlation was then performed between DNA methylation at the individual CpGs and 
EDS. This also revealed no correlation (Table 5.6). 
 
Table 5.6. Correlation of FKBP5 methylation at individual CpGs and EDS in the Latino mothers study  
  FKBP5_ cpg1 FKBP5_ cpg2 eds_1 eds_2 eds_total 
FKBP5 
_cpg1 
Pearson 
Correlation 
1 .282** -0.092 -0.070 -0.040 
Sig. (2-
tailed) 
  0.000 0.263 0.391 0.626 
N 150 150 150 150 150 
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FKBP5_ 
cpg2 
Pearson 
Correlation 
.282** 1 -0.020 -0.094 -0.019 
Sig. (2-
tailed) 
0.000   0.804 0.252 0.815 
N 150 150 150 150 150 
 
5.4.1.6 FKBP5 methylation and depression  
A correlation was performed between DNA methylation and IDAS (Inventory of 
depression and anxiety scale, see 2.3.4) to determine if there is an association between 
methylation and prenatal (IDAS1) and postnatal (IDAS) or total depression. This revealed 
no significant a negative correlation between average methylation at FKBP5 methylation 
and IDAS score (Table 5.7) or methylation at individual CpGs (Table 5.8). 
 
Table 5.7. Correlation of FKBP5 methylation and prenatal (idas1) and postnatal (idas2) or total (idas total) maternal 
depression in the Latino mothers study 
  FKBP5_AVG idas1 idas2 idas_total 
FKBP5_AVG Pearson 
Correlation 
1 -0.114 -0.005 0.043 
Sig. (2-
tailed) 
  0.164 0.950 0.599 
N 150 150 150 150 
 
 
Table 5.8.  Correlation of FKBP5 methylation and prenatal (idas1) and postnatal (idas2) or total (idas total) maternal 
depression in the Latino mothers study 
  
FKBP5_ 
cpg1 
FKBP5
_cpg2 idas1 idas2 idas_total 
FKBP5
_cpg1 
Pearson 
Correlation 
1 .282** -0.077 -0.115 0.044 
Sig. (2-tailed)   0.000 0.350 0.160 0.593 
N 150 150 150 150 150 
FKBP5
_cpg2 
Pearson 
Correlation 
.282** 1 -0.103 0.058 0.031 
Sig. (2-tailed) 0.000   0.211 0.480 0.710 
N 150 150 150 150 150 
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5.4.1.7 BDNF methylation in the Latino mothers study 
 
DNA methylation was measured across promoter 1-4 of the BDNF gene. Seven CpG sites 
were investigated and identical to those CpGs studied in previous studies (See Table 1.5, 
Figure 1.8) and at a homologous region to that investigated in the rat studies (Figure 1.9) 
(Figure 5.8). 
 
Figure 5.8.  A schematic representation of the human BDNF exon IV promoter region showing sequence analysed by 
bisulphite sequencing and the numbered CpGs. 
 
An example of a pyrosequencing run demonstrating methylation levels across the 10 CpG 
sites in the BDNF promoter IV are shown in (Figure 5.9). Importantly, not all samples gave 
good quality reads for all CpGs in the pyrosequencing, therefore only the first 7 CpGs were 
analysed for which most samples had results for.  
 
 
 
Figure 5.9. Bisulphite pyrosequencing of BDNF 
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Levels of methylation across the mothers at the 7 CpG sites in the BDNF promoter IV in 
the Latino mothers cohort were: CpG1, 4.03%; CpG2, 2.49%; CpG3, 2.88%; CpG4, 7.28%; 
CpG5, 3.22%; CpG6 2.2%; CpG7, 5.77% and average methylation across the 7 CpGs was 
3.97%  (Figure 5.10). 
 
 
Figure 5.10. BDNF methylation in the Latino mothers study. Percentage average + Standard Deviation of DNA 
methylation at each of the 4 CPGs are shown together with the average methylation of all CpGs within an individual. 
 
5.4.1.8 BDNF methylation and prenatal (T1) and postnatal (T2) discrimination  
 
A correlation was performed between average DNA methylation at BDNF and prenatal 
EDS (eds 1), postnatal eds (eds 2) and total eds to determine if there is an association 
between methylation and discrimination. This revealed no significant correlations (Table 
5.9). 
 
Table 5.9. Correlation of average BDNF and EDS in the Latino mothers study  
  BDNF_AVG eds_1 eds_2 eds_total 
BDNF_AVG Pearson 
Correlation 
1 -0.048 -0.063 -0.044 
Sig. (2-
tailed) 
  0.562 0.444 0.595 
N 149 149 149 149 
 
0
2
4
6
8
10
12
CpG 1 CpG 2 CpG 3 CpG 4 CpG 5 CpG 6 CpG 7
B
D
N
F
 M
e
th
y
la
ti
o
n
 (
%
)
155 
 
 
A correlation was then done between DNA methylation at the individual CpGs and EDS 
determine if specific CpGs might correlate. This also revealed no correlations between 
CpG methylation and EDS score (Table 5.10). 
 
Table 5.10.  Correlation of BDNF methylation at individual CpGs and EDS in the Latino mothers study 
  
BDNF
_ cpg1 
BDNF
_ cpg2 
BDNF
_ cpg3 
BDNF 
_cpg4 
BDNF
_ cpg5 
BDNF
_ cpg6 
BDNF
_ cpg7 eds_1 eds_2 
eds_
total 
BDNF_ 
cpg1 
Pearson 
Correlati
on 
1 0.058 0.026 -0.142 -0.034 -0.048 -0.117 0.046 0.104 0.12
2 
Sig. (2-
tailed) 
  0.485 0.749 0.084 0.682 0.562 0.159 0.581 0.205 0.14
0 
N 149 149 149 149 149 149 147 149 149 149 
BDNF_ 
cpg2 
Pearson 
Correlati
on 
0.058 1 -0.107 -0.091 0.113 -0.022 -0.152 0.030 0.036 0.06
9 
Sig. (2-
tailed) 
0.485   0.195 0.269 0.170 0.786 0.067 0.716 0.664 0.40
4 
N 149 149 149 149 149 149 147 149 149 149 
BDNF_ 
cpg3 
Pearson 
Correlati
on 
0.026 -0.107 1 0.125 .247** .170* -0.013 -0.034 -0.031 -
0.05
6 
Sig. (2-
tailed) 
0.749 0.195   0.128 0.002 0.038 0.875 0.679 0.706 0.49
4 
N 149 149 149 149 149 149 147 149 149 149 
BDNF_ 
cpg4 
Pearson 
Correlati
on 
-0.142 -0.091 0.125 1 0.110 .170* .212** 0.034 0.006 -
0.01
4 
Sig. (2-
tailed) 
0.084 0.269 0.128   0.183 0.038 0.010 0.677 0.943 0.86
1 
N 149 149 149 149 149 149 147 149 149 149 
BDNF_ 
cpg5 
Pearson 
Correlati
on 
-0.034 0.113 .247** 0.110 1 .195* -0.009 -0.003 -0.045 -
0.02
2 
Sig. (2-
tailed) 
0.682 0.170 0.002 0.183   0.017 0.913 0.975 0.587 0.79
1 
N 149 149 149 149 149 149 147 149 149 149 
BDNF_ 
cpg6 
Pearson 
Correlati
on 
-0.048 -0.022 .170* .170* .195* 1 .231** -0.094 -0.080 -
0.05
7 
Sig. (2-
tailed) 
0.562 0.786 0.038 0.038 0.017   0.005 0.253 0.333 0.48
8 
N 149 149 149 149 149 149 147 149 149 149 
BDNF_ 
cpg7 
Pearson 
Correlati
on 
-0.117 -0.152 -0.013 .212** -0.009 .231** 1 -0.118 -.175* -
0.14
9 
Sig. (2-
tailed) 
0.159 0.067 0.875 0.010 0.913 0.005   0.154 0.034 0.07
2 
N 147 147 147 147 147 147 147 147 147 147 
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**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
5.4.1.9 BDNF methylation and depression  
A correlation was performed between BDNF DNA methylation and IDAS to determine if 
there is an association between methylation and prenatal (IDAS1) and postnatal (IDAS) or 
total depression. This revealed no correlations between average methylation at BDNF 
methylation and IDAS score (Table 5.11) or methylation at individual CpGs (Table 5.12). 
 
Table 5.11. Correlation of BDNF methylation and prenatal (idas1) and postnatal (idas2) or total (idas total) maternal 
depression in the Latino mothers study 
  BDNF_AVG idas1 idas2 idas_total 
BDNF_AVG Pearson 
Correlation 
1 0.002 -0.017 0.038 
Sig. (2-
tailed) 
  0.976 0.839 0.642 
N 149 149 149 149 
 
Table 5.12.  Correlation of BDNF methylation and prenatal (idas1) and postnatal (idas2) or total (idas total) maternal 
depression in the Latino mothers study 
 
  
BDNF
_ cpg1 
BDNF
_ cpg2 
BDNF
_ cpg3 
BDNF
_ cpg4 
BDNF
_cpg5 
BDNF
_cpg6 
BDNF
_cpg7 idas1 idas2 
idas_tot
al 
BDNF
_cpg1 
Pearson 
Correlati
on 
1 0.058 0.026 -0.142 -0.034 -0.048 -0.117 -0.047 -0.040 -0.032 
Sig. (2-
tailed) 
  0.485 0.749 0.084 0.682 0.562 0.159 0.570 0.627 0.698 
N 149 149 149 149 149 149 147 149 149 149 
BDNF
_cpg2 
Pearson 
Correlati
on 
0.058 1 -0.107 -0.091 0.113 -0.022 -0.152 -0.048 -0.048 0.080 
Sig. (2-
tailed) 
0.485   0.195 0.269 0.170 0.786 0.067 0.564 0.563 0.332 
N 149 149 149 149 149 149 147 149 149 149 
BDNF
_cpg3 
Pearson 
Correlati
on 
0.026 -0.107 1 0.125 .247** .170* -0.013 0.026 -0.016 0.105 
Sig. (2-
tailed) 
0.749 0.195   0.128 0.002 0.038 0.875 0.748 0.851 0.204 
N 149 149 149 149 149 149 147 149 149 149 
BDNF
_cpg4 
Pearson 
Correlati
on 
-0.142 -0.091 0.125 1 0.110 .170* .212** 0.041 0.046 0.023 
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Sig. (2-
tailed) 
0.084 0.269 0.128   0.183 0.038 0.010 0.619 0.578 0.783 
N 149 149 149 149 149 149 147 149 149 149 
BDNF
_cpg5 
Pearson 
Correlati
on 
-0.034 0.113 .247** 0.110 1 .195* -0.009 -0.076 -0.022 0.010 
Sig. (2-
tailed) 
0.682 0.170 0.002 0.183   0.017 0.913 0.358 0.792 0.908 
N 149 149 149 149 149 149 147 149 149 149 
BDNF
_cpg6 
Pearso
n 
Correla
tion 
-
0.048 
-
0.022 
.170* .170* .195* 1 .231** 0.067 -
0.022 
0.019 
Sig. (2-
tailed) 
0.562 0.786 0.038 0.038 0.017   0.005 0.418 0.792 0.819 
N 149 149 149 149 149 149 147 149 149 149 
BDNF
_cpg7 
Pearso
n 
Correla
tion 
-
0.117 
-
0.152 
-
0.013 
.212** -
0.009 
.231** 1 0.022 0.010 -0.021 
Sig. (2-
tailed) 
0.159 0.067 0.875 0.010 0.913 0.005   0.790 0.902 0.800 
N 147 147 147 147 147 147 147 147 147 147 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
5.4.2 Epigenetic regulation of NR3C1 in mother with prenatal and postnatal 
depression and anxiety in their offspring. 
 
Mothers living in the Wirral, UK at 20wks of pregnancy (prenatal) and 5 weeks following 
birth (postnatal) were asked to complete a questionnaire for depression (EPDS) and 
anxiety (see methods). Saliva DNA was measured for methylation at NR3C1 in mothers 
and their offspring. In the mothers DNA was taken at the age of 27.6 years  and in infants 
at the age of 3 years. 
Levels of methylation across the mothers at the 4 CpG sites were: CpG1, 1.22%; CpG2, 
3.513%; CpG3, 4.784%; CpG4, 7.22% and average methylation across the CpGs was 2.36%. 
In the infants methylation was CpG1, 1.77%; CpG2, 3.64%; CpG3, 5.07%; CpG4, 9.29% and 
average methylation across the CpGs was 2.7% (Figure 5.11). 
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Figure 5.11.  NR3C1 methylation in the WCHADS mothers and their offspring. Percentage average + Standard 
Deviation of DNA methylation at each of the 4 CPGs are shown together with the average methylation of all CpGs within 
an individual. 
 
5.4.2.1 Maternal prenatal anxiety and depression and NR3C1 methylation: A correlation 
was performed between DNA methylation across the CpGs for average methylation in 
mothers who had suffered from prenatal depression and anxiety. This revealed no 
significant correlation (Table 5.13). 
 
Table 5.13. Correlation of average NR3C1 methylation with prenatal anxiety and depression the WCHADS mothers  
 
  Mother CpG12 
prenatal 
anxiety 
Prenatal 
depression 
Mother CpG12 Pearson 
Correlation 
1 -0.044 -0.155 
Sig. (2-
tailed) 
  0.608 0.067 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
A correlation was then done between DNA methylation at the individual CpGs and EPDS 
determine if there is an association between methylation and depression. This also revealed 
no correlations between CpG methylation and EDS score (Table 5.14). 
 
Table 5.14.  Correlation of NR3C1 methylation at individual CpGs in mothers who suffered from prenatal anxiety and 
depression  
 
 
  
Mum 
CpG1 
Mum 
CpG2 
Mum 
CpG3 
Mum 
CpG4 
Prenatal 
depression 
Prenatal 
anxiety  
Mum CpG1 Pearson 
Correlation 
1 -0.002 -0.039 -.187* -0.156 -0.097 
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Sig. (2-
tailed) 
  0.981 0.641 0.026 0.066 0.256 
 
N 143 143 143 143 140 140 
 
Mum CpG2 Pearson 
Correlation 
-0.002 1 0.075 0.094 -0.105 -0.010 
 
Sig. (2-
tailed) 
0.981   0.372 0.265 0.215 0.910 
 
N 143 143 143 143 140 140 
 
Mum CpG3 Pearson 
Correlation 
-0.039 0.075 1 .234** -0.035 0.032 
 
Sig. (2-
tailed) 
0.641 0.372   0.005 0.686 0.704 
 
N 143 143 143 143 140 140 
 
Mum CpG4 Pearson 
Correlation 
-.187* 0.094 .234** 1 0.020 0.010 
 
Sig. (2-
tailed) 
0.026 0.265 0.005   0.819 0.906 
 
N 143 143 143 143 140 140 
 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
 
5.4.2.2 Maternal postnatal depression and NR3C1 methylation: A correlation was 
performed between DNA methylation across the CpGs for average methylation and postnatal 
anxiety and depression. This revealed no significant correlation (Table 5.15). 
 
Table 5.15.  Correlation of average NR3C1 methylation with postnatal anxiety and depression the WCHADS mothers  
  Mother CpG12 
postnatal 
anxiety 
Postnatal 
depression  
Mother 
CpG12 
Pearson 
Correlation 
1 -0.016 -0.012 
 
Sig. (2-
tailed) 
  0.863 0.893 
 
N 
  
132 
 
 
A correlation was then done between DNA methylation at the individual CpGs and EPDS 
determine if there is an association between methylation and depression. This also revealed 
no correlations between CpG methylation and EPDS scores (Figure 5.16). 
 
Table 5.16.  Correlation of NR3C1 methylation at individual CpGs in mothers who suffered from postnatal anxiety and 
depression  
 
  
Mum 
CpG1 
Mum 
CpG2 Mum CpG3 Mum CpG4 
Postnatal 
depression 
postnatal 
anxiety  
Mum 
CpG1 
Pearson 
Correlation 
1 -0.002 -0.039 -.187* -0.069 -0.120 
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Sig. (2-
tailed) 
  0.981 0.641 0.026 0.434 0.182 
 
N 143 143 143 143 132 125 
 
Mum 
CpG2 
Pearson 
Correlation 
-0.002 1 0.075 0.094 -0.020 0.036 
 
Sig. (2-
tailed) 
0.981   0.372 0.265 0.822 0.687 
 
N 143 143 143 143 132 125 
 
Mum 
CpG3 
Pearson 
Correlation 
-0.039 0.075 1 .234** 0.002 0.094 
 
Sig. (2-
tailed) 
0.641 0.372   0.005 0.985 0.295 
 
N 143 143 143 143 132 125 
 
Mum 
CpG4 
Pearson 
Correlation 
-.187* 0.094 .234** 1 0.128 0.172 
 
Sig. (2-
tailed) 
0.026 0.265 0.005   0.145 0.055 
 
N 143 143 143 143 132 125 
 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
 
5.4.2.3 Maternal stress and NR3C1 methylation: A correlation was performed between 
DNA methylation across the CpGs for average methylation and life events in pregnancy to 
determine if there is an association between methylation and depression. This revealed no 
significant correlation (Figure 5.17). 
 
Table 5.17.  Correlation of NR3C1 methylation in mothers who suffered from life events during pregnancy 
  
Mum 
CpG1 
Mum 
CpG2 
Mum 
CpG3 
Mum 
CpG4 
Mum 
CpG12 
life events in 
pregnancy 
Mum 
CpG1 
Pearson 
Correlation 
1 -0.002 -0.039 -.187* .574** -0.112 
Sig. (2-
tailed) 
  0.981 0.641 0.026 0.000 0.185 
N 143 143 143 143 143 143 
Mum 
CpG2 
Pearson 
Correlation 
-0.002 1 0.075 0.094 .791** -0.098 
Sig. (2-
tailed) 
0.981   0.372 0.265 0.000 0.245 
N 143 143 143 143 143 143 
Mum 
CpG3 
Pearson 
Correlation 
-0.039 0.075 1 .234** 0.041 -0.093 
Sig. (2-
tailed) 
0.641 0.372   0.005 0.631 0.271 
N 143 143 143 143 143 143 
Mum 
CpG4 
Pearson 
Correlation 
-.187* 0.094 .234** 1 -0.021 -0.005 
Sig. (2-
tailed) 
0.026 0.265 0.005   0.803 0.952 
N 143 143 143 143 143 143 
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Mum 
CpG12 
Pearson 
Correlation 
.574** .791** 0.041 -0.021 1 -0.136 
Sig. (2-
tailed) 
0.000 0.000 0.631 0.803   0.106 
N 143 143 143 143 143 143 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
5.4.2.4 Methylation of NR3C1 in infants exposed to prenatal depression and anxiety 
A correlation was performed between DNA methylation across the CpGs for average 
methylation and EPDS to determine if there is an association between methylation and 
depression. This revealed no significant correlation (Table 5.18). 
 
Table 5.18.  Correlation of NR3C1 methylation at individual CpGs in infants exposed to life events in pregnancy 
  
GR CpG 
1/2 
Prenatal 
anxiety 
Prenatal 
depression 
GR CpG 
1/2 
Pearson 
Correlation 
1 0.113 0.054 
Sig. (2-
tailed) 
  0.081 0.409 
N 
 
238 238 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
A correlation was performed between infant DNA methylation across the CpGs for average 
methylation and prenatal anxiety and depression. This revealed no significant correlation in 
any of the CpGs with prenatal anxiety and depression (Figure 5.19). 
 
Table 5.19. Correlation of NR3C1 methylation at individual CpGs in infants exposed to prenatal anxiety and 
depression  
  GR CpG 1 GR CpG 2 GR CpG 3 GR CpG 4 
Prenatal 
depression 
Prenatal 
anxiety 
GR CpG 1 Pearson 
Correlation 
1 0.100 0.051 -0.049 0.034 0.085 
Sig. (2-
tailed) 
  0.119 0.429 0.444 0.600 0.193 
N 
 
244 244 244 239 239 
GR CpG 2 Pearson 
Correlation 
 
1 .213** 0.017 0.036 0.099 
Sig. (2-
tailed) 
 
  0.001 0.788 0.582 0.127 
N 
   
244 239 239 
GR CpG 3 Pearson 
Correlation 
   
.436** 0.038 0.031 
Sig. (2-
tailed) 
  
  0.000 0.559 0.633 
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N 
    
239 239 
GR CpG 4 Pearson 
Correlation 
    
-0.022 -0.064 
Sig. (2-
tailed) 
   
  0.732 0.328 
N 
    
239 239 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
5.4.2.4 Methylation of NR3C1 in infants exposed to postnatal depression and anxiety 
A correlation was performed between DNA methylation across the CpGs for average 
methylation and EDS to determine if there is an association between methylation and 
depression. This revealed no significant correlation (Table 5.20). 
 
Table 5.20. Correlation of NR3C1 methylation at individual CpGs in infants exposed to postnatal anxiety and 
depression  
  GR CpG 1 GR CpG 2 GR CpG 3 GR CpG 4 
Postnatal 
depression 
Postnatal 
anxiety  
GR CpG 
1 
Pearson 
Correlation 
1 0.100 0.051 -0.049 0.060 0.124 
 
Sig. (2-
tailed) 
  0.119 0.429 0.444 0.404 0.088 
 
N 
 
244 244 244 197 189 
 
GR CpG 
2 
Pearson 
Correlation 
 
1 .213** 0.017 -0.068 -0.018 
 
Sig. (2-
tailed) 
 
  0.001 0.788 0.340 0.805 
 
N 
  
244 244 197 189 
 
GR CpG 
3 
Pearson 
Correlation 
  
1 .436** -0.013 0.055 
 
Sig. (2-
tailed) 
  
  0.000 0.857 0.449 
 
N 
   
244 197 189 
 
GR CpG 
4 
Pearson 
Correlation 
   
1 0.000 0.044 
 
Sig. (2-
tailed) 
   
  0.995 0.550 
 
N 
    
197 189 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
 
5.4.2.4 Methylation of NR3C1 in infants exposed to life events during pregnancy 
A correlation was performed between DNA methylation across the CpGs for average 
methylation and life events during pregnancy. This revealed no significant correlations 
(Table 5.21). 
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Table 5.21.  Correlation of NR3C1 methylation at individual CpGs in infants exposed to life events in pregnancy 
 
  CpG1 CpG2 CpG3 CpG4 CpG12 
life events 
in 
pregnancy 
CpG1 Pearson 
Correlation 
1 -0.002 -0.039 -.187* .574** -0.112 
Sig. (2-
tailed) 
  0.981 0.641 0.026 0.000 0.185 
N 
 
143 143 143 143 143 
CpG2 Pearson 
Correlation 
 
1 0.075 0.094 .791** -0.098 
Sig. (2-
tailed) 
 
  0.372 0.265 0.000 0.245 
N 
  
143 143 143 143 
CpG3 Pearson 
Correlation 
  
1 .234** 0.041 -0.093 
Sig. (2-
tailed) 
  
  0.005 0.631 0.271 
N 
   
143 143 143 
CpG4 Pearson 
Correlation 
   
1 -0.021 -0.005 
Sig. (2-
tailed) 
   
  0.803 0.952 
N 
    
143 143 
CpG12 Pearson 
Correlation 
    
1 -0.136 
Sig. (2-
tailed) 
    
  0.106 
N 
     
143 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
5.4.2.6 Correlation between mother and infant levels of methylation: Correlations were 
performed between DNA methylation across the CpGs in NR3C1 between mothers and their 
offspring to determine to what degree methylation levels might be inherited. This revealed 
that the average level of methylation did not correlate (Figure 5.22), but the level of 
methylation at CpG3 in the mother significantly negatively correlated with DNA methylation 
at CpG2 in their offspring (Table 5.23).  
 
Table 5.22.  Correlation of average NR3C1 methylation in mothers and their infants 
  
GR 
CpG 
1/2 Mun_GRCpG12  
GR CpG 1/2 Pearson 
Correlation 
1 0.099 
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Sig. (2-
tailed) 
  0.283 
 
N 243 120 
 
 
 
Table 5.23.  Correlation of NR3C1 methylation at individual CpGs in mothers and their infants 
  
GR 
CpG 1 
GR 
CpG 2 
GR 
CpG 3 
GR 
CpG 4 
Mum_GRCpG1 Pearson 
Correlation 
-0.032 0.021 0.004 0.064 
Sig. (2-
tailed) 
0.728 0.823 0.967 0.486 
N 120 120 120 120 
Mum_GRCpG2 Pearson 
Correlation 
0.172 -0.034 -0.066 -0.068 
Sig. (2-
tailed) 
0.061 0.712 0.474 0.460 
N 120 120 120 120 
Mum_GRCpG3 Pearson 
Correlation 
-0.004 -.219* -0.108 -0.099 
Sig. (2-
tailed) 
0.964 0.016 0.242 0.282 
N 120 120 120 120 
Mum_GRCpG4 Pearson 
Correlation 
0.057 -0.149 -0.022 -0.008 
Sig. (2-
tailed) 
0.535 0.105 0.812 0.933 
N 120 120 120 120 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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5.5 Discussion 
 
This study tested the hypothesis that one of the mechanisms by which stress is able to 
increase risk for depression is by programming changes in the neuroendocrine regulation 
of stress control through the epigenetic programming of stress regulatory genes.   
The results from Study 1 supported that offspring exposed to reduced postnatal care and 
increased maternal stress show increased methylation at the Nr3c1 gene and BDNF gene 
promoters. That these offspring then show reduced maternal care and increased 
maternal anxiety suggests that methylation at these genes could be important. This 
reduced methylation is no longer present in the F2 generation exposed to both prenatal 
and postnatal stress. 
It was therefore tested whether similar epigenetic changes might occur in humans. 
Specifically, if prenatal or postnatal maternal depression associated with changes in 
NR3C1, FKBP5 or BDNF methylation. Also, whether stress at prenatal or postnatal stages 
impacted methylation. Finally, it was tested whether infants exposed to postnatal stress, 
or prenatal stress, show changes in NR3C1 methylation. 
We firstly tested for associations between DNA methylation at the stress related genes 
and perceived discrimination during the prenatal and postnatal periods in Latina women 
in the US, then with depression. Two hypotheses are that this may serve as a risk for the 
effects of discrimination on mother and child; or this may relate to the impact of 
discrimination on the development of psychiatric disorders including maternal 
depression, major depression and anxiety. Indeed there is a very high rate of stress-
related illness in the Latina ethnic group in the US (Romero et al., 2007; Anderson and 
Mayes, 2010; Santos et al., 2018). Pearson correlations were used to test associations. 
The NR3C1 exon 1F methylation it was firstly found that all individual CpGs correlated 
with each other, i.e. higher methylation at any one of the 4 CpGs associated with higher 
methylation at the three other sites. Examining perceived discrimination there was a 
statistically significantly negative association with average NR3C1 methylation and EDS, 
i.e. increased methylation with reduced total EDS. Testing the CpGs individually it was 
seen that increased CpG1 methylation correlated with reduced total EDS, prenatal EDS 
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and postnatal EDS. There were no associations with NR3C1 methylation and IDAS either 
total, prenatal or postnatal. 
Epigenetic regulation at NR3C1 exon 1F is key in several processes of the stress-response 
regulation  and  differences in methylation in relation to social environment and stress 
have been reported in numerous studies (Table 1.5). In studies focused on psychological 
distress, human studies have reported some varied results in terms of NR3C1 exon 17 
methylation with one showing increased methylation (Dammann et al., 2011) and two 
finding decreased methylation (Alt et al., 2010; Yehuda et al., 2015), while three reported 
no change (Alt et al., 2010; Steiger et al., 2013; Yehuda et al., 2015). In studies of early life 
adversity, one found that children exposed to maltreatment, showed decreased 
methylation at one (corresponding to the CpG1 in this study) and increased methylation 
at neighbouring CpGs (Romens et al., 2015), while a study on maternal and paternal 
experience of the Holocaust showed gender differences with decreased and increased 
methylation, respectively (Daskalakis and Yehuda, 2014) (Figure 5.12). The NR3C1 
methylation association with EDS could represent a risk factor and possibly highlight 
stress related factors as biomarkers for mothers at risk of the adverse effects of 
discrimination on themselves, and possibly, on their offspring, which would need to be 
tested. 
 
 
Figure 5.12. Schematic of the NR3C1 promoter with human studies of methylation at exon 1-7.Individual studies are 
shown demonstrating increases or decreases in methylation in relation to stress exposure and depression. 
167 
 
 
Another important modulator of glucocorticoid signaling in response to stress is FKBP5. 
In this study using Pearson correlations we found no associations with methylation at this 
gene in either prenatal or postnatal EDS or IDAS. However, analyzing the methylation data 
using ZIP regression (see below in limitations) did reveal negative correlations. Numerous 
studies of FKBP5 methylation have demonstrated positive links with stress, particularly 
PTSD, though the Tyrka et al. study on childhood maltreatment showed decreases in 
methylation (Tyrka et al., 2015) (Figure 5.13). Importantly, no study has investigated 
prenatal and postnatal depression. 
 
 
Figure 5.13. Schematic of the FKBP5 intron 7 promoter showing human studies. Individual studies are shown 
demonstrating increases or decreases in methylation in relation to stress exposure and depression. 
 
BDNF methylation was positively associated with postnatal EDS at one CpG site out of the 
7 measured. This positive association might suggest that depression in these mothers 
could have resulted in a decrease in BDNF expression. As BDNF is important in 
neurogenesis, this reduction could affect neural development in areas important for the 
perception and processing of social stimuli, resulting in the higher EDS scores.  Reduced 
levels of BDNF in the serum have been found in a study of postnatal depression comparing 
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36 mothers with depression and 36 mothers without (Gazal et al., 2012) and numerous 
studies similarly report increases in BDNF methylation in depression (Figure 5.14). 
 
 
Figure 5.14. Schematic of the BDNF exon 4 promoter showing results of human studies. Individual studies are shown 
demonstrating increases or decreases in methylation in relation to stress exposure and depression. 
 
In the WCHAS study NR3C1 methylation in mothers with levels of prenatal and postnatal 
depression were measured. Average methylation did not associate with prenatal or 
postnatal anxiety though there was a non-significant trend (p=0.055) of increased 
methylation at one of the CpGs positively correlating with increased postnatal anxiety. 
There was another non-significant (p=0.066) negative correlation with prenatal 
depression, but no association with postnatal depression. The trend for a negative 
association of NR3C1 methylation with prenatal depression would seem to support the 
negative association also seen in the Latina cohort. 
In DNA methylation from the WCHAS infants there were no associations between NR3C1 
methylation and any of the maternal measures of prenatal anxiety or depression, 
postnatal anxiety or depression or life events. Interestingly, when correlating DNA 
methylation between mothers and infants, though there were no associations between 
average methylation, it was found that increased CpG3 methylation in mothers 
significantly associated with decreased CpG2 methylation in the infants, while increased 
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mother CpG2 methylation showed a non-significant trend (p=0.061) for increased CpG1 
methylation in the infants. 
Some limitations need to be taken into consideration while interpreting the results of this 
Study 3. Regarding statistical analyses, for the Latino study, Pearson correlations were 
used. However, this did not take into account the number of zero counts in the EDS and 
IDAS scores or did it adjust for covariates. The methylation data above has been tested 
using a ZIP regression, which is a zero-inflated Poisson models, adjusting for covariates 
and multiple-test comparisons to further model count data that has an excess of zero 
counts. This again showed discrimination negatively associated with methylation at CpG 
sites within the glucocorticoid receptor (NR3C1) but in addition found significant negative 
associations with CpGs in BDNF and FKBP5 (Argentieri et al., 2017; Santos et al., 2018; 
Alyamani and Murgatroyd, 2018). For this study within this thesis, however I was unable 
to master these statistical tests to be able to confidently repeat on my own. 
This study importantly focused only on defined regions of the stress-related genes 
(identified from the Literature Review) at a few key CpGs to avoid possible impact of 
multiple analyses. However, there may be other neighbouring CpG sites or regions that 
might be important to investigate. Importantly, in contrast to the rat analyses in Study 1 
and Study 2 on hippocampus the methylation analysed here was from peripheral cell 
samples of blood and saliva. These tissues are heterogeneous, which may account for 
some of the variability in methylation. Although there are some studies suggesting 
methylation levels in blood and post mortem brain are often substantially correlated  
(Walton et al., 2015; Nemoda et al., 2015; Smith et al., 2015), it cannot be certain to what 
degree DNA methylation in peripheral tissues reflects methylation in brain regions. 
However, the findings of Study 1 and Study 2 in highlighting the involvement of immune 
systems might support some link.  
Overall, this Study 3 supports that there are some epigenetic changes in nr3c1 
methylation that correlate with maternal stress that follow some of the findings from the 
rat methylation results in Study 1, suggesting that this could be a marker for maternal 
stress and depression. 
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6 Study 5: Explore components in milk that are altered by exposure to depression in 
rats. 
 
6.1 Introduction 
Key factors and nutrients in breast milk (Table 1.6) are important in infant 
neurodevelopment and regulation of child behavioural development (Martin et al., 
2016a). However, stress and depression have been shown to reduce the levels of milk 
production, possibly through impacting hormones such as oxytocin (Dewey, 2001); 
(Hatton et al., 2005). A study by (Kordus, 2014) Mansbacher et al. (2012) on 10,000 
children and their mothers showed an indirect correlation between breastfeeding and 
behavioural disorders which were less likely to occur the longer the duration of 
breastfeeding. This is supported by other longitudinal studies such as (Oddy and 
McMahon, 2011) who showed that those children who had been breastfed for over half 
a year were less aggressive than those who were not breastfed. Though it seems that milk 
components have an effect on infant behaviour and that stress can influence milk 
components, it is not clear what lactational mechanisms, if any, could link maternal stress 
to infant behaviour. 
There is hypothesis, termed lactroctine programming, that hormones from the mother, 
ingested through milk, are able bind to receptors within the young triggering hormonal 
signaling cascades in the offspring (Figure 1.7). One candidate is cortisol or 
corticosterone. Numerous studies in rats and mice have shown that increasing 
corticosterone consumption to pups through mother’s milk or artificially is able to 
regulate sensitivity of the HPA axis, improve spatial memory and reduce anxiety (Casolini 
et al., 1997; Catalani et al., 2000). Startlingly, opposite results have been found in human 
studies, by which infants ingesting higher levels of cortisol consequently showed greater 
anxiety and stress related behaviours (Grey et al., 2013). 
A number of key hormones know to regulate behaviour are found in breast milk. The 
question is whether these are regulated in milk through maternal stress. For example, 
171 
 
oxytocin and prolactin levels in milk might change in response to depression that may 
influence milk production or impact behaviour of the offspring. 
Immune factors are found in abundance in breast milk where they are important for the 
development of the infant immune system (Garofalo, 2010) as well as neurodevelopment 
(Koo et al., 2014). Importantly, maternal health influences the levels of inflammatory 
factors in the milk. Whitaker et al, on a study of 134 mothers found that high pre-
pregnancy BMI and excessive gestational weight gain correlated with increased levels of 
the pro-inflammatory marker CRP in their breast milk (Whitaker et al., 2017). One study 
on immune factor levels in the milk of 481 mothers was able to demonstrate that 
differences in the individual immune composition of the mother’s milk influenced early 
life infant health outcomes, namely eczema and food allergy risk (Munblit et al., 2017). 
One possible mechanism is the existence of gut receptors for numerous milk hormones 
and cytokines that support the notion that proteins in breast milk remain bioactive and 
influence the offspring. However, there is still very little understood as to the 
consequences of infants receiving varying concentrations of breast milk inflammatory 
markers or hormones. However, the presence of such a mechanism of transfer from the 
mother to infant could be important in the intergenerational transmission of stress. 
In this study we measured cortisol, endocrine factors and immune markers in the milk 
from the CSS rats and rats exposed to acute stress to understand the role of maternal 
depression and milk components.  
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6.2 Aims  
The overall aim of this study is to examine stress-related endocrine and immune factors 
in milk following stress and its possible role in the inheritance of stress and depression. 
We further aimed to develop a method for measuring these factors in rat milk, many of 
which have not been examined before in milk. 
 
6.3 Objectives  
1. Test whether maternal stress and depression influence milk production. 
2. Explore whether endocrine factors are altered in milk following maternal depression 
and stress. 
3. Investigate whether immune factors are altered in milk following maternal depression 
and stress.  
4. Test the relationships between maternal serum levels of immune and endocrine factors 
relate to milk levels. 
5. Test the relationships between milk levels of endocrine and immune factors relate to 
serum levels of those factors in offspring. 
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6.4 Methods 
6.4.1 Milk samples 
 
Animal model: Rats from the trans-generation inheritance of CSS study were used to 
collect milk studies. Collected by Dr Ben Nephew, this was done by allowing the pups to 
suckle from the mother and then killing the pups and emptying the stomachs for the milk 
 
6.4.2 Analysis of milk factors using ELISA 
The samples were centrifuged at 1500×g for 10 min at 10 °C (Beckman coulter Avanti J-
26 XP centrifuge, rotor JA-25.15) to separate the solid part of the milk from the clearer 
supernatant (milk serum). The milk serum was then tested using ELISA. 
 
Figure 6.1. Rat milk samples showing solid and small amount of milk plasma 
 
 
6.4.3 ELISA  
6.4.3.1(Single-plex) 
Oxytocin, corticosterone, I-CAM, bdnf, and GR were quantified individually from milk 
serum using single-plex ELISA. The same procedure, was carried out for each of these 
substances. A 96 –well microplate was used. 100 μl of provided standards and 50 μl of 
polyclonal antibody to the desired substance (i.e. oxytocin, or corticosterone etc) were 
added to 100 μl of each sample. The plate was mixed gently, covered, and incubated in a 
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dark fridge at 4°C for 24 hours. Following this, the well contents were removed and wells 
washed three times using the supplied wash solution. 200 μl of pNpp substrate (p-
nitrophenyl phosphate) was added to each well to allow colour development. After 
incubation for 1 hour at room temperature, 50 μl of stop solution was added to stop the 
reaction and development of colour. To complete, the optical density of each well was 
read at 405nm wavelength using the Synergy HT micropate reader (Biotex).  Standard 
curves were then made (Figure 6.2) using GraphPad and values for the samples calculated 
 
Figure 6.2.  Standard curves for Oxytocin and Corticosterone for measuring milk levels 
 
6.4.3.2 ELISA (multiplex) 
A MILLIPLEX® MAP Rat Cytokine/ Chemokine Magnetic Bead Panel was used to quantify 
the following factors were from milk serum: IL-1β, IL-4, IL-6, IL-10, TNFα, IFNϒ. Icam-1, 
and from TIMP-1, were also measured from another Muliplex plate (See Table 2.1). The 
method involved, washed a 96-well filter plate was with 200 μl of supplied wash buffer, 
removed by vacuum filtration. 225 μl of assay buffer, 25 μl of provided standards, 25 μl 
of sample (1:2, 1:5, 1:8) diluted and 25 μl of fluorescent coded magnetic beads were 
added to each sample well. The plate was then incubated for 16-18 hours on plate shaker 
a t2-8°C , and then the contents removed and wells washed twice with 200 μl wash buffer 
(Automatic plate washer for magnetic beads  Bio Tek system). 25 μl of biotinylated 
detection antibodies were then added to each well. The plate was then sealed and 
covered with foil, and incubated on a plate shaker for 1 hour at room temperature. 25 μl 
of Streptavidin-phycoerythrin was then added to each well before covering with foil and 
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incubating on a plate shaker for 30 minutes at room temperature. The well contents were 
removed again, and wells washed 2 times with 200 μl wash buffer (Automatic plate 
washer for magnetic beads Bio Tek system). Lastly, 125 μl of sheath fluid (xMAP® ) was 
added to each well, and the plate read on luminex (100 μl, 50 beads per bead set). See 
(Figure 6.3) for a schematic overview of the experimental method. 
 
 
Figure 6.3.  Schematic for the milk ELISA method outline 
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6.5 Results 
6.5.1 Milk corticosterone levels and stress: 
Levels of corticosterone were measured in the milk taken at day 16 from F2 pups, i.e. milk 
produced from the F1 dams. This revealed significantly lower corticosterone in the CSS 
group (2-tail t-test p = 0.05) (Figure 6.4). 
 
 
Figure 6.4. Corticosterone levels in milk from F1 Dams. Mean + SEM of milk corticosterone levels in F2 pups as a 
measure of F1 milk corticosterone in control (n=8) and CSS (n=7). * 2-tailed t-test p= 0.05. 
 
As there was a difference in CSS corticosterone in milk (Figure 6.4) and a trend in 
serum we therefore tested if there was a correlation between milk levels of 
corticosterone and serum levels in the mother if the raised corticosterone levels in 
the serum of the F1 mothers are transferred to the milk. A Pearson correlation 
revealed a significant negative correlation between serum corticosterone levels of F1 
Dams and levels of corticosterone in the milk (P=0.048) (Table 6.1). 
We then tested if levels of corticosterone in the milk a pup drinks are associated with 
serum levels of corticosterone in the pups. A Pearson correlation revealed no 
significant association between milk corticosterone levels and serum corticosterone 
levels in the F2 rats receiving the milk (Table 6.1). 
0
2
4
6
8
10
12
14
16
18
20
M
il
k
 C
o
rt
ic
o
st
e
ro
n
e
 (
n
g
/
m
l)
F1 Control
F1 CSS
177 
 
Table 6.1. Pearson correlations of corticosterone in F1 milk, F1 serum and F2 serum 
 
 
 
We tested the effects of acute stress on levels of corticosterone in milk. This was done in 
F0 dams exposed to CSS and acute restraint stress. This revealed that while CSS and 
control dams did not differ (2-tailed t-test, p= 0.48) and corticosterone levels did not differ 
in control dams following stress (2-tailed t-test, p= 0.54) there was a significant decrease 
in corticosterone in the CSS rats following an acute stressor (2-tailed t-test, p= 0.046) 
(Figure 6.5). 
 
 
 
 
Figure 6.5. Corticosterone levels in milk from CSS F0 Dams exposed to acute stress. Mean + SEM of milk levels of 
corticosterone in F1 adults of F0 Dams exposed to CSS and acute stress. n=9, 8, 7 and 8 respectively.* 2-tailed t-test p= 
0.0.5 
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6.5.2 Milk neuroendocrine levels in CSS and following acute stress 
 
We tested the effects of acute stress on levels of oxytocin in milk. This was done in F0 
dams exposed to CSS and acute restraint stress. Importantly, over half the samples gave 
values below the last point on the standard curve so could not be included. With limited 
sample numbers tough this revealed that while CSS and control dams did not differ (2-
tailed t-test, p= 0.44) and oxytocin levels did not differ in control dams following stress 
(2-tailed t-test, p= 0.32) there was a trend towards a decrease in oxytocin in the CSS rats 
following an acute stressor (2-tailed t-test, p= 0.08) (Figure 6.6). 
 
 
Figure 6.6. Corticosterone levels in milk from CSS F0 Dams exposed to acute stress. Mean + SEM of milk levels of 
oxytocin in F1 adults of F0 Dams exposed to CSS and acute stress. n=6, 4, 5 and 2, respectively. 
 
6.5.3 Milk bdnf levels: 
Levels of bdnf were measured in the milk taken at day 16 from F2 pups however; this 
failed to produce results above background for any samples. 
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6.5.4 Milk immune levels: 
Levels of cytokines IL-4, IL-1B, IL-6, IL-10, IFN-gamma and TNF-alpha were measured in 
the milk taken at day 16 from F2 pups. From 50 samples, IL-4 games only 3 samples above 
background, IL-1B had 2, IL-6 gave 13, IL-10 gave 2 values, IFN-gamma produced 6 
readings and TNF-alpha gave measurable readings for 9 samples, neither enough to allow 
statistical analyses. 
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6.6 Discussion 
 
This study investigated levels of endocrine and immune factors in milk for the F1 CSS and 
control dams. This revealed that the F1 CSS dams (i.e. the F2 mothers) had lower 
corticosterone levels in the milk. Interestingly, this negatively correlated with 
corticosterone levels in their serum and between groups. A number of studies have 
shown that stressors can lead to alterations in milk cortisol/corticosterone levels (see 
1.5.7.5). However, this is the first study to show trans-generational effects of stress, i.e. 
an indirect stressor and maternal depression, leads to changes in milk corticosterone. 
Interestingly, corticosterone levels in the F0 dams did not differ following the CSS 
suggesting that reduced maternal care as infants is important in programming such 
changes, no chronic stress in itself. 
Several studies in rats have shown that ingestion of glucocorticoids via mother’s milk has 
is able to program effects of stress in offspring that persist into adulthood. For example, 
there are studies by which rat dams that consumed glucocorticoids in their water, 
increased glucocorticoids in their blood and their milk. As juveniles, individuals who 
ingested elevated glucocorticoids through their mother’s milk showed better memory 
and coping behaviour during stressors, together with decreased anxiety and altered HPA 
axis response to stress (Casolini et al., 1997; Catalani et al., 2000; Meerlo et al., 2001). 
This association of increased milk corticosterone and reduced stress in the offspring is not 
found in humans, with two studies showing the opposite effects. A study of 257 
Breastfeeding mothers with higher plasma cortisol concentrations, used as a proxy for 
milk cortisol concentrations, rated their infants as significantly more fearful than did 
breastfeeding mothers with lower plasma cortisol concentrations (Glynn et al., 2007). 
Analysis of cortisol concentrations in milk among 52 breastfeeding mothers revealed that 
higher concentrations of cortisol in breastmilk associated with increased fear, sadness, 
anger and frustration in infants (Grey et al., 2013). 
Interestingly we found a significant negative correlation between serum corticosterone 
levels of F1 Dams and levels of corticosterone in the milk suggesting that mothers with 
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reduced levels of the stress steroid produce release higher levels in the milk. Perhaps this 
supports the rodent studies linking higher milk corticosterone levels with reduced stress 
in their offspring. We did not find association between milk corticosterone levels and 
offspring serum corticosterone levels. Though this was only basal levels, perhaps levels in 
response to stress or as adults might then differ and would be important to measure. 
Investigating oxytocin we found levels in milk of around 5-20 ng/ml, similar to levels of 
around 18.9 ng/mL reported in human studies (Mishra et al., 2014). Interestingly, this was 
reduced in the F0 CSS dams exposed to acute stress. Though the numbers of animals in 
each group were relatively small, it is interesting that oxytocin in milk is reduced following 
stress. Though no other study appears to have tested for this studies in monkeys suggest 
that oxytocin delivered to the new-born in the perinatal period can have significant and 
positive impacts on the brain and behaviour (Simpson et al., 2014). 
Testing ELISAs for bdnf, prolactin, interleukins and growth factors failed to produce 
results about background, or enough results above background to allow for analyses 6.4.4  
To further detect, possibly novel, proteins, it was planned for the samples to be analysed 
using proteomics. This would have been in collaboration with the WPH Proteomics Facility 
RTP at the University of Warwick following similar published protocol (Hettinga et al., 
2015) with peptide and protein identification performed by analysing all MSMS spectra 
with MaxQuant v.1.2.2.5. However, due to the ELISA results, which showed we still 
needed to standardise the protein measure protocol, this was not performed. 
It was also planned that mothers from the Latino Maternal Depression study (in 
collaboration with Santos Hudson, University of South Carolina) would supply milk 
samples that would be shipped on ice to the MMU. However, this was unable to be 
organised in time. 
The major limitations of this Study 4 is that the milk ELISA protocol still needs to be 
standardised. The milk samples seemed to vary just by looking at them, with some slightly 
different shades of creamy-white and with different levels of solids that gave different 
amounts of milk plasma following centrifugation. One possibility is to test different 
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methods of homogenisation before centrifugation, though it is unclear to what extent this 
might interfere with readings if releasing more insoluble proteins. 
In sum, this Study 4 shows that levels of stress and maternal-behaviour related hormones 
are affected by stress in the CSS model providing support for another mechanism for the 
intergenerational inheritance of depressed maternal care and anxiety. 
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7 Final Discussion 
 
Stress during early life such as exposure to prenatal and to postnatal depression and 
receiving reduced levels of parental care can produce long-lasting behavioural effects on 
the offspring. Such long-term disruptions in stress-related behaviours have been seen in 
both human and rodent studies in offspring exposed to a variety early-life stressors such 
as maternal depression (Murgatroyd et al., 2015a). Importantly, offspring exposed to 
early life stress have increased susceptibility to maternal depression themselves 
(Murgatroyd and Nephew, 2013). This suggests a mechanism by which stress could be 
trans-generationally inherited through maternal stress. However it is unclear what the 
molecular mechanisms could be that might drive this transmission of maternal stress 
between generations. 
The overall aim for this thesis was, using animal models and human studies, to address 
and test hypotheses for molecular mechanisms underlying the intergenerational 
transmission of maternal care behaviour, stress and depression.  
A literature review was firstly performed in which to explore evidence for possible 
mechanisms and identify key factors. The revealed several hypothetical mechanisms by 
maternal depression might be able to increase the risk of developing stress-related 
behavioural disorders in the offspring. Firstly, changes in endocrine factors important in 
regulation of the HPA axis, depression and maternal behaviour could be altered in the 
mother that effect prenatal environment of the offspring in utero or postnatal levels of 
maternal care or milk it receives. Growth factors and hormones important in metabolism 
are key to neurodevelopment, changes in which could lead to subsequent changes in 
behaviour and stress regulation. Immune factors are also crucially linked to stress and 
changes in inflammatory factors in the mother can impact prenatal development or 
postnatal environment through changing maternal behaviour or being passed through 
milk.  Epigenetic mechanisms are important for regulating long-term changes in gene 
expression. Numerous studies have identified epigenetic changes at regulatory regions of 
genes important for stress regulation either through exposure to stress postnatally, 
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prenatally, in adolescence of adulthood. Most studies have focused on a few key genes, 
namely NR3C1, FKBP5 and BDNF. The literature review also highlighted that these genes 
were similarly regulated in both rodent models and human studies supporting conserved 
mechanisms. Related to the epigenetic findings, it was also clear that gene expression is 
regulated following early life stress and though key genes for stress have been 
investigated it appears that numerous other pathways might be involved. Finally, 
maternal depression and stress might alter maternal milk composition that the offspring 
then receives and reacts to. Studies were found that showed key factors important in HPA 
regulation were found in milk and altered by maternal stress and that changes in these 
factors in milk can induce behaviour changes in offspring. 
Together, the review found strong evidence of key mechanisms that importantly were 
supported by bother human and rodent findings. It is also clear that these mechanisms 
also overlap if epigenetic changes link to gene transcription changes that regulate 
immune or endocrine components that in turn control impact prenatal or postnatal 
environments important for development (Alyamani and Murgatroyd, 2018).  
In Study 1 an animal model was tested for the generation inheritance of endocrine, 
immune, epigenetic and gene regulatory changes in three generations of rats in which the 
mother of the first generation was exposed to stress. This revealed that stress factors 
important in the HPA axis were increasingly dysregulated. The F0 dams show no changes 
in corticosterone, the F1 dams show an increase and here we find a decrease. This 
supports hypotheses that chronic stress exposure over prenatal and postnatal periods can 
dampen the HPA axis. Hormones involved in maternal behaviour and depression were 
not affected and neither were factors important in growth and metabolism. Testing a 
collection of immune factors revealed the presence of one factor, I-CAM1 that became 
increasingly reduced in the F2 animals in pups and dams. This factor is important in 
immune regulation and blood brain barrier development suggesting an increasing role of 
inflammation regulation with the inheritance of the depressed maternal care. Epigenetic 
changes at Nr3c1 and bdnf were found in the F1 dams but not the F2s that followed gene 
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expression changes. This suggests that with the inheritance of maternal stress there are 
shifts in the epigenetic regulation of specific genes. 
In sum, Study 1 demonstrates generational changes in a key stress steroid involved in the 
HPA axis and a factor important in immune function supporting mechanisms for these in 
regulating the transmission of maternal stress (Nephew et al., 2017).  
In Study 2, transcriptome analyses found widespread gene expression changes in the 
hippocampus of the F1 dams and fewer differentially regulated genes in the F2s. Gene 
ontology analyses revealed the most genes coded for receptors and calcium binding 
proteins that are known to be important in stress regulation and have been highly linked 
dot depression in both rodent and human studies. Interestingly, in the F2 dams, two-
thirds of genes differentially expressed were also altered in the F1s, supporting a high 
degree of inheritance of gene expression changes following stress. This has never been 
investigated before and suggests key pathways important in the transmission of stress 
(Alyamani et al. in preparation for publication).  
This thesis then investigated whether mechanisms found in rodents translated to human 
studies. In Study 3, two human studies of mothers tested for levels of prenatal and 
postnatal maternal depression and stress were investigated for epigenetic changes in 
stress genes identified in the literature review. These are the first investigations of 
methylation at stress-related genes in mothers with prenatal and postnatal maternal 
depression. In a Latino study of mothers with prenatal and postnatal measures of 
depression and exposure to stress in the form of perceived discrimination, there were 
changes in DNA methylation at NR3C1 following stress but not with depression. BDNF 
methylation also associated with stress while KFBP5 was not associated with stress or 
depression. Investigation of NR3C1 in a second study in the UK of mothers measured for 
depression and anxiety together with their offspring revealed a non-significant trends, 
negative with prenatal depression and positive with postnatal anxiety supporting again a 
role of NR3C1 epigenetic regulation in mothers with perinatal stress and depression. 
There were no correlations between exposure to prenatal or postnatal depression in 
infants and NR3C1 methylation though there were some significant associations between 
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maternal and infant methylation supporting a level of inheritance of epigenetic marks at 
the NR3C1 gene. 
Together, results from Study 3 demonstrate that there are some epigenetic associations 
with maternal depression at the NR3C1 gene. This supports some of the findings from the 
F1 dams in Study 1 and highlights key conserved me mechanisms in the role of epigenetic 
regulation at this gene in maternal depression (Santos et al., 2018).   
Finally, this thesis explored the hypothesis that key endocrine and immune factors might 
be altered in milk following stress. In Study 4, Measuring factors in milk of dams inheriting 
depressed maternal care and following stress revealed reductions in corticosterone and 
oxytocin. This supports that maternal stress and depression can influence endocrine 
factors in the milk. Some research suggests that infants receiving milk with different levels 
of cortisol or corticosterone can develop altered stress-related behaviours. The results 
from Study 4 suggest that lactocrine programming is another key mechanism important 
in intergenerational inheritance of stress  (Nephew et al., 2017) (Table 7.1). 
 
 
Table 7.1. Overview of stress, endocrine, immune and epigenetic changes across generations together with maternal 
care in the CSS intergenerational stress model 
Mechanisms F0 F1 F2 
Maternal care d2- , d9  , d16- D2  , d9-, d12- D2  ,d9  , d16 
Maternal restless d2- , d9   , d16- d2  , d9-,  d12- d2  , d9 , d16  
Milk intake d2 - ,d9  , d16 d2  , d9-, d12- d2- , d9-,  d12- 
HPA regulation, 
corticosterone, ACTH 
-  CORT 
       ACTH 
 CORT d23 
 ACTH d23 
Maternal-related 
hormone 
-      Oxytocin  
     Prolactin  
- 
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Growth hormones 
and reproductive 
hormones 
- 
- 
  -FSH, -GH 
  -VEGF, -GM-CSF 
- 
Immune factors - 
- 
-Direct reduction Icam-1 
Behaviour-related 
neuropeptides 
- 
- 
-α-MSH, -β-Endorphin, -
Substance P, -Orexin A  
- 
- 
 -Bdnf 
Epigenetics 
regulation 
- 
- 
     Nr3c1 
 Bdnf 
- 
 Bdnf 
Endocrine and 
immune factors in 
milk  
- 
- 
- 
  CORT 
        
 CORT  
- 
- 
 
 
Overall, this thesis, investigating a rodent model and translating some results to human 
studies, together with literature research reveals key evidence and support for the role 
of neuroendocrine and immune changes, epigenetic alterations driving changes in 
regulation of stress-related genes and transcriptome alteration and modifications in 
endocrine factors in breast milk the intergenerational inheritance of stress (Figure 7.1). 
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Figure 7.1. Summary of the Investigating Mechanisms Underlying Intergenerational Inheritance of Depression  
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7.1. Further research 
 
The results of this thesis support the role of endocrine and immune factors, epigenetic, 
gene regulatory and milk hormones in the transmission of stress from mother to offspring 
that in turn develop depressed maternal care themselves. These processes serve as 
mechanisms for intergenerational inheritance of stress. 
Some limitations of this research in Study 1 are that some group numbers, particularly for 
some of the F1 measures could have been larger. Many of the immune factors measured 
by multiplex ELISA were too low for the standard curve and so were unable to be 
quantified. Therefore single-plex could have been used for more of these. However, even 
that cannot be guaranteed as TNF-alpha for example still did not give results when also 
used in single-plex. Epigenetic regulation of Nr3c1 and bdnf were only measured in Dam 
hippocampus, but would be interesting to measure in pups and adults. Also in testing in 
males would allow to see if the changes were sex-specific. Testing in other tissues such as 
other hypothalamus, important for the HPA axis would be interesting and also blood cells 
like in the human analyses of Study 3. 
Another aspect of the CSS model is that only F2 maternal care was measured. For trans-
generational analyses (1.1) it would be important to measure if any changes from the CSS 
were inherited to the F3 generation and perhaps even the F4. From the Study 1 
conclusions, it might be expected that the reductions in maternal care and stress u 
become even stronger. 
In Study 2 the major limitation is the relatively low number of animals. Though many 
studies also include similar numbers, the relative variation see in the ELISA support that 
higher group sizes might increase the power of the findings, either reducing the number 
of gens found in the F1s or perhaps other related genes. He results from Study 1 show 
epigenetic changes are important and it would be interesting to test for this genomewide. 
There are methods such as genomewide bisulphite sequencing, i.e. an extension of the 
gene-specific method used in Study 1, that would allow to see the extent of changes and 
if particular classes of genes are regulated. If this was done on the hippocampus that one 
could see how much epigenetic regulation relates to gene expression. It would also allow 
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to see how much epigenetic marking is inherited through the generations across the 
genome. If the F0 dams were also tested together with F3 then it would enable to see if 
a key set of genes are maintained and if those genes shared between F1 and F2 are 
affected in F0 and passed on to F3. 
The human studies in Study 3 investigated maternal depression in two different cohorts 
and in one of the cohorts DNA from the infants are studied. This was on blood and saliva 
DNA as brain material is obviously impossible to work on in maternal depression. The 
numbers in the groups in the maternal depression is relatively low as some studies have 
investigated over a thousand, however I assume it can be difficult to recruit many mothers 
at similar stages of pregnancy in one area that can be similarly measured. As in Study 2, 
it would be interesting to also look genomewide for expression if the same types of genes 
identified in the rat model might also differ in humans, such as calcium binding proteins 
and receptors. Also extending the epigenetic studies genomewide would, give a large 
picture of any changes as perhaps there are also classes of genes with shared functions 
that might be epigenetically marked. As child DNA is also available from the WCHADS 
performing the studies on mother and infant would allow to test for the level of 
epigenetic inheritance. 
In Study 4 levels of corticosterone and oxytocin were measured. The main limitation of 
this was the relatively small numbers in groups owing to the fact that many samples did 
not give readings higher than background. It would be important to increase the 
sensitivity of this method for measuring milk. Relatively few studies have investigated rat 
milk. It was planned to perform proteomics on the samples using LC-MS-MS, which has 
been done on human and cow milk, but not rat. Rat milk has smaller quantities and also 
more difficult to collect. The results from the ELISA though suggested that the proteomics 
might not be suitable until methods could be developed to allow larger quantities of milk 
plasma that could be better detected for proteins. It was also planned to investigate 
human milk from the Latina study, however proved difficult to organize. Future work 
would therefore be good to test further factors in milk, if the method could be improved, 
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and test whether stress and maternal depression impacts milk corticosterone and 
oxytocin in a similar way to the rats. 
Overall, future work would be interested to scale up from these experiments to look at 
proteomics, transcriptomics and epigeneomics in more generations in animal models and 
in larger human studies. 
 
7.2. Conclusion 
 
The results of this thesis support the role of molecular mechanisms in the transmission of 
stress from mother to offspring that also develop depressed maternal care themselves. 
Serum levels of endocrine factors important in stress regulation and maternal behaviour 
together with an important immune regulatory factors appear to play important roles. 
Epigenetic mechanisms regulate key stress-regulatory genes and transcriptome changes 
in important genes with shared functions are important factors in the brain. Finally, stress 
and maternal-related hormones in the milk are a further potential mechanism involved 
in the transmission of stress through generations. Translating studies to humans, it was 
seen that similar epigenetic changes are also see supporting the importance of animal 
studies in gaining insights to factors underlying the development of stress-related 
disorders in humans.  
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Appendix I 
Mean scores for each question of the Everyday Discriminatien scale questionare (EDS) 
EDS questions Mean score at T1 (SD) Mean score at T2 (SD) 
1. You are treated with less 
courtesy 
0,59 (1,08) 0,42 (0,90) 
2. You are treated with less 
respect 
0,47 (0,96) 0,30 (0,78) 
3. You receive poorer service at 
restaurants or stores 
0,46 (0,93) 0,30 (0,70) 
4. People act as if they think you 
are not smart 
0,47 (0,89) 0,22 (0,63) 
5. People act as if they are afraid 
of you 
0,09 (0,49) 0,06 (0,31) 
6. People act as if they think you 
are dishonest 
0,15 (0,52) 0,09 (0,36) 
7. People act as if they are better 
than you 
0,63 (1,15) 0,29 (0,70) 
8. You are called names or 
insulted 
0,19 (0,62) 0,11 (0,41) 
9. You are threatened or 
harassed 
0,12 (0,95) 0,04 (0,22) 
Mean score per question 0,35 (0,84) 0,20 (0,13) 
Mean of the total score  3,09 (5,08) 1,83 (3,79) 
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